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Abstract 
Inter-molecular interaction is at the heart of biological function. Proteins can interact 
with ligands, peptides, small molecules, and other proteins to serve their structural or 
functional purpose. With advances in combinatorial chemistry and the development 
of high throughput binding assays, the available inter-molecular interaction data is 
increasing exponentially. As the space of testable compounds increases, the 
complexity and cost of finding a suitable inhibitor for a protein interaction increases. 
Computational drug discovery plays an important role in minimizing the time and 
cost needed to study the space of testable compounds. This work focuses on the 
usage of various computational methods in identifying protein interaction inhibitors 
and demonstrates the ability of computational drug discovery to contribute to the 
ever growing field of molecular interaction. 
 
A program to predict the location of binding surfaces on proteins, STP (Mehio et al., 
Bioinformatics, 2010, in press), has been created based on calculating the propensity 
of triplet-patterns of surface protein atoms that occur in binding sites. The use of STP 
in predicting ligand binding sites, allosteric binding sites, enzyme classification 
numbers, and binding details in multi-unit complexes is demonstrated. STP has been 
integrated into the in-house high throughput drug discovery pipeline, allowing the 
identification of inhibitors for proteins whose binding sites are unknown. 
 
Another computational paradigm is introduced, creating a virtual library of β-turn 
peptidomimetics, designed to mimic the interaction of the Baff-Receptor (Baff-R) 
  ii 
with the B-Lymphocyte Stimulator (Blys). LIDAEUS (Taylor, et al., Br J Pharmacol, 
2008; 153, p. S55-S67) is used to identify chemical groups with favorable binding to 
Blys. Natural and non-natural sidechains are then used to create a library of 
synthesizable cyclic hexapeptides that would mimic the Blys:Baff-R interaction. 
 
Finally, this work demonstrates the usage and synergy of various in-house 
computational resources in drug discovery. The ProPep database is a repository used 
to study trends, motifs, residue pairing frequencies, and aminoacid enrichment 
propensities in protein-peptide interaction. The LHRLL protein-peptide interaction 
motif is identified and used with UFSRAT (S. Shave, PhD Thesis, University of 
Edinburgh, 2010) to conduct ligand-based virtual screening and generate a list of 
possible antagonists from the EDULISS (K. Hsin, PhD Thesis, University of 
Edinburgh, 2010) compound repository. A high throughput version of AutoDock 
(Morris, et al., J Comput Chem, 1998; 19, p. 1639-62) was adapted and used for 
precision virtual screening of these molecules, resulting in a list of compounds that 
are likely to inhibit the binding of this motif to several Nuclear Receptors. 
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1 Computational Methods for Molecular Recognition
1.1 Molecular Function
Figure  1-1: The roles played by proteins in various molecular functions. A shows the 
binding of the HyHel Antibody (blue and green) to the Lysozyme antigen (PDB 
structure 3HFM [1]). B shows the binding of an inhibitor molecule to the binding site 
of HIV-1 Reverse Transcriptase, inhibiting its RNaseH activity (PDB structure 3LP3 
[2] ). C shows the Eta Human DNA polymerase in complex with the DNA (PDB 
structure 3MR2 [3]). 
 
Biological function is a result of molecular interaction. Proteins constitute the main 
functional and structural building blocks in organi
metabolism, cell growth and signaling
Proteins interact with themselves to make up larger functional complexes, and they 
also interact with small molecules like peptides, sugars, 
interactions are also vital to the molecular functions and have proved to be the 
backbone of drug design theory (
interactions can shed some light on different biochemical pathways in organisms, 
 
sms. Digestion, immunity, motion, 
 are all controlled by protein interaction. 
and other ligands. These 








and can help scientists use this new information to uncover the mysteries that lie 
within organisms. 
 
Research on intermolecular interactions was originally dependent on wet lab 
experiments. Unfortunately, these experiments require a lot of time, effort, skill and 
money. With the emergence of powerful computing capabilities, and as computers 
have become cheap and integrated in everyday life, the in-silico research paradigm 
has slowly started proving itself to be of great importance [4-13]. The ultra fast 
computer speed and the low cost per experiment allow scientists to repeat the same 
experiments over and over again at little additional cost. 
1.2 Computational Biology 
Computational biology plays an important role in the study of molecular interaction. 
The continuous increase in computational power [14] has made it possible to both 
simulate previously unfeasible large and complex systems and at increase the level of 
accuracy. For example, a docking experiment with modern GPU-CUDA technology 
[15] is simulated in less than 5 minutes [16]. Twenty years ago, the same experiment 
would have taken days or even weeks. This enormous speed makes computational 
biology a useful partner for wet lab experiments. The applications of computational 
biology are vast and widespread. These applications include tasks like simple data 
storage, genomic searching, protein modeling, protein structure prediction, protein 
interaction prediction, and drug discovery. The contribution of computational 
methods to each of these areas is discussed below. 
1.2.1 Electronic Databases
Figure  1-2: The increase of deposited structures in the Protein Data Bank since 1990. 
Numbers from 1972 to 1990 are small and hence not 
deposited structures was steadily increasing between 1990 and 2006, and appears to 
have reached a plateau starting 2007. Nevertheless, the PDB now houses over 67,000 
structures and this provides a rich resource of information for co
Interestingly, no new folds have been discovered since 2007.
 
The simplest form of participation of the 
interaction is the electronic storage of large quantities of data and subsequently 
 
shown. Number of yearly 
mputational studies. 
 




publishing these databases online along with fast searching tools. The Protein Data 
Bank (PDB) [17] houses more than 67000 protein coordinate structures (58.5K Xray, 
8.5K NMR, 302 EM). Thi
providing a comprehensive resource of three dimensional coordinates of protein 
structures, covering 1393 SCOP f
resource is at the heart of all the statistical analyses computed on protein structures, 
folds, and interactions.
 
Figure  1-3: The distribution of 
organisms. 
 
s database has been continuously growing (
olds [18] and 1233 CATH topologies 
 
Swissprot protein sequences across the 4 kingdoms of 
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Figure  1-2), 




The UniProt Knowledgebase/SwissProt [21] is another widely used database, 
holding more than 500,000 annotated protein sequences from Archea, Bacteria, 
Eukaryota, and Viruses (Figure  1-3). This database is equipped with various mining 
programs like the basic local alignment search tool (BLAST) [22] for similarity 
searches, MotifScan [23] for pattern searching, and T-Coffee [24] and ClustalW [25] 
for sequence alignment. The incorporation of all these tools within a single web 
interface has provided researchers with means of conducting fast computational data 
mining operations. 
 
Another important computational contribution to the field of molecular interaction is 
that of the NCBI at NIH [26], through the databases like PubMed1 and PubChem2. 
With Pubmed, searching all biological and medical journal papers is possible with 
several advanced search options to filter by date, author, journal, and keywords. 
Pubchem is a similar resource, dealing with all published chemical compounds, with 
bioactivity annotation and links to the bioassays used in testing them. The NIH also 
includes specialist databases for Nucleotide3, Single Nucleotide Polymorphism4 
(SNP), and many more, designed for conducting detailed searches of published 
nucleotide sequences and SNPs. 
 
These databases and others provide an instantaneous and free means of searching all 
the documented knowledge in the field of molecular interaction. They play an 







important role in the unification of data and the developments of common standards 
needed to facilitate the storage, annotation, and mining of all the data produced by 
the worldwide scientific community. 
1.2.2 Gene homology and Protein Sequence 
 
Figure  1-4: The relationship between sequence identity and three dimensional 
similarity: a minimum of 30% sequence identity is needed to infer a structural 
similarity. Research done by Sander and Schneider [27], Figure adapted from 
Rodriguez and Vriend [28]. 
 
Gene expression provides large room for the input of computational biology 
especially given the major progress of informatics in other areas of pattern matching 
(regular expressions in text [29] and language syntax definitions [30]). This problem 
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could be applied to the DNA searching routines, where the genome is read as long 
sequences of nucleotides, and then pattern matching algorithms could find the ORFs 
in that genome. Another application is centered on an observation made by Sander 
and Schneider [27] (Figure  1-4), who linked sequence similarity with protein 
function. This led to the development of tools like Blast [22], T-Coffee [24], and 
ClustalW [25] that would compute the sequence similarity between two or more 
DNA/Protein sequences. These programs are now highly evolved and use mutation 
matrices like BLOSUM (blocks of amino acid substitution matrix) [31] and PAM 
(Point Accepted Mutation) [32] substitution matrices, which give mutation scores 
between amino acids (rather than using the original hit or miss paradigm). 
1.2.3 Protein fold and structure 
Proteins are described according to four structural levels . The primary structure of a 
protein is the sequence of aminoacids that constitute that protein. The secondary 
structure of a protein classifies stretches of aminoacids according to their geometric 
configuration: α-helices and β-sheets. The tertiary structure of a protein is the final 3-
dimensional conformation that the entire protein takes, by folding these helices, 
sheets, and loops to form a specific structure. The quaternary structure describes the 
arrangement in which the different chains and subunits of a certain protein complex 
undergo to form the larger complex. This sequence and geometric description of the 
protein structure gives rise to several applications like structural alignment and fold 
categorization. 
Sequence similarity usually leads to structural similarity. However, structural 
similarity among proteins is more conserved than sequence similarity, with remote 
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protein homologues having dissimilar sequences while their 3D structures are highly 
conserved [33, 34]. The motivation behind structural similarity of proteins is that two 
proteins with a similar structure are expected to bind similar (or the same) molecules 
[35]. Thus, the need for the structural alignment of protein domains presents itself, 
especially with the increase of the number of structurally determined proteins (Figure 
 1-2). Many structural similarity programs are currently available (for eg, FAST [36], 
MultiProt [37], and SuperPose [38]). Algorithms in this field vary between matching-
based techniques (3D sequence-independent structural comparison [39, 40]), 
optimization based techniques (genetic algorithm-based protein structure 
comparisons [41], and grid-based techniques [42]. Currently, these structural 
superposition algorithms have found their way to be subroutines of molecular 
imaging software like Pymol [43], UCSF Chimera [44], and Accelrys DS Visualiser 
[45].  
 
Structural and fold classification of protein domains is a step forward from structural 
similarity algorithms, aimed at combining primary, secondary and tertiary structure 
information to cluster proteins into structural and functional families. Perhaps, the 
most famous methods of protein fold classification are CATH [19, 20] and SCOP 
[18] (the primary methods used in the PDB to predict protein folds). CATH is a 
hierarchic classification of protein domains based on protein class (C), architecture 
(A), topology (T), and homologous superfamily (H). Class refers to the secondary 
structure of a domain, architecture refers to the overall shape of the orientations of 
these secondary structures (manually assigned), topology refers to the similarity of 
secondary structure at the domain core, and homologous superfamily corresponds to 
high sequence and structural similarity between the domains 
Classification of Proteins) is based on the evolutionary and structural relation
all structurally known proteins (classification is also per domain like CATH). These 
classification paradigms demonstrate yet another contribution of computational 
theory to the field of molecular recognition, helping with summarizing complex 
geometric shapes into words and quantifiable substructures and providing more 
insight into the prediction of the function of protein domains from their primary, 
secondary, and tertiary structural descriptions.
1.2.4 Predicting Protein function
 
Figure  1-5: The relationship between protein fold and function is not a strictly one to 
one relationship (a). Proteins with similar folds can have different functions (
leading to a one to many relationships. Many to one re
where proteins with different folds exhibit the same function 
 
 
The relationship between the fold the function is not always straightforward (
 1-5). Proteins with the same folds, for example TIM barrels, can have multiple 


















fact, a more accurate approach to predict the function of a protein is through the 
study of the binding site of that protein. Some protein function prediction methods 
rely on the geometry of a binding site as similar geometries would bind similar 
ligands and hence, perform a similar function [49]. Geometric hashing [50] is one of 
the widely used paradigms for the geometric comparison of protein surfaces, 
utilizing the same methodology behind computational face recognition to identify 
topological patterns of protein surfaces. Other algorithms utilize physiochemical 
annotation as well as geometric patterns to define pocket similarities. Examples of 
these physiochemical properties include hydrophobicity and electrostatic potential 
[51], amino acid distributions [52], and atom type classifications [48].  
 
Modern function prediction algorithms are classified into several groups [53]. 
Similarity group methods [54-56] utilize sequence similarity searches against large 
databases of known proteins. Phylogenomic approaches [57, 58] build phylogenetic 
trees of all evolutionary homologues of a certain protein based on sequence 
similarity. Pattern based methods [59-61] make use of locally conserved sequence 
patterns instead of global sequences. Clustering approaches [62, 63] try to cluster all 
the known sequences, leading to the functional characterization of the un-annotated 
sequences. Finally, machine learning methods [64-67] utilize artificial intelligence 
and to learn characteristic combinations of protein properties and use them in the 
prediction of protein functions. 
1.2.5 Docking 
Figure  1-6: The three different docking categories. (A) shows the binding of a small 
molecule (FK506) to FKB12. (B) shows lysozyme (magenta) binding to the HyHel 
Fab antibody. (C) shows the multiprotein binding of SKP1 (blue), SKP2 (magenta), 
and CUL1 (green) to 
Docking algorithms are another important contribution by informatics to the field of 
molecular recognition. These programs try to simulate the interaction between 
molecules by binding, or docking, a target molecule to a receptor molec
scoring that conformation using an energy function. This docking problem however 
may be classified into 3 categories. The first category consists of simulations that try 
to dock small molecules onto a certain protein (
consists of simulations that try to dock pairs of protein molecules (
third category is the most complex, and consists of simulations to dock several 
molecules together to form large multimolecular assemblies (
form the E3 Ligase. 
 






Figure  1-6 B). The 
 1-6 C).  
Figure  1-7: The fitting of several ligands (in sticks) onto the 
generated by LIDAEUS
 
The first category of docking tasks is per
With one of the interacting partners being a small molecule (referred to as the 
ligand), the amount of flexibility on that ligand is limited in comparison with the 
flexibility of the receptor protein. This decreas
algorithm. Even so, the space of conformations is still huge and limiting it is always 
a preferable option prior to beginning the docking simulations (for eg, by confining 
the searchable protein surface to a limited patch
occur). Our group currently relies on two protein
LIDAEUS [69] is a fas
compounds in around 14 hours. It relies on limiting the searchable protein surface to 
a small patch, and creates 
Then ligands are quickly fitted onto these 
 to perform a fast docking simulation [68]
haps the simplest (yet not simple at all). 
es the search space of the docking 
 where the interaction is thought to 
-ligand docking algorithms. 
t docking algorithm, capable of screening more than 4 million 
site points of interaction surrounding that interaction patch. 









 1-7) and the conformations are scored and ranked using parameters similar to the 
Tripos forcefield [70]. AutoDock [71] performs more accurate searches by 
simulating ligand bond rotamers for the ligand. It is also possible to include receptor 
side chain flexibility in the simulations as well. As a result of this refinement, 
AutoDock simulations take around 5 minutes per ligand (which makes screening a 4-
million -compounds-library a near impossible task). Our normal procedure is to 
prescreen a large dataset with LIDAEUS and then re-dock the top N hits with 
AutoDock to produce high resolution results. 
 
The second category of docking involves the docking of two large molecules. This 
type of docking is computationally expensive, since the rotation and translation of 
every molecule is to be considered, resulting in a 6-dimensional search. Unlike the 
protein – small molecule docking, each rotation or translation of any of the partner 
molecules results affects a large number of atoms. The energy calculations also 
involve a very large number of close atoms (as the protein-protein interface is usually 
large). This increases the complexity of protein-protein docking simulations. Many 
algorithms are available to simulate this type of docking like Hex [72], RosettaDock 
[73], and FibreDock [74]. Hex uses spherical polar Fourier correlations to define the 
3D shape of the docking partners and perform shape complimentarity calculations. 
Docking refinements with molecular mechanics and electrostatic interactions can 
also be used. RosettaDock searches the rigid body and side chain conformational 
space of two interacting partners to find a minimum energy complex using Monte-
Carlo minimization simulations [75]. FibreDock is an advancement of the FireDock 
[76] program. It uses normal modes [77-79] to simulate backbone flexibility and 
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integer linear programming [80] to optimize side chain conformations. Monte-Carlo 
simulations are then used to calculate the energy of interaction and hence rank the 
different docking orientations. 
 
The third category of docking simulations involves docking multiple molecules 
together to create a large multimolecular complex. Three of the methods that tackle 
this task are CombDock [81], EMatch [82], and MultiFit [83]. CombDock requires 
high (atomic) resolution structures and performs the docking task by docking all 
pairs together then heuristically predict the overall final assembly. EMatch deals with 
intermediate resolution cryo-EM density map of the complex, and fits the individual 
structures onto this map to create the multimolecular complex. MultiFit accepts low 
resolution density maps of the assembly and atomic resolution structures, and tries to 
fit those structures together in a puzzle solving technique. 
 
Figure  1-8: Comparison of ligand-free conformation (green) and product-bound 
conformation (magenta) at loop L1 (residues 33-56) and L2 (residues 244-248) 





All docking simulations face the challenges of protein flexibility, induced fits, 
allosteric interactions, and entropy calculations as these events and calculations are 
often unpredictable. The three dimensional structures we have for the proteins are 
snapshots describing the state of these constantly moving molecules at a certain point 
of time. While parts of the protein stay rigid or exhibit minimal change of 
conformation, side chains (especially long ones like Arg) and loops are often mobile 
(for example, the displacement of the binding site loops in Pseudomonas aeruginosa 
D-Arg Dehydrogenase [84], Figure  1-8). In other cases, the introduction of a certain 
compound might lead to a change in the conformation of the protein atoms 
surrounding it, leading to an induced fit of that molecule into the pocket of the 
receptor (for example, the binding of bisphenol A and 4-α-cumylphenol by 
ERRGamma [85], Figure  1-9). In most cases, this induced fit is necessary for the 
binding of the ligand to the receptor, and trying to assess the interaction between the 
apo structure of the protein and that ligand leads to a weaker binding assessment. 
Allosteric interactions are a special form of induced fits, where the conformational 
change induced by a ligand binding to a protein takes place at a remote location on 
that protein, creating new binding sites and/or enhancing current ones (e.g. the 
allosteric alterations in pyruvate kinase upon binding to fructose 2,6 bisphosphate 
[86] (Figure  1-10). Docking programs cannot predict these allosteric changes and 
thus fail to accurately characterize the interaction of the ligand. Finally, the last 
hurdle for docking programs relates to the fundamental calculations of the binding 
energy of two molecules, which is divided into enthalpy and entropy. Enthalpy 
corresponds to the covalent, van der Waals, hydrogen bond, and electrostatic 
energies and these are well characterized. Entropy, on the other hand, denotes the 
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energy that is needed to move the system from a state of disorder (or chaos), to the 
ordered state in which the binding has occurred. This is a difficult calculation 
including aspects of global solvent calculations and approximation of contributions 
from side chain mobility. In the absence of a fast and accurate method of entropy 




Figure  1-9: Induced-fit binding of 4-α-cumylphenol to the ERRγ-LBD apo form. (A) 
shows the superposition of residues in close proximity to the ligand (orange for apo 
conformation, and blue for induced conformation). (B-a) shows induced re-
positioning of Glu275 and Leu309 by the binding of 4-α-cumylphenol and (B-b) 
their conformation in the apo form. (C-a) shows Val313 in its induced conformation 




Figure  1-10: The transition of PyK between the inactive T state and the active R 
state, with the help of the allosteric ligand F-2,6-BP to stabilize the structure in the 




However, these challenges do not render docking simulations useless. Modern 
docking programs have become more successful at realistically simulating binding 
interactions and identifying ligands that bind to the receptors in vitro. Moreover, the 
monetary and time advantages possessed by these algorithms are huge. LIDAEUS 
[69] docks 4 million small molecules onto a receptor within 14 hours. Autodock [71], 
which is a more accurate and thus, “slow”, docks a small molecule within 5 to 10 
minutes. Hex [72] currently docks 2 large globular proteins in less than 5 minutes by 
using the new GPU-CUDA technology [15]. This high speed combined with the fact 
that these simulations can be run at negligible cost (compared to the costs of buying 
materials and running complex screening robots in wet lab) make docking a very 
desirable option and one of the most important in silico contributions to the field of 
molecular recognition. 
1.3 Computational Drug Discovery and Virtual Screening 
Drug discovery is an important application of the study of molecular recognition. 
This field aims at discovering the suitable chemical compounds that would inhibit (or 
sometimes catalyze) a certain molecular interaction. The basic idea for molecular 
inhibition is to find a suitable chemical compound that would bind to the target under 
study, and either block that site of interaction, denying the original partner from 
binding to the target, or induce a structural change in the target, making it impossible 
for the binding partner to bind to the receptor.  
 
Available chemical space is vast and screening it entirely is not feasible at the 
moment (or in the near future). It is estimated that the number of small organic 
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molecules constituting the chemical space is more than 1060 [87]. Out of this large 
space, the Chemical Abstracts Service5 at the American Chemical Society6 currently 
reports around 55 million registered organic and inorganic chemical molecules. 
Practically then the chemical space to be looked at is infinite since the number of 
synthesized and characterized compounds is extremely small in comparison to that 
space. Our inability to sample the chemical space (by synthesizing and testing every 
possible chemical compound) presents the major challenge for drug discovery. 
However, even with the already sampled 55 million compounds, screening these 
compounds for every target is a very expensive procedure and thus unattainable. 
These obstacles pave the way for the incorporation of informatics into drug 
discovery to help cover the sampled chemical space. 
 
1.3.1 Compound Libraries 
In drug discovery, the terms “lead-like” and “drug-like” are often used to describe 
chemical compounds. Small molecules that bind to a target are often called “leads”. 
These small molecules are used as starting points for building larger molecules with 
a tighter interaction to the target. Drug-like molecules are those that have potential to 
be later used as pharmaceuticals. This potential is quantified by several properties, 
mainly absorption, distribution, metabolism, excretion, and Toxicity (ADMet) [88]. 
These properties affect the drug-potential of a molecule. Absorption is important so 
that the drug will function upon oral (or sometimes intravenous) administration. 
Distribution of the drug is necessary for the molecule to reach its designated binding 





site. Very fast metabolism of the drug leads to inactivity of the molecule. Excretion 
of that drug is important to avoid the accumulation of foreign substance in the human 
body. Finally, toxicity is an important factor in determining the drug potential of a 
molecule to avoid further complications or patient death. 
 
Compound databases are crucial to any computational drug discovery program. In 
order to try to bind small ligands to a certain target, you need 3 dimensional 
structures of these compounds. Many databases are currently available to deliver this 
service. ZINC [89] houses over 13 million purchasable compounds in ready to dock 
3D formats. CHEMCATS7 reports over 41 million commercially available products 
from 1215 catalogs (11.75 M unique compounds). Our in-house compound database, 
EDULISS [90], houses over 5.5 million compounds (over 4M are unique). These 
compounds can be filtered by common drug-like parameters like the Lipinski rule of 
5 [91], the Oprea filters [92, 93], and the Astex rule of 3 [94]. Options are included 
for similarity and pharmacophore searches. 
 
A lot of research has been invested into the development of drug-like or lead-like 
profiles for chemical compounds. These profiles provide a means of fast 
prescreening of chemical compounds prior to in silico or in vitro screening in an 
effort to decrease the searchable space and confine it into a subspace that consists of 
useful compounds only. The most widely used profiles are the Lipinski rule of 5 
[91], Oprea filters [92, 93], and Astex rule of 3 [94]. The Lipinski rule of 5 accepts 




molecules with molecular weight <= 500 daltons, aLogP <= 5, hydrogen bond 
acceptors <= 10, and hydrogen bond donors <= 5. The Oprea filter accepts molecules 
with molecular weight <=460 daltons, aLogP between -4 and 4.2, hydrogen bond 
acceptors <= 9, hydrogen bond donors <= 5, rotatable bonds <= 10, and rings <= 4. 
Finally, the Astex rule of 3 is more selective, accepting molecules with molecular 
weight <= 300 daltons, aLogP <= 3, topological polar surface area <= 60 Å2, and 
rotatable bonds <= 3. Of the 5.5 million compounds in the EDULISS database, 3.9 
million compounds fit the Lipinski rule of 5, 3.4 million compounds fit the Oprea 
filters, and 520 thousand compounds fit the Astex rule of 3. 
1.3.2 Protein Based Drug Discovery  
As the title hints, protein based drug discovery aims at finding drug-like or lead-like 
molecules by studying the protein target itself. This method is particularly useful 
when there is a good knowledge base about the protein target and when the 
information about the experimental ligand is not very abundant. Two paradigms to 
perform this task are available: searching for binding molecules via sequence and 
structural alignment and searching for binding molecules via docking programs. 
 
Similar proteins should have similar functions and thus, bind similar molecules [27]. 
This is the main drive behind sequence and structural alignment techniques leading 
to drug discovery. Sequence alignment methods (introduced in section  1.2.2) are 
capable of finding homologous proteins to the target. If the binding sites of these 
proteins are similar to that of the target, there is a high probability that molecules 
known to bind to these proteins would bind to target. This scenario is usually a good 
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option when the three dimensional structure of a protein is unknown. Another option 
is to use the sequence identity to predict (or model) the structure of that protein (with 
programs like MODELLER [95]). Then this theoretical structure is used for 
structural based approaches. Another similarity based option is using structural 
similarity to identify structurally homologous proteins (methods discussed in sections 
 1.2.3 and  1.2.4). These methods are capable of picking up structures with structural 
similarity to the target, regardless of sequence similarity. Molecules that bind to 
these homologous proteins are likely to bind to the target as well (especially if the 
binding sites are structurally similar). Molecules generated via similarity methods 
can also be used for ligand based drug discovery methods (section  1.3.3) as well. 
 
Docking is the other option in protein based drug discovery. This option is only 
viable when a three dimensional structure of the target exists (or a high quality 
model). This option requires knowledge of the location of the binding site of the 
molecular interaction to be inhibited. It also requires a library of compounds to be 
used for virtual screening. Docking methods are discussed in section  1.2.5 and 
compound libraries are discussed in section  1.3.1. Chapter  2 of this work presents a 
novel algorithm (Surface Triplet Propensities, STP) that predicts the location of 
binding sites on proteins [96]. This helps in running docking simulations on targets 
where the interaction sites are unknown. Chapter  3 discusses the various applications 
of the novel STP method like generation of pseudo ligands for docking programs, 
prediction of the enzyme classes, and ranking protein-protein docking orientations. 
Chapter  4 discusses the spatial and chemical characteristics of binding sites and how 
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these qualities can be used in the detection of these sites and targeting them for drug 
discovery.  
1.3.3 Ligand Based Drug Discovery 
 
Figure  1-11: The mapping scheme used by ROCS in the fast molecular similarity 
searches. Figure retrieved from the ROCS official webpage8. 
 
Ligand based drug discovery methods rely on mimicking the ligand shape and 
interactions in order to select or create a list of possible inhibitors of a certain 
interaction. A few algorithms have been designed to perform shape similarity 
comparisons like ROCS [97] and UFSRAT [98]. ROCS uses the overall molecular 
volume to define the shape of a molecule in addition to atom type descriptors (Figure 
 1-11). UFSRAT also uses atom type descriptors, but defines the shape of molecule 
through a series of descriptors (mean, standard deviation, and skew) that define 
distributions of distances between atoms in a molecule (Figure  1-12). Using shape 
comparison methods, compound libraries can be screened for compounds that mimic 
an originally known binding molecule. Since similar molecules are expected to 
                                                 
8 http://www.eyesopen.com/rocs 
interact with the same target in a similar manner 
algorithms constitute a powerful method to search for drugs and inhibitors of a 
certain interaction. 
 
Figure  1-12: The UFSRAT method of defining distances between atoms to perform 
structural similarity calculations using the distribution of distances of all atoms to 4 
key points: (1) the center of gravity of a molecule, (2) the closest a
(1), (3) the furthest atom location from (2), and (4), the furthest atom location from 
(3) [98]. 
 
Another ligand based method to inhibit a complex is to manually (or semi
automatically) design a list of compounds that mimic a certain interaction. These 
compounds are designed to have an overall shape, and refined to exhibit cer
chemical features (donors, acceptors, hydrophobic, and acidic substructures) at 
special points, mimicking the same chemical features of the original ligand. Chapter 
 5 of this work describes a method that falls within this category of computational 
drug discovery approaches: designing compounds to mimic the 
Baff-Receptor ligand that binds to the 
[97], these shape comparison 
β
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1.3.4 Interaction Databases 
Another approach in computational drug discovery is building interaction databases. 
Such databases would house the known information about a certain type of 
interaction. Such an assembly of information provides a way to search for trends and 
motifs for that type of interaction. Examples of such databases include PepX [99] 
(protein-peptide interactions), GWIDD [100] (protein-protein interactions), and 
PDBbind [101, 102] (protein-small molecule interactions). PepX contains a 
nonredundant protein-peptide interaction dataset of 505 complexes. GWIDD 
(Genome-wide protein docking database) currently contains 25,559 experimental and 
modeled structures covering 771 organisms. Finally, PDBbind contains a total of 210 
entries covering 70 different proteins, all annotated with experimentally measured 
binding affinity data. 
 
ProPep [103] is an in-house protein-peptide interaction database. It consists of 481 
non-redundant structures representing protein–peptide interactions where the protein 
is between 50 and 600 residues long and the peptide is between 3 and 50 residues in 
length. This dataset holds information about the protein and peptide residues 
involved in the interaction, the accessible surface area these residues (before and 
after binding), as well as the van der Waals and hydrogen bond interactions across 
the protein-peptide, protein-water, and peptide-water interfaces. Chapter  6 discusses 
the usage of this database to study the LxxL α helical motif. Using this database, we 
were able to pinpoint a structurally conserved LHRLL α helical motif that binds to 
nuclear receptors. Computational methods are then used to find inhibitors for this 
interaction. 
1.4 Overview of this work
Figure  1-13: The contributions of this work to major sub
drug discovery. 
 
This work discusses various methodologies in computational drug d
 1-13). Chapters  2,  3, and 
prediction of the location of protein
geometrical study of these binding sites, and the usage of information gathered about 
binding sites in various applications
numbers. Chapter  5 
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2 Surface Triplets Propensities 
2.1 Introduction 
2.1.1 Background 
In silico experiments targeting protein interactions can be classified into several 
groups. Homology based algorithms use sequence or fold homology to infer protein 
function similarity. In 1991, Sander and Schneider [27] showed that a sequence 
identity of greater than 25% can infer structural similarity and hence, possibly 
functional similarity. Many studies [104-109] have successfully used sequence and 
structural similarity to characterize protein interaction. However, the fact remains 
that structure cannot always predict function (as in the case with TIM barrels that 
have the same fold but different functions [47]). Energy based algorithms focus on 
molecular mechanics and dynamics to try to find the most energy favorable 
conformation for a complex (protein-protein or protein-ligand). This type of 
algorithm requires a very accurate definition of the atomic forces (in type and value) 
and is very computationally expensive. Moreover, the difference between a good and 
a bad conformation is usually extremely small in magnitude, and hence this task 
becomes more difficult. Another type of algorithm is statistics based. These 
algorithms gather information on a certain type of interaction from all the structures 
that have already been crystallized in order to “train” the algorithms on predicting 
similar interactions. Such methods have utilized complex computational methods 




At first, the in-silico algorithms faced a big problem: the lack of biological data that 
could be used to model molecular interactions. However, the structural databases 
have been growing fast, especially with the existence of structural genomics 
initiatives, aiming at filling the gaps in the databases by crystallizing “unrelated” 
proteins (usually less than 30% sequence similarity with currently crystallized 
proteins) [117]. With this expansion in the space of structural databases, especially 
by not focusing on a certain type or fold, in-silico algorithms can begin to explore the 
infinite universe of protein interactions. 
 
An important application of studying protein-ligand interactions is its contribution to 
drug discovery. Finding compounds that can activate or deactivate certain proteins 
can mean finding a drug that would stop or slow down a certain disease. This process 
has two scenarios. The first is where the binding site of interest is known and the 
objective is to search for a ligand that would bind with relatively high affinity to this 
site (eg. FKBP12 [118], cyclophilin [119, 120]). The second is where the protein of 
interest is known, but the binding site on that protein is not and then, predicting the 
location of binding sites becomes crucial (eg. The complement immune system 
components 5 and 7 [121, 122] , thiosulfate sulfurtransferase (rhodanese) [123, 
124]). 
 
Several ways have been designed to search for protein binding surfaces. Some 
methods search for conserved regions and argue that conserved regions tend to be 
functionally significant [52, 125]. Other methods use force fields [51, 126] and 
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biochemical annotations and spatial motifs [127, 128]. A method has been designed 
to calculate the “Interface Propensities” of residues which indicates how frequently 
these residues tend to appear on binding sites [129]. This method was further 
explored to produce the PLB index (propensity for ligand binding) [130, 131]. 
However, calculating propensities for residues may yield noisy results since the 
packing and folding of proteins can bury some of the atoms in these residues beneath 
the protein surface. A residue based propensity might favor such buried atoms in 
appearing on binding surfaces. To avoid this noise, atom based propensity is 
calculated instead. This, however, introduces the problem of classifying protein 
atoms. 
 
A classification of protein atoms into Atomic Groups was proposed by Tsai et al. 
[132]. Atoms are classified into 13 types called Atomic Groups based on heavy 
atoms, how many covalent bonds they have, and how many of these covalent bonds 
are actually with hydrogen atoms. Atomic Groups are denoted by XmHn, where X is 
a Carbon (C), Nitrogen (N), Oxygen (O), or Sulfur (S); m is the total number of 
covalent bonds X has, and n is the number of these bonds that are actually shared 
with a Hydrogen atom. These atomic groups have different radii and exhibit different 
biochemical properties. The interface propensities for these Atomic Groups is 
calculated and used to design an algorithm for predicting protein binding sites 
(Sections  2.3 and  2.4). 
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2.2 Surface Triplets Propensities (STP) algorithm 
The STP algorithm is based on creating a score table for surface patterns, indicating 
the likelihood of a certain pattern to occur in a binding site. These score tables are 
calculated by training the algorithm on a certain representative dataset that represents 
an interaction type in the Protein Data Bank (PDB). Surface patterns are represented 
by triangles – triplets of atoms that can be simultaneously touched by a probe sphere 
of the size of a water molecule (Section  2.2.1).  
 
Constructing such a score table from a dataset can be divided into several parts. First, 
a routine is needed to fetch the surface atoms and triangles from the proteins. A 
Second routine is needed to classify surface atoms between those that belong to the 
binding sites and those which do not. Finally, a third routine is needed to calculate 
the statistics and propensities of different atom/triplet types. Figure  2-1 summarizes 
this procedure. 
 
Figure  2-1: The framework of constructing the score tables from a representative 
dataset of the PDB starts by gathering surface triplets (Triominoes), finding out 
which triplets belong to a known binding site in that dataset (Analysis), and 
computing the propensities (Statistics). 
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2.2.1 Classification and triplet grouping of surface atoms 
Protein atoms are classified into 13 atomic group types [132]. The atomic groups are 
defined according to the substitution pattern and number of covalent bonds on 
carbon, nitrogen, and sulfur atoms (Table  2-1). These atomic groups have different 
radii, electronegativity, and physiochemical properties. Consequently, searching for 
atomic group patterns on the surface of the protein would resemble searching for a 
physiochemical characteristic of that surface. Surface atoms are identified by rolling 
a water molecule (a probe sphere of radius 1.4Å) over the protein surface. A triplet 
(triangle) is defined as a group of 3 surface atoms that can be simultaneously touched 
by the rolling water molecule probe. Neglecting handedness, there are a total of 455 
distinct ‘triplet-types’ that can be generated from combinations of the 13 different 
atom types. The “triominoes” program (written by Graham Kemp) takes in a PDB 
file and identifies the surface atoms and triplets. Figure  2-2 shows the triangles 
computed by the triominoes program. Triplets and atoms on the surface would be 
written out and used by other programs to continue the task of constructing the score 
table. 
Table  2-1: The 13 atomic groups according to the classification of [132]. Atomic 
Groups are classified based on the heavy atoms (N, C, O, and S) and then 
subclassified by the number of covalent bond that heavy atom has and how many of 
these covalent bonds are with a hydrogen atom. Each of these atomic groups has a 
distinct radius and volume, contributing to unique physiochemical properties. 
Atom Type Example 
N3H0 Pro N 
N3H1 Amide N 
N3H2 Arg NH1 
N4H3 Lys NZ 
O1H0 Carbonyl O 
O2H1 Ser OG 
C3H0 Carbonyl C 
C3H1 Tyr CD1 
C4H1 Ala CA 
C4H2 Pro CB 
C4H3 Ala CB 
S2H0 Met SD 




Figure  2-2: Triangles and Atoms on the Surface: A shows the general view of a 
protein structure, while B shows the details of the atomic classifications on such a 
surface. A triangle is identified as a triplet of atoms that is simultaneously touched by 
a probe sphere of the size of a water molecule. 
 
A 14th atomic group was created for Arg amides (since it’s not possible to distinguish 
the NH2 (N3H2 atomic group) from the NH (N2H1 atomic group) of these residues 
in crystal structures). A subroutine to correct the types of sulfur atoms in disulfide 
bonds was also added. This subroutine would find all pairs of sulfur atoms which are 
less than 2.5 Å apart and change their type from S2H1 to S2H0. Atomic groups are 
ordered from 1 to 14.  
2.2.2 Nomenclature 
For computational reasons, the atomic groups are given special identifiers (Appendix 
Table  9-1). Triplets are named according to their constituting atomic groups. Since 
order is not important to our search, triplets made up of the same atoms in different 
permutations are considered to be the same. This classification gives rise to 455 
different ‘triplet-types’. A triplet is named according to its constituent atomic groups 
in an increasing order. 
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2.2.3 Classifying triplets and building score tables 
The “analyze” program calls the triominoes program repeatedly to output two 
triangle files; the first containing triplets found on the entire surface of the protein 
and the second containing triplets found on the surface of the protein-ligand 
complex. Consequently, the first file will contain some atoms and triplets that are not 
found in the second file. These unique triplets and atoms have been concealed from 
the probe by the ligand upon binding, and therefore belong to the binding site 









































α designates one of the 455 possible triplet type; 
InterProp(α) is the proportion of all ligand-binding-site triplets that are of type α; 
SurfProp(α) is the proportion of all surface triplets that are of type α; 
InterCount(α) is the count of occurrences of triplet type α in ligand binding interfaces in the 
dataset; 
SurfCount(α) is the count of occurrences of triplet type α on protein surfaces in the dataset; 
i spans the 455 triplet types. 
Equation  2-1: Calculation of the triplet propensities. This calculation is only done 
once and the CalculatedPropensities are recorded in a score table. After that, the 
notion propensity refers to a value that is fetched from the score table. 
 
The “statistics” program performs a simple statistical study to calculate the atom-
propensities and the triplet-propensities that constitute the score table. The 
probability of finding a specific triplet in an interface and that of finding the same 
atom/triplet on the entire surface are calculated. The propensity of a triplet is 
calculated as the logarithmic (base 2) of the ratio between these probabilities. 
Formally, the scores would be calculated according to 
propensities are read from a scoretable that includes all the CalculatedPropensities 
for the 455 triplet types.
2.3 Constructing the STP Score Tables for the Protein
Peptide, and Protein
Figure  2-3: The classification of protein interactions into Protein
different proteins interacting to form the SCF E3 Ligase complex), Protein
(B, showing the binding of FKBP12 to the FK506 ligand molecule), and Protein





-Protein Interaction Datasets 
-Protein (A, showing 
Tyr Kinase bound to 2 
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We refer to the interacting molecules as the receptor and the partner. Based on the 
type and size of the partner, protein interactions can be classified into three groups: 
protein-ligand, protein-peptide, and protein-protein (Figure  2-3). Peptides are defined 
as stretches of amino acids between 3 and 50 residues in length. Peptide sequences 
that are longer than 50 residues are classified as proteins. Ligands are defined as non-
amino acid molecules having more than 10 carbon atoms which make at least 4 van 
der Waals interactions with the protein. Based on this classification, three score 
tables are created. The protein-ligand, protein-peptide, and protein-protein score 
tables are each constructed from an appropriate dataset (Sections  2.3.1 and  2.3.2). 
For any interaction type, the binding site is defined as the triangles on the surface of 
a receptor that have been concealed from a water probe upon binding to a partner. 
2.3.1 The Protein-Ligand Score Table 
A representative dataset of the Protein Data Bank (PDB) was compiled by Yi-Gong 
Sheng and stored in a database on the cycfs server under the name db_ecoli. This 
dataset was designed to represent all the known ligand binding sites found in the 
2007 version of the PDB. This dataset is refined by using crystal structures with 
resolution better than 1.7 Å. A ligand is considered if it makes at least 4 van der 
Waals interactions with the protein, and if the maximum distance between any 2 
atoms of this ligand is less than 23 Å. No two proteins in this test data set have a 
sequence identity greater than 50%. 
 
The table JOB INFO in that database includes 352 protein-ligand interaction entries 
belonging to 316 different PDB structures and constituting a nonredundant 
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representative dataset of the protein-ligand interaction in the PDB. The coordinate 
files for these entries (in different formats like PDB, mol2, and sdf) are stored in the 
directory “/usr/cycfs/work/ecoli/lid_run/” and are divided into several folders. A file 
corresponding to an entry in the table JOB INFO is accessed through the value stored 
in the DIR column in the table JOB INFO. This value is the folder name inside 
“/usr/cycfs/work/ecoli/lid_run/” where the coordinate files are stored. Each directory 
includes 2 PDB files; one starting with the word ”Prot” and this is a PDB file 
containing the coordinates of the protein and another file containing the coordinates 
of the ligand. 
Table  2-2: List of PDB entries that make up the representative dataset of protein-
ligand interactions (Yi-Gong Sheng's work). Some entries have multiple binding sites. 































































































































































































































































































































Most of the binding sites belong to unique PDB entries. Table  2-2 lists all the PDB 
ids as suggested by Yi-Gong's work. Most of the structures in this dataset included 1 
ligand. However, some PDB entries include 2 or 3 binding sites, and these are shown 
in Table  2-3. 
 
Table  2-3: PDB entries in the protein-ligand interaction dataset with multiple binding 
sites 






































































Due to the atom classification in the PDB structures, some entries were problematic 
to deal with. Many entries contained atoms with alternate locations. These cases 
were handled by writing a routine which takes in a PDB file, locates the atoms with 
alternate locations, and outputs the same file having adjusted it by keeping only those 




For DNA-containing entries (1JX4, 1RFF, and 1U4B), a special routine was 
established to deal with these entries, omitting all DNA molecules, without 
misinterpreting the binding surface between the protein and the DNA as an outer 
surface. This allows for the characterization of the protein-ligand interface properly. 
 
Some entries bind the ligands in internal pockets in the protein, totally inaccessible to 
the external environment of the protein. These cases represent binding sites cannot be 
characterized by the surface triplet approach and are therefore outside the scope of 
this study and have hence been deleted from the training set. These entries are: 
1DZ4, 1QOP, 1KQF, 1L3L, 1R5L, and 1T7F. Moreover, entry 1GTV was deleted 
since the ligand in this structure was not characterized properly. 
 
Finally, the asymmetric unit of entries 1P3D, 1JKX, and 1VHT contained duplicate 
structures (Figure  2-4). To avoid counting the same atoms twice, the “biological unit 
1” for each of these structures was downloaded from www.pdb.org and used instead 
of the default model. With all these deletions and editing, the representative dataset 
of the protein-ligand interaction in the PDB was reduced to 309 structures.  
 
The triplets and atomic groups on the protein surface and in binding sites were 
characterized as per Section  2.2.3. The propensities were calculated and are listed in 
Table  9-4 and Table  9-7. 
Figure  2-4: Crystal structure of the UDP
containing 2 duplicate structures. In such cases, the 
the crystal structure. 
 
2.3.2 The Protein-Peptide Score Table
Another score table was generated for Protein
Peptide Binding Sites 
by Simon D. Harding for his PhD studies 
nonredundant representative dataset of the protein
The updated version of ProPep (updated by myself and reported in
been used and included 475 entries (
detailed in Table  9-3 
 
The dataset originally contained 481 structures. Five structures (1ATI, 1F59, 2A79, 
2ZLD, and 3BFN) contained UNK 
excluded. Structure 4
DNA entries were dealt
(Section  2.3.1). 
-N-acetylmuramic acid (PDB id 1P3D), 
biological unit is used instead of 
 
-Peptide Binding Sites. The Protein
score table was generated from the ProPep database generated 
[103]. The ProPep database holds a 
-peptide interactions in the PDB. 
Table  2-4). The score tables for this dataset are 
and Table  9-6. 
amino acids in the protein and have been 
Cpa included a GLX amino acid and has also been excluded. 





 chapter  6) has 
Ligand score table 
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Table  2-4: Protein-Peptide interaction dataset: PDB codes of the structures and the 
chains that contribute to the interfaces [103]. 148L:ES means pdb entry 148L, 
interface characterized as interaction surface between chains E and S. 































































































































































































































































































































































































































































































2.3.3 The Protein-Protein Score Table 
A third score table, for Protein-Protein Binding Sites, was produced during my 
masters studies [133]. This score table was generated from a dataset created by 
Keskin et al. [134]. Table  2-5 identifies the binding partners listed in that dataset 
after all the necessary adjustments were made (removal of theoretical models and 
NMR ensembles, replacement of obsolete structures, and usage of biological models 
when the asymmetric unit includes 2 duplicate structures). The score tables for this 
dataset are detailed in Table  9-2 and Table  9-5. 
 
This dataset was used to construct a protein-protein score table as part of my masters 
studies [133]. The dataset was designed by Keskin et al. (2004) [134] as a 
representative dataset of protein-protein interactions in the PDB, comprising 295 
structures (Table  2-5). Structures 1BZI, 1CDA, 1DF2, 1I15, 1IF3, 1K9N, 1LT2, 
1MLP, 1PAI, 1RLX, and 2BU0 are theoretical models and were omitted. Structures 
1A7F, 1AZE, 1DT7, 1JEG, and 1JWD are NMR models and hence model 1 from 
each structure was used. The NMR models 1A0N and 1BON had corresponding 
mean models in structures 1AZG and 1BOM respectively, and those counterparts 
were used. Structure 1SEB was omitted for containing UNK residues. Structure 
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1G6R had 2 duplicate structures and was substituted with the biological model 1. 
DNA containing entries were also dealt with as per Section  2.3.1.  
Table  2-5: Protein-Protein interaction dataset: PDB codes (first 4 characters) of the 
structures and the chains (last 2 cahracters) that contribute to the protein interfaces 
[134]. 10GS:AB means pdb entry 10GS, interface characterized as interaction 
surface between chains A and B. 











































































































































































































































































































2.4 Predicting Binding Sites by Color coding the surface 
The direct application of the collected atom and triplet propensities is to predict the 
location of binding sites. This function could be carried out by scoring patches on the 
surface of proteins. Patches that belong to the binding surface are expected to score 
higher than the other patches on the protein surface. Figure  2-5 outlines the 
procedure followed in order to predict the location of binding surfaces. The program 
that uses these propensities to predict the location of binding sites is called Surface 
Triplets Propensities (STP). 
 
Figure  2-5: The binding site prediction process of STP. Triplets on the surface are 
extracted (Triominoes), then patches on the surface are scored using the score tables 
generated earlier (Scoring), and a visual output is created for different molecular 
viewing programs like PyMol, RasMol, and Chimera. 
 
2.4.1 The 90-10 Testing Scheme and the Notion of Top Triangles 
Computational Biology algorithms always face the challenge of proper and unbiased 
testing. The 90-10 testing scheme is used in all the testing routines. This scheme 
enables the testing of an algorithm with its own dataset, without any bias or 
redundancy. The training set of 309 proteins is divided into 10 mutually exclusive 
subsets, each constituting 10 percent of the set and comprising 31 structures. The 
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structures of each subset are tested with a score table generated from the remaining 
90% of the original dataset. Since the dataset is nonredundant, this method of 10-fold 
cross validation is statistically correct and unbiased. 
In some of the tests reported below, the notions of Top10, Top20, and Top30 are 
used. These correspond to the triplets with PatchScores greater or equal to 90, 80, 
and 70 respectively (when the PatchScores are scaled from 0 to 100).  
2.4.2 Scoring Patches 
The scoring process calls the triominoes program to create a list of atoms and triplets 
found on the surface of a specific protein. Each surface atom is then scored via a 
“sliding window” scheme. Each triplet is given a PatchScore which is defined as the 
average of the propensities of all the surface triplets whose centroids are found 
within a certain distance from this atom. This PatchScore would indicate the 
likelihood of an atom to belong to a binding site based on information from its 
surrounding atoms. The averaging function was used so that surfaces with more 
atoms on the surface are not favored over less-dense surfaces. A non-favorable patch 
might contain a highly favorable triplet and vice versa. The averaging function limits 
the effects of such noise on the general scoring. To better define a patch, Figure  2-6 
illustrates a patch on a surface of a protein. Grouping the triplets into patches took 
the topology into consideration by creating a Graph of all the surface triplets, joining 
adjacent triplets with Graph Edges. This way, triplets that are spatially close but 





Figure  2-6: A Patch on the surface is shown in red surrounding the central atom 
highlighted in green. The picture on the left shows the solvent accessible surface 
while the one on the right shows the triangles computed by the triominoes program. 
 
2.4.2.1 Color coding the surface 
To give a visual output, PatchScores attributed to each atom are scaled from 0 to 100 
(internal atoms are given a dummy PatchScore). Most molecular viewers are capable 
of using B-Factors (converted from PatchScore) to color the protein structure from 
blue to red (blue being the least favorable for a binding surface and red the most 
favorable). The coloring process then outputs scripts that can be used by visual 
programs like UCSF Chimera [44], RasMol [135], and PyMol [43] to color the 
surface of the molecule. It is informative to look at the coloring effect on the solvent 
accessible surface (solvent-excluded molecular surface as designed by [136]). This 
surface can be seen in Chimera and Pymol. In Pymol [43] for example, a user clicks 




2.4.2.2 The Effect of varying the Patch Diameter on Binding Site Prediction 
The effect of varying the Patch Diameter was studied in order to determine the best 
value(s) for this diameter. Several tests were run to assess the output of the coloring 
program on diameter values ranging from 1Å to 40Å, at 1Å steps. In these tests, the 
notion of Top Triangles is used. A Top X triangle is a triangle with a scaled 
PatchScore (from 0 to 100) greater or equal to 100 – X. For example, a top 20 
triangle should have a PatchScore of 80 or above on a 0 to 100 scale. 
 
Three specific values were monitored: (1) the fraction of several Top Triangles 
categories within 5Å of a ligand (Figure  2-7), (2) the fraction of ligands that are 
within 5Å of at least 1 Top Triangle category (Figure  2-8) and (3) the difference in 
average propensity between the binding interface and the rest of the protein surface 
(Figure  2-9).  
 
The “90-10” testing scheme was used (Section  2.4.1), dividing the dataset into 10 
mutually exclusive testing sets of 31 structures. The remaining 278 structures were 
used to create the score table for the different triplet types. Each structure is then 
colored according to its respective score table created from the remaining 278 
structures. We calculate a fraction of triangles value per structure, corresponding to 
the proportion of Top Triangles that are within 5 Å of any ligand atom. For example, 
if we have 25 Top 10 triangles (PatchScore 90-100) on structure X, and 20 of these 
triangles are within 5 Å of the ligand in structure X, then the fraction of triangles 
value is 20/25 = 0.8. The average fraction of triangles computed in Figure  2-7 
correspond to the average value of all the 
structures in the dataset. The same scheme was used to calculat
ligands next to a Top Triangle as well as t
 
Figure  2-7: The Fraction of Top Triangles in the vicinity of a ligand (5Å from any 
ligand atom) as it varies with different coloring patch diameters. For each diameter, 
309 fraction of triangles values 
proportion of Top Triangles that are within 5 Å of any ligand atom. For example, if 
we have 25 Top 10 triangles (PatchScore 90
triangles are within 5 Å of the ligand in structure X, then the 
value is 20/25 = 0.8. The averages
fraction of triangles calculated for the 309 
he PatchScore difference.
are calculated (1 per structure), corresponding to the 
-100) on structure X, and 20 of these 
fraction of triangles 
 of these 309 values per diameter 
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Figure  2-8: The Fraction of ligands in the Protein
in the vicinity of at least 1 Top Triangle (5Å from 
diameter, 309 true/false values were calculated, indicating whether the ligand is 
within 5Å from a Top Triangle. The plotted output is the fraction of structures having 
a “true” result 
Figure  2-9: Distribution of the increase of average 
and Entire Surface as it varies with the patch diameter used to calculate the 
PatchScores. For each structure, PatchScores for all surface atoms are c
(based on a certain patch diameter). Then the average 
atoms is subtracted from the average 
values are calculated for every Patch Diameter and their averages are plotted.
-Ligand interaction dataset that are 
the triangle centroid). For each 
PatchScore between binding sites 
PatchScore










As shown in Figure  2-7, there is a bell-shaped-like relationship between the patch 
diameter and the fraction of Top Triangles close to ligands, with the peak of the bell 
in the Patch Diameter range of 14Å to 26Å. That suggests that selecting the patch 
diameter in this range will provide the best possible coloring outcome. Figure  2-9 
backs up this conclusion with the slope of the curve being at its highest in the 14Å to 
26Å interval.  
 
For patch diameters greater than 26Å, the difference in average propensities between 
the binding interface and the rest of the surface does not increase and its curve 
flattens. This means that increasing the patch diameter beyond the 26Å threshold 
does not enhance the binding site prediction quality. Figure  2-8 shows that as the 
patch diameter increases, the fraction of ligands in the vicinity of a high scoring 
patch decreases. That is expected since the lower the patch diameter is, the more the 
occurrence of small local hotspots. That gives ligands a higher probability to be next 
to one of those hotspots. It could be suggested that when searching for binding 
surfaces for smaller molecules, a smaller patch diameter could be used in the surface 
coloring. Larger molecules would essentially require a larger patch diameter. Figure 
 2-10 shows the changes in the surface coloring as the patch diameter varies. 
Figure  2-10: The effect of varying the patch diameter on the coloring output of STP. 
FKBP12 (PDB structure 2DG3) has 
couple of pictures corresponds to the front and back faces of FKBP. The ligand 
binding site lies in the center of the front face (the left image in each group of 2)
 
The distribution of inter
Distances between any pair of binding site atoms (atoms that are concealed from the 
probe sphere upon the binding of a ligand) in
Histogram in Figure 
[7Å – 11.5Å], giving more confidence to the choice o
7.5Å). 
been colored at different patch diameters. Each 
-triangular distances was also studie
 a structure were measured. The 
 2-11 shows a normal distribution, with a peak in the range of 









Figure  2-11: The Distribution of Inter-triangular distances within ligand binding sites 
according to the STP dataset shows a positively skewed bell shaped curve with a 
peak in the interval of [7.5 Å, 12 Å]. 
 
 
2.5 Testing the Ligand Score Table 
2.5.1 Individual Cases 
The algorithm has been tried out on several structures to assess its practical 
performance, ease of use, and accuracy. Those structures are introduced below and 
the STP predictions are shown. 
 












































ce Mean 10.61Å 
Stdev 5.36 Å 
Skew 0.96 





Figure  2-12: FKBP12 after being colored by STP. “A” shows the binding site and the 
ligand FK506, and “B” shows the back side of the protein. 
 
FKBP12 belongs to a class of proteins known as the Peptidyl-prolyl cis/trans 
isomerases (PPIases) also known as rotamases and is involved in various molecular 
pathways like protein folding, signaling, trafficking, and transcription. Although the 
main function of FKBP class proteins is the activation of T-Cells (through the 
binding to FK506), this binding has side effects and implications in resisting various 
neurodegenerative diseases (e.g. Parkinson’s) [118]. Upon coloring with STP, the 
binding site of FKBP12 was predicted correctly (Figure  2-12). The PDB structure 
2DG3 was used and colored according to the protein-ligand score table. The entire 
surface was colored from blue to green except for the binding pocket which was 
colored yellow, orange, and red. The program located the binding pocket 
successfully and without ambiguity. 
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2.5.1.2 The Gonadotropin-Releasing Hormone Receptor (GnRH-R)  
GnRH-R belongs to the Rhodopsin G-Protein Coupled Receptor (GPCR) family. Its 
original ligand is a decapeptide which acts as a regulator of Luteinising Hormone 
(LH) and Follicle Stimulating Hormone (FSH); making GnRH-R an attractive target 
for controlling sexual functions [137, 138]. GnRH-R expression is also found in a 
number of carcinomas including breast and prostate [139, 140]. 
 
Figure  2-13: HGnRH after being colored by STP. “A” shows the top of the protein 
(extracellular part) with the bound ligand, “B” shows the bottom of the protein 
(intracellular part), and “C”, “D” and “E” show the sides of the protein that 
correspond to the trans-membrane domain. 
 
There is no crystal structure for this protein. It has been modeled based on the β2 
Adrenergic receptor (PDB ID 2R4R, 17% sequence identity, RMSD 2.751 Å) and 
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Rhodopsin (PDB ID 1U19, 16% sequence identity, RMSD 2.211 Å). An STP 
analysis was performed on this model and the results are shown in Figure  2-13. A 
large part of the GnRH-R surface is very hydrophobic since it is a transmembrane 
protein, and therefore the existence of the red patches on the transmembrane regions 
(Figure  2-13 C, D, E) is apparent. Two large cavities exist on the top and the bottom 
of the structure (Figure  2-13 A, B respectively), but only one of them was highly 
colored, and that was the one that was actually a ligand binding site. It is noteworthy 
that the colored half of the cavity is distorted in the inactive form of the receptor. 
2.5.1.3 The ABL Tyr Kinase SH3 Domain  
 
Figure  2-14: Abelson Leukemia virus tyrosine (ABL Tyr) Kinase SH3 Domain after 
being colored by STP showing the 2 shallow binding sites marked clearly. 
 
The Abl-SH3 domain is linked to the down regulation of the Abl Kinase; binding to 
Pro-rich peptides having the PXXP motif or a PolyPro Type II helix conformation 
(PPII). This regulation takes place by interacting with the upper lobe of the Tyr 
Kinase, stabilizing it in the inactive form [141]. The PDB Structure 1ABO was tested 
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with STP and the two binding sites on the surface of the protein were unambiguously 
predicted (Figure  2-14). The strength of this prediction is that this binding site is 
shallow and would not be picked up by programs that search for geometric clefts on 
protein surfaces. 
2.5.1.4 The SCFCdc4 Ubiquitin Ligase 
 
Figure  2-15: SCFCdc4 Ubiquitin Ligase (PDB ID 1NEX) after being colored by STP. 
Two binding sites are discovered and highlighted by STP, the first (A) binds to the 
CBF3 subunit of the SCFCdc4 Ubiquitin Ligase complex, and the second site (B) is 
the Cdc4-phosphodegron (CPD) Phosphopeptide recognition site.  
 
The SCFCdc4 Ubiquitin Ligase is responsible for the ubiquitination of the Cyclin-
Dependent Kinase inhibitor Sic1, which in stable form is responsible for a G1 phase 
arrest [142]. The WD40 domain of the SCFCdc4 (PDB ID 1NEX) has been colored 
with STP (Figure  2-15). STP predicted 2 distinct binding sites, one at the far side of 
the domain (Figure  2-15 A), and the other on the edge of a cavity at the other end 
(Figure  2-15 B). The first predicted site surface binds the CBF3 subunit of the 
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SCFCdc4 Ubiquitin Ligase, while the second predicted site is the Cdc4-
phosphodegron (CPD) binding site responsible for Phosphopeptide recognition, and 
is the most conserved part of the WD40 domain of the SCFCdc4 Ubiquitin Ligase 
[142]. 
2.5.1.5 Human 11-β Hydroxysteroid Dehydrogenase Type 1 
 
Figure  2-16: The Human 11-β Hydroxysteroid Dehydrogenase after being colored by 
STP. 
 
The 11-β Hydroxysteroid Dehydrogenases (11β-HSDs) are responsible for 
converting glucocorticoids (like cortisone and dehydrocorticosterone) back and forth 
between their active and inactive forms. Unlike 11β-HSD type 2, the 11β-HSD type 
1 (studied here) can catalyze this conversion in both directions. This enzyme plays a 
role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and 
inflammation [143]. This enzyme was studied in the Walkinshaw lab by Jillian Adie 
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and Iain McNae. A crystal structure was produced and studied with STP (Figure 
 2-16), and the active site was successfully predicted. Two other red patches are 
visible on the surface, and they belong to the dimerization site of the protein. 
 
2.5.2 Collective Testing and Validation 
2.5.2.1 Propensity distributions 
 
Figure  2-17: Distribution of the triplet propensities across the ten 90-10 testing 
subsets with the minimum (blue), maximum (red), average (green), and standard 
deviation (error bars) of the propensities of all triangular types. All ten subsets show 
similar attributes, confirming the consistent quality of STP scoring. 
 
We studied the distribution of propensities in our dataset. The 90-10 testing scheme 























Distribution of Triplet Propenisties 
across the 10 cross validation sets
Minimum Value Mean Value Maximum Value
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database were extracted and their propensities recorded. As per (Figure  2-17 and 
Figure  2-18), the distribution of each 90-10 subset was plotted separately. The 
distributions did not vary among the subsets and this is an indicator of the stability of 
the algorithm that maintained a constant performance across the 10 subsets. 
Approximately, propensities are in an interval between -3.5 and 5 with a mean of 
around 0.8 and standard deviation around 1.2. The trends shown across all 10 subsets 
indicate that the distribution is normal. That leads to 90% of the triplets occurring at 
a propensity between -1.77 and 3.22 (Mean ± [2 × Standard Deviation]).  
Table  2-6: The 5 most frequent triplets and 5 least frequent triplets in the training 
dataset protein-ligand binding sites and their propensity scores. The occurrence 
corresponds to the number of times a triplet appears in the test dataset of 309 
structures. The negative propensity of the most frequent triplets is not surprising as it 
means higher probability of occurrence, which decreases the propensity. The inverse 
is also true for rare triplets, where occurring once in a binding site will increase the 
propensity tremendously. Triplets that are abundant in binding sites are discussed in 








C3H0, C4H2, O1H0 796 65791 -1.21 
C4H1, C4H2, O1H0 666 62708 -1.4 
C4H2, C4H2, O1H0 663 54617 -1.2 
C4H2, N3H1, O1H0 927 46342 -0.48 
C3H0, C4H1, O1H0 452 36134 -1.16 
C3H0, C3H1, S2H1 3 12 3.16 
C4H1, S2H0, S2H0 1 14 1.35 
O2H1, O2H1, O2H1 1 14 1.35 
C4H1, O2H1, S2H1 2 15 2.25 







Table  2-7: The 10 most frequent triplets in binding sites in the training dataset 
protein-ligand binding sites and their propensity scores. The occurrence corresponds 
to the number of times a triplet appears in the test dataset of 309 structures. 
Triplet Type Occurrence in Binding Sites Propensity 
C3H1, C3H1, C3H1 951 2.24 
C4H2, N3H1, O1H0 927 -0.48 
C3H0, C4H2, O1H0 796 -1.21 
C4H2, C4H3, O1H0 706 -0.36 
C4H2, C4H3, C4H3 695 0.98 
C4H1, C4H2, O1H0 666 -1.4 
C4H2, C4H2, O1H0 663 -1.2 
C3H1, C3H1, C4H3 638 2.09 
C4H3, C4H3, C4H3 604 1.93 
C4H1, C4H2, N3H1 598 -0.49 
 
Only 10 triplet types lie outside this range in the score table generated from the entire 
dataset. Most of these triplets occur less than 200 times throughout the entire dataset 
(the average occurrence of a scoring triplet is 4000), except for two triplet types: 
(C3H0, N4H3, O1H0) (1493 occurrences and propensity of -1.86) and (C4H2, 
C4H2, N3H0) (998 occurrences and propensity of -2.29). The occurrence of these 
triplets suggests that although they are rare, they can still be found on protein 
surfaces (5 and 3 occurrences per protein structure respectively). Out of 1493 
occurrences, only 12 of the (C3H0, N4H3, O1H0) triplet type were in a ligand 
binding site. Similarly, the second type exists 6 times in a binding site out of 998. 
Such triplets can be used as strong indicators to the nonexistence of a binding site 
since they are not extremely rare (25% of an average atom type occurrence) and 
exhibit a binding site propensity rate of only 0.9% and 0.6%. Listings of rare and 
















































































Distribution of the triplet propensities 












Figure  2-18: The distribution of triplet propensities across the ten 90-10 subsets. No 
major difference is noted. 
 
2.5.2.2 Distinction of Binding Sites from their Surrounding Surfaces 
This test aims to assess whether the STP score table yields a clear distinction 
between binding site triplets and entire surface triplets. A binding site is defined as a 
set of water accessible triplets that are concealed from the water probe when the 
ligand binds to the protein. For each set of the 10 fold cross validation sets  2.4.1), 
two distributions were recorded: distribution A containing the propensities of all 
surface triplets in a 90-10 subset, and distribution B marking the propensities of 
binding site triplets in that subset. A distribution shift was calculated as shown in 













Figure  2-19: Distribution Shifts of triplet propensities across the ten 90-10 subsets of 
the Protein-Ligand interaction dataset. For each subset, the distribution shift is 
between the distribution of all binding site triplets propensities and the distribution of 
all surface triplets propensities in a certain structure. 
 
All 10 subtests showed a consistency in the success of the algorithm. The distribution 
of propensities in the ligand binding sites had a higher mean than the entire surface 
distribution in general. The shift, when measured against the standard deviation of 
the entire surface distribution, ranged between 0.65 and 0.85 (Figure  2-19) indicating 
that triplets in binding surfaces are favored among the entire triplet distribution. This 
provides evidence for the success and power of the coloring scheme of STP. 
 
Instead of testing the shift between individual triplet propensities in binding site and 
entire surface distributions, a new test was carried out to calculate such a shift 























































Shift of the mean of the distribution 




structure, two attributes were recorded; the average propensity of binding site triplets 
and the average propensity of all surface triplets. The two distributions resulting from 
these two attributes were then tested and the distribution shift (Equation  2-2) was 
quantified (Figure  2-20 and Table  2-8). The average propensity of all triplets in the 
ligand-binding sites is higher (mean 0.32, standard deviation 0.41) and can be 
distinguished from average propensities for the entire surface (mean -0.3, standard 




Figure  2-20: Distribution Shifts of propensities across the ten 90-10 subsets of the 
Protein-Ligand interaction dataset. For each subset, the distribution shift is between 
the distribution of the average of all binding site triplets propensities and the 






















































Shift of the mean of the distribution of Average 
Propensity in Binding Sites and Entire Surfaces
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Table  2-8: Distribution of the average propensities of triplets in binding sites has a 
higher mean than the distribution of the average propensities of all surface triplets. 
Each test set constitutes a mutually exclusive 10% of the dataset used while the 
remaining 90% are used for training (according to the 90-10 testing scheme, Section 
 2.4.1) 
Set 
Mean Propensity of  
Surface Atoms 



























































The distributions of average binding site propensities and average surface 
propensities are graphically compared in Figure  2-21. Figure  2-21B shows that the 
binding sites have an average propensity greater than the average propensity of all 
the triplets on the protein surface in 95% of the structures. Those structures for which 
STP failed to characterize the required binding site correctly were examined. In two 
cases (1GX5 and 1HYV), the structures were DNA-binding proteins and it is likely 
that the ‘signal’ from the DNA binding site was masking the small molecule binding 
sites used in the test set. In other cases (1IWH, 1MWQ, and 1O7J), STP picked-out 
the main binding site (the active sites of 1MWQ and 1O7J and the Heme binding site 




Figure  2-21: Comparison of average propensities of triplets belonging to binding 
sites and triplets belonging to the entire protein surface in the Protein-Ligand 
Interaction dataset. Figure A shows how the binding sites distribution is shifted to the 
right compared to the entire surface distribution while Figure B shows that the 
average propensity of a binding site is higher than that of the entire surface in 
approximately 96% of the cases tested. 
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2.6 Testing the protein and peptide datasets 
 
Figure  2-22: Comparison of average propensities of triplets belonging to binding 
sites and triplets belonging to the entire protein surface in the Protein-Peptide 
Interaction dataset. Figure A shows how the binding sites distribution is shifted to the 
right compared to the entire surface distribution while Figure B shows that the 
average propensity of a binding site is higher than that of the entire surface in 
approximately 92% of the cases tested. 
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Figure  2-23: Comparison of average propensities of triplets belonging to binding 
sites and triplets belonging to the entire protein surface in the Protein-Protein 
Interaction dataset. Figure A shows how the binding sites distribution is shifted to the 
right compared to the entire surface distribution while Figure B shows that the 
average propensity of a binding site is higher than that of the entire surface in 
approximately 96% of the cases tested. 
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The Protein-Peptide and Protein-Protein score tables were tested by comparing the 
average propensity of a binding site with the average propensity of all the triplets all 
over the surface. Similarly to the Protein-Ligand score table, both tests were 
conducted under the 90-10 scheme (Section  2.4.1). For each score table, each entry is 
given 2 scores, the first being the average propensity of all binding site triplets and 
the second being the average propensity of all surface triplets. These 2 attributes are 
compared (Figure  2-22 and Figure  2-23), showing that binding sites have higher 
average propensities according to both score tables, indicating the success of the STP 
algorithm. 
 
When the entire distributions of these 2 attributes are compared (Figure  2-22A and 
Figure  2-23A), a clear shift to the right is observed for the binding site average 
propensity distributions for both score tables. Examining these distributions on a case 
by case basis (Figure  2-22B and Figure  2-23B) shows that 36/475 structures (7.5%) 
in the Protein-Peptide interaction dataset had their binding sites receive an average 
propensity less than the average propensity of the entire surface. For the Protein-
Protein interaction dataset, 11/289 (3.8%) binding sites received an average 
propensity less than the average propensity of the entire surface. 
 
The results of this test show that binding sites score higher than the entire surface 
average. High scoring atoms are therefore colored bright (yellow to red) by the 
coloring routine, making them identifiable as putative binding sites. With a success 
rate of 96%, 92%, and 96% for the Protein-Ligand, Protein-Peptide, and Protein-
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Protein databases, we conclude that STP is successfully identifying and coloring the 
binding sites of these interactions. 
2.7 Comparison of STP with Other Methods 
2.7.1 Comparison with Surfnet 
Cavities in protein surfaces are often associated with ligand recognition or enzymatic 
activity [144-146] and a number of programs (SURFNET [147], Ligsite [148], and 
PocketFinder [149, 150]) are available to identify such pockets. It is a wide spread 
belief that the binding site of the protein is located in the largest cleft on the surface 
[144]. 
 
We compare STP’s power to locate the binding site with the “largest-pocket” 
paradigm. We used SURFNET to calculate cavities for the 309 structures in our 
dataset. The atoms forming the cavities identified by SURFNET were used as input 
to STP and the cavities were ranked according to the number of high scoring atoms 
(PatchScore above 70 on a scale of 0 to 100) included. The performance of STP was 
then assessed by the percentage of cases where the ligand binding site was STP-
ranked in the top 1, 2 or 3 cavities. This performance was compared with the 




Figure  2-24: The success at predicting binding sites according to cleft size (computed 
with SURFNET) and STP score of a cleft. Clefts are computed with Surfnet and 
sorted by volume (cleft size) or by the number of high scoring triplets they include 
(STP scoring). Graph shows the success rate of predicting the location of binding site 
by examining the Top 1, 2, or 3 ranked clefts according to each method. 
 
As shown in Figure  2-24 and Table  2-9, STP performs much better than just picking 
the largest cavity on the surface. On average, Surfnet found 29 cavities on the surface 
of each protein. 83.7% of the ligand binding sites were discovered in the top 3 
cavities ranked by STP. In conclusion, ranking clefts with STP is a better indicator of 
the location of the binding sites than cavity size and the incorporation of STP with 
Surfnet as depicted in this experiment gives a better prediction of the binding site 





Table  2-9: Score and Rank of the experimental binding site each test case according 
to STP (number of high scoring triplets), and Surfnet (volume). Clefts are computed 
with Surfnet and sorted by volume (size rank) or by the number of high scoring 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.7.2 Comparison With Q-SiteFinder and the Method of Morita et al. [151] 
A number of binding site prediction methods use GRID-like searches [152] in which 
interaction energies are calculated between a probe atom and the surface of the 
protein. We compared the performance of STP against two such approaches; one 
implemented in the program Q-site finder and the other described in [151]. Both use 
high scoring probes as seeds for a clustering process that attempts to locate the most 
energetically favorable locus for a ligand.  
 
A dataset of 35 structurally distinct proteins in the unbound state which share 
structural similarity with 35 proteins in the ligand-bound form was created by Laurie 
and Jackson (2005) [153]. This dataset was used to check the performance of the 
STP on proteins in the unbound state. The unbound proteins were superimposed onto 
their bound homologues. Ligands were then extracted to mark the binding sites in the 
unbound proteins. The cavities on these proteins were extracted with SURFNET and 
then ranked by STP. The binding site of 1 of these structures (1PHD) was an internal 
binding site and was omitted from the analysis.  
 
Figure  2-25 and Table  2-10 summarize the performance of STP in comparison with 
Q-SiteFinder, and the method created by [151]. The binding site is located in the top 
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predicted location by STP in 74% of the cases. This compares with 56% and 76% for 
the other two methods (Figure  2-25). The binding site is located in the top two 
predictions in 85% of the cases (the comparable hit rates for the other two 
approaches are 70% and 82% respectively (Figure  2-25). 
 
Figure  2-25: Comparison of the performance of STP with Q-SiteFinder and the 
method by Morita et al. (2008) [151] shows STP to be a competitive and successful 
binding site prediction program. Surface clefts are extracted with SURFNET and 
ranked by STP to produce the automated STP prediction of the location of the 
binding site. 
 
STP succeeds at identifying ligand binding sites in the structures 3APP and 1BYA 
where both other methods failed [151]. In both these cases the ligands are large and 
long and this has hindered their prediction: the STP method is independent of the 
ligand size. We can define a false positive as an experimentally determined binding 
site which is not among the top 3 predicted STP sites for that protein. There are 4 
such structures out of the total 34 in this test data set (1NNA, 1PDY, 1HSI, and 
6INS). For 1NNA and 1PDY their heteromerization sites dominated the signal and 
were predicted over their small molecule ligand binding sites. For 1HSI and 6INS, 
we can find no documented function for the predicted patches. Thus the false 
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positive rate from this data set is 2/34 =5.9% (though we cannot exclude the 
possibility that these predicted patches play an as yet undiscovered role in ligand 
binding).  
Table  2-10: Rank of each test structure according to STP, Q-SiteFinder, and the 
method by Morita et al. (2008). Items marked with an asterix are greater than 3 
(indicating a bad prediction); AVG is the Average Rank of the ligand binding site 
ID STP Rank 
Morita et al. (2008) 
[151] Rank 


















































































































































Water plays an important role in protein folding, function, recognition, and 
interaction [154-156]. It plays an important role in the recognition of Pro-rich ligands 
by the Abl-Src Homology 3 domain [157] and in the binding of galectin-1 to 
disaccharide lactose [158]. Moreover, adding water to a biomolecular complex can 
increase the specificity and affinity of the interaction, leading to various applications 
in drug design [159]. A new version of STP (STPWater) is designed that 
incorporates surface water molecules into the triplet patterns. The Protein-Ligand 
dataset (Section  2.3.1) was used in the creation of this score table. A 15th Atomic 
Group was added for water: “O2H2”. STPWater follows the same methodology of 
the STP algorithm presented in Section  2.2, and only differs by the incorporation of 
water molecules with the surface of the protein. 
 
2.8.1 Sampling Useful Water Molecules 
The Protein-Ligand Dataset (Section  2.3.1) contains 113726 water molecules out of 
which 97019 are surface accessible. Using all these molecules in the generation of 
the surface triplets would lead to the molecular surface of the protein being made up 
of a lot of water molecules, and the propensity signals of other Atomic Groups might 
be lost. The large number of water molecules around the protein surface is due to the 
crystallization procedures which proteins go through, ending up in a space filled with 
water molecules. Therefore, sampling “useful” water molecules to be assessed by 





Figure  2-26: The number of water molecules in the Protein – Ligand Dataset (Section 
 2.3.1) and how it varies with the minimum number of candidate hydrogen bond 
partners. HBPlus [160] counts the number of possible hydrogen bond interactions for 
a certain atom based on the distance and bond orientation of this atom and its 
surrounding partners. An minimum number of hydrogen bond partners = 2 means an 
atom has at least 2 neighboring atoms capable of forming hydrogen bonds with it. 
 
We define the “usefulness” of a water molecule by the number of possible hydrogen 
bonds it can make with the protein surface. The hydrogen bonds between water 
molecules and the protein are calculated by HBPlus [160]. This program studies the 
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geometries (distance, angles) of different hydrogen bond donor/acceptor pairs to 
assess their ability to form a hydrogen bond. Water molecules were sampled and the 
number of possible hydrogen bonds they participate in was calculated (Figure  2-26). 
Two thresholds were used in assessing the “usefulness” of a water molecule: 
Threshold A labeling a water molecule as useful if it can participate in at least 3 
hydrogen bonds, and Threshold B labeling a water molecule as useful if it can 
participate in at least 4 hydrogen bonds. These 2 thresholds were chosen since a lot 
of water molecules can participate in 2 hydrogen bonds and this might lead to over-
sampling of these molecules. Restricting the sampling of water molecules to those 
that can participate in at least 5 hydrogen bonds is also unreasonably high (such 
situations exist in very special circumstances) and might therefore lead to under-
sampling of water molecules. Thresholds A and B are used to create two versions of 
STPWater, and their performance is tested and compared. 
2.8.2 Comparison between the Two Water Thresholds and Regular STP 
The two version of STPWater are referred to as STPWater3 for STPWater created 
with Threshold A and STPWater4 for STPWater created with Threshold B. Both 
versions have been tested by comparing the distributions of average propensities of 
triplets belong to binding sites and all surface triplets. The 90-10 cross validation 
scheme was used again (Section  2.4.1). Each structure in a 10% subset of the dataset 
was tested with an unbiased score table created from the remaining 90% of 
structures. The test scheme would calculate 2 attributes for each structure: the 
average propensity of all binding site triplets and the average propensity of all 
surface triplets. The comparison of the distributions of these two attributes is detailed 
in Figure  2-27 and Figure  2-28. The difference between the average propensity of 
78 
 
binding site triplets and that of all surface triplets is quite similar for both STPWater3 
and STPWater4. Further tests have been designed to further scrutinize the 
performance of these 2 versions of STPWater. 
 
Figure  2-27: Comparison of the Average Propensities of binding sites triplets with 
the average propensities for all surface triplets as calculated by the STPWater3 score 
table. 11 structures (3.5%) exhibit binding sites with a lower average propensity than 
the average propensity of all surface triplets. 
 
STPWater3 and STPWater4 are compared with regular STP. The comparison is done 
on the basis of two criteria: the number of structures whose average propensity for all 
binding site triplets is less than the average propensity for all surface triplets and the 
proportion of “Top Triangles” (Section  2.4.1) that are in the vicinity of a ligand 
(Figure  2-29 and Figure  2-30). For the second test, each structure is colored with a 
nonbiased score table (based on the 90-10 testing scheme) and the PatchScores are 
scaled from 0 to 100. Then “Top Triangles” are detected and checked if they occur at 


















a maximum distance of 5Å from the ligand of that structure. The proportion of those 
triplets that are within this distance was calculated and used to compare the 
performance of the 3 versions of STP. 
 
Figure  2-28: Comparison of the average propensity scores of binding sites triplets 
with the average propensities for all surface triplets as calculated by the STPWater4 
score table. 13 structures (4.2%) exhibit binding sites with a lower average 
propensity than the average propensity of all surface triplets. 
 
STPWater3 shows an advantage over STPWater4 and regular STP when it comes to 
the number of structures with average propensities of binding sites triplets compared 
to the average propensities of all triplets on the surfaces of those structures (Figure 
 2-29): 11 for STPWater3, 13 for each of the original STP and STPWater4. 
Comparing the proportion of “Top Triangles” (Section  2.4.1) that are within the 
vicinity of a ligand shows that STPWater3 and STPWater4 have very similar 
performances; both of them outperforming regular STP (Figure  2-30). It is therefore 


















concluded that STPWater is a good extension of STP and has a better performance. 
The difference between STPWater3 and STPWater4 is minimal, with STPWater3 
performing slightly better (Figure  2-29). 
 
 
Figure  2-29: The number of structures that have binding sites with a lower average 
propensity than the average propensity of all surface triplets according to the original 
STP, STPWater3, and STPWater4 score tables. 
Number of Structures with average propensity of binding sites less 
























Figure  2-30: The fraction of high scoring triplets that are in the vicinity (5) of a 
ligand according to the STP, STPWater3, and STPWater4 score tables. High scoring 
triplets are those with PatchScores higher than 90 (Top 10), 80 (Top 20), or 70 (Top 
30) on a scale of 0 to 
water molecules into the STP prediction algorithm.
correspond to STP versions including water molecules with at least 3 or 4 candidate 
hydrogen bond partners respectively.
 
 
100. Results show a minute improvement by incorporating 







3 Applications of the STP Propensities 
 
Figure  3-1: Various applications of the STP propensity scores in automated 
prediction of binding sites, pseudo-ligand creation, E.C. class number prediction, 
allosteric binding sites, and binding surfaces in large multi component complexes. 
 
Various applications of the STP propensity scores are discussed in this chapter 
(Figure  3-1). The STP algorithm explained in Chapter  2 relies on color coding the 
surface which is then processed by the human eye. Section  3.1 details an STP-
dependent scoring function that scores the likelihood of a specific point around the 
protein to be adjacent to a binding site. This is then exploited to create an automatic 




























intervention. The same routine is also used to create pseudo-ligands, used as 
templates for docking programs, locating the area to be tested in docking. In Section 
 3.2, the ability to distinguish the E.C. numbers of enzymes by their surface triplet is 
tested. Six propensity score tables are created, each corresponding to the likelihood 
of STP triplets to exist in the active sites of a certain class of enzymes. These score 
tables are then used to predict the E.C. numbers of unknown active sites. Section  3.3 
details the use of STP propensities in re-ranking docking orientations, using STP as a 
scoring function that filters orientations generated by docking programs. Finally, 
section  3.4 explains the application of the STP coloring routine to large multi-
component complexes while section  3.5 details the capability of STP to predict the 
location of allosteric binding sites. 
3.1 Automated Identification of Protein Binding Surfaces 
Energy based programs are widely used for various applications like docking [69, 71, 
161], molecular dynamics [162], predicting binding sites [151-153]. We use the STP 
propensities to create an STP-based energy-like function, capable of scoring points in 
space around the protein based on their distance from surface triplets, and the 
propensity of these triplets. High scoring points (referred to as STP site points) will 
then be flagged as favorable by STP since they will be close to high scoring atomic 
groups and triplets. This leads to two direct applications. First, STP site points can be 
used for automated prediction of the binding site, without any human intervention 
(like looking at a colored surface). This is useful in case a user wants to predict the 
locations of binding sites on many PDB structures and does not have enough time to 
manually look at the colored surface of these structures. Second, STP site points will 
serve as pseudo-ligands for docking programs when the ligand is not available. Many 
docking programs [69, 71, 161]
the area in which compounds would be docked on a certain receptor. In the absence 
of a ligand, these programs are given mock points which may or may not be accurate. 
STP site points are binding site predi
ligands for these docking programs.
 
Figure  3-2: A cube of grid points around the protein is created (A). These grid points 
will be scored via a scoring functio
distance or score parameters (B). The remaining grid points will be clustered into 
groups, as shown by the different colors of gridpoints in (C). Each cluster will have a 
score, indicating the likelihood of that
 
A forcefield is defined as a scoring function capable of scoring an “interaction value” 
at any point in space. Points in space are created (as a grid) and scored via a scoring 
function (Figure  3-2). High scoring points are identified as STP 
site points are clustered to form an STP 
several clusters serving as suggestions for the location of the binding site. This poses 
several questions: 
1. How will the grid points be generated?
2. What scoring function will be used to assign scores to different points?
 rely on the existence of a known ligand to specify 
ctions and will provide more accurate pseudo
 
n. Some grid points will be discarded due to 
 cluster to be the binding site.
site point











3. How will points with high scores be identified (i.e. what is a high score)? 
4. How will the points be clustered? 
3.1.1 Grid Point Generation 
A grid was defined as a rectangular box around the protein (Figure  3-2 A). The grid 
generation program searches for maximum and minimum coordinates in the protein 
structure and pads 4Å in each dimension (x, y, and z). Grid points are then created at 
a resolution of 2Å (i.e. we have a grid point at a step distance of 2Å). For each entry 
in the representative dataset (Table  2-2), grid points around the protein surface were 
classified as binding site points if the minimum distance to any known-ligand atom is 
less than or equal to 2Å. Grid points that are more than 4Å away from the protein 
(maximum distance threshold) were neglected, as well as points closer than 2.5 Å 
(minimum distance threshold). The minimum distance threshold (2.5Å) was chosen 
to minimize steric clashes between site points and the protein atoms. The maximum 
distance threshold (4 Å) was chosen to avoid extending the binding site far into the 
space around the protein (Figure  3-2 B). Once the scoring function has been created, 
this maximum distance threshold will be tested and tuned.  
3.1.2 The Scoring Function and Identification of STP Site points 
The Site pointScore of any point (x, y, z) in space depends on the STP propensity of 
the protein surface triplets, and the distance between this point in space and these 
triplets (Figure  3-3). Therefore, a general energy-mimicking formula for the scoring 
function was designed as by Equation  3-1. Site pointScores of a certain structure are 
often scaled onto a 0-1 interval, creating a scaled Site pointScore. We define the 
notion of a score-band, similar to the notion of Top Triangles in Section  2.4.1. The 
score-bands used in this chapter and their corresponding scaled 
Top15 (0.85 to 1), Top20 (0.8 to 1), Top25 (0.75 to 1), Top30 (0.7 to 1), Top35 (0
to 1), Top40 (0.6 to 1), Top45 (0.55 to 1), Top50 (0.5 to 1), and Top60 (0.4 to 1).
Figure  3-3: Each point in space (a selection is shown in black) will be scored based 
on the surface triplets of the protein, and the distance between that point and those 
triplets (distance between the point and the centroid of a triplet is used). General 
form of the scoring function is given in 
 
Equation  3-1: The score given to any point in space is based on the propensities of all 
the protein surface triplets, and the distance 




























Figure  3-4: The assessment of several scoring functions (listed on the x-axis of the 
Figure). For each structure, grid points around the protein are scored with the various 
functions and scaled 0 to 1. The grid points that belong to the binding site (computed 
by a maximum 2 Å distance from the ligand atoms) are identified. The highest 
scoring point in a binding site is checked for its score band (Section  3.1.2). Score 
bands tested are: Top15 (0.85 to 1), Top20 (0.8 to 1), Top25 (0.75 to 1), Top30 (0.7 
to 1), Top35 (0.65 to 1), Top40 (0.6 to 1), Top45 (0.55 to 1), Top50 (0.5 to 1), and 
Top60 (0.4 to 1). Figure shows that for all score bands, using Σscore/d2 leads to 





































Figure  3-5: The distribution shift between the average Site pointScore of a binding 
site point and that of the entire protein surface site points. The higher the shift, the 
more distinguished are the binding site points from the rest of the site points around 
the surface. The x-axis denotes the power to which the distance is raised, according 
to Equation  3-1. 
 
Six values were nominated for α in Equation  3-1 (1 through 6) and tested. Grid 
points were scored according to each function, then scores where normalized on a 0 
to 1 scale. Each structure in the protein-ligand dataset was tested to check whether it 
has at least 1 binding site point in each of the score bands Top 60, Top 50, Top 45, 
Top 40, Top 35, Top 30, Top 25, Top 20, and Top 15 (Section  3.1.2); where a Top N 
band represents points with scores in the top N% of the scoring range (so a Top 60 
band refers to scores 0.4 to 1). The maximum distance threshold is tested and tuned. 
Grid points around the protein were scored and normalized, and then the minimum 
distance to the protein from any grid point in the Top 10 band was calculated. These 
distances had an average of 2.29Å and Standard deviation 0.46Å and are listed in 

































































Performance of Grid Point Scoring Functions
89 
 
the maximum distance threshold was fixed to 4Å (giving around 0.5Å margin over 
the maximum distance calculated). 
 
The proportion of structures with points in these bands where recorded for the six 
nominated scoring functions and are presented in Figure  3-4. At “α = 2”, binding site 
points are scored within higher score-bands than with the other tested values for α 
(Figure  3-4). This site point score assesses the likelihood of a point in space 
belonging to a binding site. The distance of a point to a certain triplet is important 
and plays a role in determining the role of this point in space. Scaling the distance by 
a power of two gives the most suitable distance contribution to the scoring function. 
Another remarkable result from this graph is that at “α = 2”, 99.63% of the test cases 
had binding site points in the Top 60 band. Consequently, a first screening phase will 
be added to this functionality, which removes all points that do not lie in the Top 60 
band (Figure  3-2 B). Figure  3-5 shows the distribution shift of the scores of binding 
site gridpoints minus the scores of all the gridpoints around a protein. The results 
backup the findings in Figure  3-4. 




























































































































































































































































































































































































































































































































































































































































3.1.3 Clustering STP Site points 
After the distance threshold and the scoring functions have been tuned, the only 
question left to answer is which clustering method should be used. Clustering points 
according to their spatial and score distributions is a computationally hard problem. 
There are many known clustering methods algorithms. Some methods apply pure 
computational clustering without any heuristics (QT clustering [163]) while others 
rely on calculating probabilities for each point to be in a certain clustering (EM 
clustering [164], Bayesian Clustering [165]). The use of various other methods that 
utilize machine learning (SVMs [166], Neural Networks [167], and Bayesian 
machines [168]) have also been mentioned in the literature. The QT clustering 
algorithm was chosen to be used in this work because of its simple methodology and 
its independence from heuristics and probability calculations which might complicate 
the task. The pseudocode of the original QTClustering algorithm is found in 








Algorithm  3-1: QT Clustering Algorithm Pseudocode 
QT_Clust(G, d) 
If diameter (G) ≤ 7 
 Output G #originally was if |G| ≤ 1 but adapted to suit site point generation 
Else 
 For all i ε G  
  Set flag  True 
  Set Ai  {i} #Ai is the cluster started by i 
  While flag = True and Ai ≠ G  
   Find j ε (G - Ai) such that diameter (Ai U {j}) is minimum 
   If diameter (Ai U {j}) > d} 
    Set flag  False 
   Else  
    Set Ai  Ai U {j} #add j to cluster Ai 
   End If 
  End While 
 End For 
 Identify set C ε {A1, A2, … , Ai} with maximum cardinality 
 Output C 




The QT Clustering algorithm uses a “maximum diameter” to define a cluster. The 
diameter of a set of points is defined as the maximum distance between any 2 points 
belonging to that set. Consequently, the diameter of a set containing the binding site 
points for each entry in the dataset was measured. To recap, binding site points are 
grid points around the protein surface. These points were classified as if the 
minimum distance to any known-ligand atom is less than or equal to 2Å (Section 
 3.1.1). Only entries with one ligand were taken into consideration. Diameters of 
these site point sets ranged between 7Å and 25.97 Å, with a mean of 14.7Å and 
standard deviation of 3.8Å (Figure  3-6). These values were used to define the 
geometric limits of the site point clusters, keeping these clusters spatially similar to 
the binding site points sets observed in the training set. Hence, a cluster is defined to 




Figure  3-6: The distribution of diameters of binding sites in protein-ligand dataset. 
Only entries with one ligand were considered. A diameter of a set of points is defined 
as the maximum distance between any two points in that set of points. A set of 
binding site points is defined as all grid points within a maximum distance of 2 Å 
from a ligand atom. 
 
Table  3-2: The Diameter of a binding site, defined as the maximum distance between 
any 2 site points belonging to that binding site (Section  3.1.1). A histogram is 















































































































































































































































































































































































































































































































































































































3.1.4 Creating Pseudo-Ligands with STP 
STP site points can be used as pseudo-ligands to be input for docking programs like 
LIDAEUS [69], Autodock [71], and Autodock Vina [161]. These programs depend 
on a ligand coordinates file to locate the part of the receptor on which the docking 
partners will be docked. In standard cases, a ligand exists in the crystal structure and 
is used by these programs. In the absence of a known ligand, the user has to create a 
pseudo-ligand to be used as a beacon for locating the binding site. While experienced 
users rely on professional programs like COOT [169] to create such pseudo ligands, 
inexperienced users try to introduce atoms around the protein. Some of these atoms 
are either too close or too far from the protein surface. Moreover, there are no 
guidelines for how big or small a ligand should be. STP provides a simple and useful 
solution for this problem, by creating pseudo-ligands around a protein. 
 
The primary gain from using STP to create pseudo-ligands for a protein is that STP 
will use the propensity of surface atoms to suggest where the binding site is, and then 
attempts to create clusters of atoms around the protein with the highest possible 
score. Grid points around the protein are generated (Section  3.1.1) and a scaled Site 
pointScore (Section  3.1.2) is generated per grid point. According to Figure  3-4, 
99.63% of the tested cases showed that the binding site includes points with a scaled 
Site pointScore of at least 0.4 (Section  3.1.2). Therefore, all grid points with scores 
less than 0.4 are neglected. The remaining grid points are clustered (Section  3.1.3) 
into sets, called clusters. Every cluster gets a cluster score equal to the average 
scaled Site pointScore for all site points in that cluster. 
each grid point represented by a carbon atom. Atoms of the same cluster are grouped 
in residues. An average user can rely on Pymol 
to be used a pseudo
percentage of dataset structures whose top 3 ranked pseudo ligands overlap the 
experimentally verified ligand
least 1 atom within 2 Å of a pseudo ligand)
with the original ligand in 41%, compared with 62% and 66% for the top two and top 
three ranked pseudo ligands (
Figure  3-7: The percentage of dataset structures whose experimentally verified 
ligands overlap with the top 3 ranked STP generated pseudo ligands.
                                        
9 http://tripos.com/tripos_resources/fileroot/pdfs/mol2_format2.pdf
A mol29 file is generated 
[43] to select a residue and extract it 
-ligand. The success of this routine was measured as the 
 (overlap measured as an experiment
. The top ranked pseudo ligand overlaps 
Figure  3-7). Two examples are shown 





al ligand with at 






Figure  3-8: ABL Tyr Kinase bound to the synthetic peptides (A) and FKBP12 bound 
to FK506 (B). Each structure is colored with STP to locate the binding site. Small 
spheres around the ligand represent the top ranked clusters of STP site points created 
by STP to serve as pseudo-ligands. Four clusters are presented in A and are colored 
blue, green, yellow, red (in descending order of average cluster score), while one 






The pseudo-ligand generation program leads to the incorporation of STP with the in-
house virtual screening pipeline (Figure  3-10). This automatic system is 
demonstrated on the Leishmania Mexicana CRK3 (Cyclin Related Kinase 3) protein 
kinase. Leishmania Mexicana CRKs are homologues of human Cyclin Dependant 
Kinases (CDKs). CRK3 is a cdc2-related protein kinase with activity towards histone 
H1. It has been proven to be essential to Leishmania mexicana since disrupting both 
alleles of the CRK3 gene resulted in changes in cell ploidy [170]. There is no 
existing structure for CRK3 or its human homologue CDK1 (54% sequence identity). 
CRK3 has been modelled using modeller [171] based on the structure of the protein 
CDK2 (58% sequence identity). This model of CRK3 is then targeted with the in 
house virtual screening pipeline, in a search for possible inhibitors for the active site 
of CRK3, or for CRK3-Cyclin 6 (CYC6) interaction. 
 
The CRK3 model was studied by STP for the nomination of possible binding sites 
and the generation of pseudo ligands (Figure  3-10). Two of these pseudo ligands 
were picked out: the first (referred to as ligand location A), in a ridge edged by 
Arg’25-Val`28 from one side, and Lys`53-Arg`55 from the other side, and the 
second referred to as ligand location B, in a deep pocket located around Phe`99-
Ala`104 (Figure  3-9).  
Figure  3-9: The pseudo ligands created by STP on the CRK3 model, indicating 
ligand location A and ligand location B used in this 
 
Possible inhibitors were screened with LIDAEUS 
were all selected from the Maybridge dataset in the EDU
to 64,000 compounds. The top 250 LIDAEUS hits were then taken and redocked 
with the higher resolution docking program AutoDock 
were picked from the autodock experiments, and similar compounds were mined 
from EDULISS with the program UFSRAT 
compounds screened with AutoDock at positions A and B of the CRK3 structure 
showed high binding affinities (several low nanoMolar compounds). The UFSRAT 
generated compounds showed an enrichment in the predicting binding affinities, 
whether with the introduction of predicted picoMolar binding compounds (ligand 
experiment. 
[69]. The screened compounds 
LISS database, summing up 
[71]. Highscoring ligands 




Table  3-3, the 250 
location A), or several nanoMolar to microMolar Binding compounds (ligand 
location B). Figure 
predicted binding sites. 
Figure  3-10: The incorporation of STP pseudo ligand creator in the in house virtual 
screening pipeline generates possible bindi




 3-11 shows the binding of the best two ligands to the STP 
 





Table  3-3: The binding affinity and binding energy ranges generated by the 
AutoDock screenings described in 
inhibitors for the CRK3 binding in two distinct locations predicted by STP.
Virtual Screening 
Experiment 
CRK3 Pseudo Ligand A
CRK3 Pseudo Ligand A 
UFSRAT Homologues
CRK3 Pseudo Ligand B
CRK3 Pseudo Ligand B 
UFSRAT Homologues
 
Figure  3-11: The binding of top compounds to the CRK3. A shows the binding of 
compound 8SPH1-253
affinity of 399 pM. B shows the binding of compound 24SPH1
(position of pseudo ligand 2) at a pre
 
3.2 Predicting Enzyme Class 
Proteins interact with their binding partners as a part of larger pathways where each 
step has a designated function. Since surface atoms and residues play a vital role in 
these interactions, it 
determine the function binding pocket of a certain protein. Determining the function 
of a protein is usually approached from sequence and structure homology
Figure  3-10 indicates a high likelihood of possible 
Affinity Range 
Energy Range
 [ 3.52 nM, 45.76 mM ] [-
 
[399 pM, 1.74 mM] [-
 [725.69 pM, 2.92mM] [-
 
[22.7 nM, 169.69µM] [-
-022 to CRK3 (position of pseudo ligand 1) at a predicted 
dicted affinity of 726 pM. 
with STP 















172-177] or pattern matching [48, 51, 52, 178-182] perspectives. This section 
addresses the question of whether STP surface triplets are helpful in predicting the 
first level E.C. numbers of enzymes. Enzymes are abundant in structural databases, 
important for molecular function, and well characterized in general (chemically and 
biologically). A large amount of research is invested in enzymes and that leads to a 
wealth of information about their active sites and mechanisms through data sources 
like the CAZymes Analysis Toolkit [183], the CoFactor database [184], and MacIE 
[185]. The objective is to design a system that takes in a binding site, and predict its 
enzyme class number based on the triplets it contains. 
3.2.1 Enzyme Classes 
Enzymes are classified into six major classes and are known by their Enzyme 
Commission (E.C.) number. An E.C. number of an enzyme is made up of 4 parts, 
each part indicating a sub-classification of the class indicated by the previous part. In 
this experiment, we will be interested in the first-level classification of enzymes, 
signaled by the first digit of the E.C. Number. Oxidoreductases (E.C. 1) are 
responsible for oxidation or reduction reactions in the body. Transferases (E.C. 2) are 
responsible for the transfer of chemical groups from substrates to products. 
Hydrolases (E.C. 3) cleave bonds via hydrolysis. Lyases (E.C. 4) eliminate rings and 
double bonds, but not through hydrolysis or oxidation. Isomerases (E.C. 5) are 
responsible for inducing geometric changes in molecules. Ligases (E.C. 6) are 
responsible for joining molecules together, usually coupled with the hydrolysis of a 
chemical group on one of these molecules. 
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3.2.2 The Training Dataset 
A representative dataset of the enzymes in the Protein Databank is needed by STP to 
predict the enzyme class of a protein. The Protein-Ligand Dataset (Section  2.3.1) is 
used for this purpose; all enzyme structures are extracted and annotated with their 
Enzyme Class specification. 198 of the dataset’s 309 structures are enzymes, 
distributed among 40 oxidoreductases (E.C. 1), 57 transferases (E.C. 2), 79 
hydrolases (E.C.  3), 15 lyases (E.C. 4), 9 isomerases (E.C. 5), and zero ligases (E.C. 
6) (Table  3-4). Because our dataset contained no ligases, a different dataset should be 
compiled to cover the entire span of the Enzyme Classes. 
 
MacIE [185] is an online database of enzymes in the PDB, containing a dataset 260 
PDB codes, representing all 249 unique E.C. Numbers and 331 CATH Codes [19]. 
This dataset is unique by chemical action; every enzyme in this dataset corresponds 
to a unique chemical mechanism. Unfortunately, using this database proved to be 
unfeasible. Fourteen out of the first forty analyzed structures had a poorly defined 
binding site; the ligands (if present) are often defined as one or two metal atoms (for 
example, PDB structures 1EZV, 1VNC, 2FRV, and 1A7U). This makes it hard to 
define the binding surface of the protein by STP, which needs a considerably larger 
ligand to define a binding surface. Using MacIE’s enzyme dataset was therefore 
cancelled. Instead, we added the 13 ligase structures from MacIE to the protein-
ligand dataset, creating a comprehensive dataset covering all 6 enzyme classes. Two 
of these 13 structures were neglected (2TS1 and 1F7U, both have poorly defined 
active sites), and we end up with a dataset of 209 enzymes (Table  3-4). 
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Table  3-4: The enzymes in the protein-ligand dataset. Table shows 209 structures 
distributed among 79 Hydrolases (Enzyme Commission Number “E.C.” 3), 9 
Isomerases (E.C. 5), 14 Lyases (E.C. 4), 39 Oxidoreductases (E.C. 1), 57 
Transferases (E.C. 2). The remaining 11 Ligases (E.C. 6) have been imported from 






















































































































































































































































































































































































































































3.2.3 Predicting Enzyme Classes Methodology 
To give a good prediction of the Enzyme Class, a score should be calculated for each 
triplet type indicating the tendency of this triplet to occur in the binding sites of a 
certain enzyme class. Six score tables are created (one for each enzyme class) 
containing the tendency of a triplet to occur in the binding sites of different enzyme 
classes. This tendency will be called the Enzyme Class Propensity (ECP). The ECP 
is calculated similarly to the triplet propensities in Equation  2-1, but this time, the 
comparison is done between the frequency of occurrence of a certain triplet in the 
binding sites of a certain class of enzyme and the rate of occurrence of that triplet in 





















































α denotes a triplet type;; 
ClassProb(Φ, α) is the proportion of all triplets in Φ-class-binding-sites that are of type α; 
EnzymeProb(Φ, α) is the proportion of all enzyme-binding-site triplets that are of type α; 
ClassCount(Φ, α) is the count of occurrences of triplet type α in Φ-class ligand binding 
interfaces in the dataset; 
EnzymeCount(Φ, α) is the count of occurrences of triplet type α in binding sites of all 
enzymes in the dataset.; 
“i” spans the 455 triplet type;. 
ECP(Φ, α) is the Enzyme Φ-Class Propensity score for a triplet Type α. 
Equation  3-2: The Enzyme Class Propensity (ECP) 
 
After the six ECP score tables have been generated, classifying the enzyme class of a 
certain enzyme is simply a matter of finding which score table gives the binding site 
of this enzyme the highest score. The binding site triplets are extracted and scored 
with all six ECP score tables. Each binding site receives six overall scores (one from 
each ECP table); each score being the average of the ECP scores of all the triplets in 
that binding site based on an ECP score table. The maximum of these six overall 
scores signals the class of the enzyme. For example, if the highest score (among the 
six overall scores) for a certain binding site is that generated from the hydrolase ECP 
score table, then that binding site is classified as a hydrolase. 
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3.2.4 Performance of STP in predicting Enzyme Classes 
The enzyme classification system is tested on the structures making up its training 
set. The test is not performed according to the 90-10 testing scheme like the other 
STP and STPwater programs and that is because of the limited training set in use. 
The scarcity of isomerases, ligases, and lyases plays a key role in not adopting the 
90-10 testing scheme, which would then mean creating an ECP scoretable for 
isomerases from merely 8 isomerase structures to test the 9th, which will include a 
large loss of the information held by the triplet propensity scores. Therefore the 
training set is tested fully with the generated ECP score tables. 
 
STP showed a first level EC number identification success of 65%, correctly 
identifying 137 structures, and failing to identify 74 structures (Table  3-5). The 
success rate for each enzyme class can also be measured. Hydrolases are classified 
correctly in 66% of the test cases. That compares with 64% for the transferases, 59% 
for the oxidoreductases, 57% for the lyases, 82% for the ligases, and 78% for the 
isomerases (Figure  3-13). The high success rate for ligases and isomerases is 
possibly due to the low number of structures for these two classes in the training 
dataset (11 ligases and 9 isomerases) while the large classes (transferases, 
hydrolases, and oxidoreductases) show success rates closer to the entire subset 
success rate. Further scrutiny shows that 44% of the wrongly predicted 
oxidoreductases were classified as transferases, 44% of the wrongly predicted 
hydrolases were classified as ligases, and 33% of the wrongly predicted transferases 
were classified as hydrolases (Figure  3-12). This indicates a similarity between the 
profiles of these enzymes and will be discussed further in Section  3.2.5. 
Figure  3-12: The distribution of the false predictions of the four largest enzyme 
classes. Ligases and isomerases had two false predictions each and therefore the 
statistics in these cases are unreliable. Results show a high tendency to 



















































































































































































































































Figure  3-13: The performance of STP in predicting the Enzyme Classes of the 6 
Enzyme Classes. 
 
This performance is compared to that of the method designed by Dobson and Doig 
(2005) [186]. This method relies on a support vector machine (SVM) trained on a 
non-redundant dataset to classify enzymes by their first-level E.C. Number. The 
SVM takes as input several attributes related to the geometry and secondary structure 
of the tested enzyme (surface area, volume, Stride [187] assignments of secondary 
structure, fractal dimension [188], and number of residues). This method succeeds in 
predicting the EC number of 35% of the tested enzymes. In contrast, STP succeeds in 
predicting the EC numbers in 65% of the tested cases. This advantage posed by STP 
is possibly due to the nature of the STP algorithm which relies on the triangular 
composition of the pocket under study. These triangular patterns implicitly define 











































physiochemical attributes of that pocket and lead to a fast and reliable classification 
of the enzyme. 
3.2.5 One versus One Class Predictions 
With the existence of six enzyme classes, the problem of one versus one class 
predictions is defined as the classification of a certain structure into any of two 
possible classes (rather than a possible six). This is applicable when the enzyme in 
question is suspected of being any of two classes and is thus tested  accordingly. 
Dobson and Doig (2005) [186] refers to this problem as the 15 one class versus one 
class problems (as there are 15 combinations of 2 classes out of 6) and they report 
their success rates (Table  3-6). The same experiment is conducted with use of the 
ECP score tables where each of the 15 one versus one problems is tested for the 
accuracy. For example, testing Hydrolases versus Lyases means all Hydrolases and 
Lyases are scored with the Hydrolase and Lyase ECP score tables. Each structure is 
then classified according to the table that gives it the higher score. The results of 
these 15 one versus one problems are listed and compared to those of Dobson and 
Doig (2005) [186]. STP-ECP scores perform better than the Dobson and Doig [186] 
method in each of the 15 one versus one class predictions, except in the case of 
Oxidoreductase versus Hydrolase class prediction, where the success rate of 
Oxidoreductase is 76.9% with STP-ECP score tables and 79.7% with Dobson and 
Doig [186]. However, the total success rate for the Oxidoreductase versus Hydrolase 





Table  3-6: Predicting Enzyme Classes (first-level EC numbers) divided into 15 one 
class versus one class problems. The performance of the STP-ECP (Enzyme Class 
Propensity) score tables is compared to that of the method by Dobson and Doig 
(2005) [186]. In bold is the only statistic where Dobson and Doig’s method [186] 
outperforms STP-ECP. In a problem of A vs B, accuracy of A is the percentage of A 
instances predicted correctly, and similarly for B. Total accuracy is the percentage of 
all A or B instances predicted correctly. 
Problem 
Accuracy (%) 
Dobson and Doig [186] STP-ECP score tables 
A B A B Total A B Total 
Oxidoreductase Transferase 68.4 64.8 66.2 79.5 87.9 84.5 
Oxidoreductase Hydrolase 79.7 61.3 67.4 76.9 77.2 77.1 
Oxidoreductase Lyase 75.9 75.0 75.5 94.7 85.7 92.5 
Oxidoreductase Isomerase 73.4 74.5 73.8 87.2 88.9 87.5 
Oxidoreductase Ligase 81.0 75.0 79.8 84.6 90.9 86.0 
Transferase Hydrolase 58.6 58.8 58.7 82.8 77.2 79.6 
Transferase Lyase 35.9 75.0 48.4 81.0 85.7 81.9 
Transferase Isomerase 53.9 66.7 57.5 84.5 100 86.6 
Transferase Ligase 59.4 75.0 61.4 84.5 90.9 85.5 
Hydrolase Lyase 46.2 78.3 55.0 78.5 82.9 80.6 
Hydrolase Isomerase 58.8 68.6 61.1 78.5 88.9 79.5 
Hydrolase Ligase 49.4 70.0 51.7 75.9 100 78.9 
Lyase Isomerase 50.0 68.6 58.6 92.9 100 95.7 
Lyase Ligase 50.0 60.0 52.4 85.7 90.9 88.0 
Isomerase Ligase 62.7 70.0 64.8 100 100 100 
 
The lowest total accuracies scored by STP-ECP (Table  3-5) were recorded (by 
increasing accuracy) for the oxidoreductase : hydrolase, hydrolase : ligase, 
hydrolase: isomerase, transferase: hydrolase, and hydrolase:lyase sub-problems. 
Interestingly, all these problems included hydrolases as a candidate classification, 
indicating that hydrolases are more prone to being confused with other classes. 
Combined with the observations in Figure  3-12 (Section  3.2.4), we see that 33% of 
the wrongly predicted transferases were classified as hydrolase. The same goes for 
31% of the wrongly predicted oxidoreductases and 17% of the wrongly predicted 
lyases. We conclude that hydrolase active sites are less distinct from the other 
enzyme classes according to the STP-ECP score tables. Nevertheless, the accuracy 
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scores are encouragingly high, with the lowest total accuracy score (for the 
oxidoreductase:hydrolase subproblem) at a value of 77.2%. 
3.3 Using STP Propensities to Rank Docking Orientations 
Protein-protein docking programs generate a large and varied list of possible docking 
orientations between two binding partners. The energy/shape functions in these 
programs are sometimes insufficient to discriminate between orientations, leading to 
the true docking pose being absent from the best hits. This section demonstrates the 
use of STP to re-rank such docking orientations in an attempt to get a better 
prediction of how two complement proteins, C5 and C7, interact during mammalian 
immunological response. 
3.3.1 The HyHEL-10 Fab-lysozyme Complex 
Table  3-7: Performance of Hex in the recognition of known complexes. A 6D-search 
over 5.4 × 108 alternative test orientations is carried out at increasing fourier 
transformation expansion orders, N. The lowest energy orientation within 3 Å 
(calculated as that of the Cα deviations) from the experimental ligand location is 
taken and its rank is noted. [72]. 














2DHB 2 0.00 2 0.00 1 1.55 
2CCY 1 0.04 1 0.04 1 1.59 
1CSE 37 0.73 1 0.08 1 0.92 
2SNI 15 0.58 1 0.42 1 0.42 
2KAI 17 0.41 3 0.69 7 0.81 
2PTC 132 0.52 2 0.48 1 0.48 
1CGI 1 0.38 1 0.38 1 0.38 
1CHO 1 0.45 1 0.55 1 0.55 
1BGS 1 0.82 1 0.82 1 0.88 
1GGI 1 2.47 1 0.90 1 0.90 
1TET 5 1.48 1 1.16 1 1.09 
1FPT 102 1.04 1 0.42 1 0.42 
2IGF 3 0.71 1 0.77 1 0.77 
1JEL 4867 0.81 1060 0.81 2 0.81 
1BQL 524 1.85 12 0.96 1 0.39 
3HFL 318 1.01 5 1.00 1 1.00 
3HFM 7 2.19 27 1.09 3 1.03 
1VFB 8344 1.49 216 0.20 9 0.20 
1MLC 1401 0.00 116 0.00 187 0.84 
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1MEL 9898 1.03 27 1.03 3 1.03 
1JHL 385 0.62 8 0.38 1 1.08 
1FBI 14 1.09 1 1.09 1 0.38 
1NCA 68 1.53 1 0.32 1 0.32 
1NMB 160 2.43 1630 1.39 1009 1.39 
1NSN 19992 1.11 716 0.75 1130 2.29 
1IAI 1381 1.48 111 0.37 20 1.39 
1DVF 11145 0.00 88 1.38 49 0.44 
1KB5 140 0.34 1 0.34 78 1.38 
1IGC 1328 1.74 269 0.81 1 0.34 
 
Hex 5.1 [72] is the main docking engine for this experiment. Hex uses spherical 
polar Fourier correlations to define the protein surfaces and tries over 540 million 
docking orientations for each pair of docking partners. Those orientations are scored 
based on shape complementarity, electrostatic interactions, and molecular mechanics. 
Hex performs remarkably well in most cases of docking globular domains (Table 
 3-7). However, as reported by Ritchie and Kemp [72], Hex sometimes fails to 
identify the right orientation. Frequently, the correct orientation is examined by Hex 
during the global search, but is not ranked highly according to the shape 
complementarity algorithm. This shortcoming can been corrected using STP to 
rerank the orientations [133]. 
Table  3-8 A snapshot of the top 5 HyHEL-10 Fab-Lysozyme docking orientations 
after being ranked by STP shows that STP finds the best orientations unambiguously 
[133]. Interface triplets on both receptor and partner are identified, and the average 
propensity is calculated as a score for the orientation. The orientation with the 
highest average interface propensity is ranked first. 
Dock ID Hex Rank 
STP Average 
Propensity (Rank) 





















We have previously demonstrated a similar experiment where ranking docking 
orientations were performed on the HyHEL-10 Fab-lysozyme complex [133] . In that 
case, the three-dimensional structure of the complex between the antibody and 
lysozyme was known. The key results, listed in Table  3-8, show that the true docking 
orientations, which were ranked 58th and 12th by Hex, were ranked first and second 
by STP. 
3.3.2 The C5/C7 interaction of the Human Immune Complement System 
We have used the ranking procedure to carry out a detailed study of the interaction 
between the C5 and C7 subunits of the immune complement system. A complement-
mediated response to infection is vital to recognize, and kill, pathogens and toxic 
entities. Inappropriate complement activity, whether activation at inappropriate sites 
or at excessive/inadequate levels, leads to numerous inflammatory disorders and/or 
tissue damage [122, 189]. The activation of complement pathways and thus, the 
attack on pathogens, is a result of a cascade of intermolecular binding, enzymatic 
cleavages and protein complex assembly [121]. Although many of the binding 
partners and their roles have been identified [190, 191], there is still very little 
understanding of the molecular level interactions and how those binding partners 
behave in order to create the necessary complexes needed for the complement-
mediated immune response. Specifically, although the C5-C6-C7-C8-C9 proteins 
which form the lipid bilayer penetrating attack complex (Figure  3-14) are known, the 




Figure  3-14: The Membrane attack complex formation, picture taken from [192], Fig 
2-35. 
 
The membrane attack complex (MAC) is assembled by C5 binding to C6, and then to 
C7 and C8 [121]. Then a membrane pore is formed by the assembly of several copies 
of C9 to the initial complex. The C-terminal domain of C5, the C345C domain, has 
been shown to interact with both C6 and C7, through their C-terminal factor I-like 
modules (FIMs [193]). Bramham et al. have determined the solution structures of the 
C5-C345C domain [191] (Figure  3-15) and C7-FIMs [194] (Figure  3-16) in isolation 
but not yet in complex. They are interested in finding how these two proteins interact 
since characterizing the intermolecular details of the interaction between C5 and C7 
should provide insight into how the MAC begins to assemble. This valuable 
information should also shed some light on possible ways to fight the complications 
that arise from inappropriate complement activity in terms of how to up/down-
regulate or inhibit the formation of the MAC. Gasque et al [122] provide evidence of 
the involvement of complement in the initiation/exacerbation of central nervous 
system inflammation and tissue injury, and suggests that successful inhibition of the 





Figure  3-15: The structure of the C5-C345C domain in surface (A) and cartoon (B) 
views, and colored by STP 
 
Figure  3-16: The structure of the C7-FIMs in surface (A) and cartoon (B) views, and 
colored by STP 
 
Three docking experiments were designed to explore the possible ways of interaction 
between C5-C345C and C7-FIMs, and the different parameters are shown in Figure 
 3-17. Electrostatic interactions were always used in all the dockings. However, the 
post processing step was varied within the docking simulations between “Bumps and 
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Volumes”, “MM Minimization”, and “MM Energy”. The first option enables a 
bumps counter, in which the number of steric clashes between non-bonded pairs of 
heavy atoms in each solution is calculated and used in scoring the docking 
orientations. The second option utilizes a single (rigid body) molecular mechanics 
energy for scoring those orientations. The third option applies a Newton-like energy 
minimization to each docking solution. These energies are calculated using Lennard-
Jones and hydrogen bond potentials as defined in the OPLS forcefield in addition to 
electrostatic interactions (Hex 5.1 user manual). 
 
Figure  3-17: The Hex parameters used to dock C5-C345C onto C7-FIMs in the three 
experiments denoted as A, B, and C 
 
Hex was set to return the top 500 solution clusters in each experiment, where similar 
docking orientations (based on calculating RMS distances between the different 
poses of the ligand domain in different orientations) are automatically grouped in 
clusters. These 500 solutions were subsequently scored via STP. The binding site 
triplets and atoms were extrapolated, and each solution orientation was given two 
scores: a triplet score equal to the average of STP propensity scores of all triplets in 
the binding site, and an atom score equal to the average of STP propensity scores of 
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all atoms in the binding site. Docking orientations that were ranked in both the top 
100 results by Hex and the top 100 by STP triplet scores or STP atom scores were 
classified as “spotlight” orientations to be subjected for further analysis. 
 
 
Figure  3-18: Representative orientations of different docking clusters of the C7-FIMs 
(green) and C5-C345C (blue) proteins showing the top hits according to the STP/Hex 
combined score involving the Val 54 to Gln 63 α-helix that is favored by STP as a 
binding site. In most orientations, the interaction involves both modules of the C7-
FIM pair (top 2 orientations), however some orientations were on the other side of 
the α-helix which also receives a high STP score (bottom orientation). 
 
In this case, an assessment of the success of the STP predictions of the binding sites 
is not an easy task due to the absence of a three-dimensional structure of the C7/C5 
α-Helix 
favored by STP  
as a binding site 
on the C7 protein 
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complex. Hex produced a large number of orientations for the C5/C7 complex, but 
conjugating the Hex scores with STP scores led to the favoring of orientations taking 
place on either side of the α helix extending from Val 54 to Gln 63 in the C7-FIMs 
(Figure  3-18). 
 
An NMR titration experiment was designed to determine which residues of the C7-
FIMS were perturbed upon binding to C5, by examination of the resonances from the 
backbone amide groups in series of HSQC spectra. Although in this titration the 
NMR experiment does not show the location of the C5 protein in the complex, it 
indicates the likely location of the interface. This experiment showed that the 
strongest effect occurs on and around the α-helix extending from Val 54 to Gln 63 in 
the C7-FIMS; the same helix predicted by STP to be a binding site (Figure  3-19). 
This result is also backed up by the fact that the C7 fragment in this study constitutes 
a pair of factor I-like modules in a compact pseudosymmetric arrangement [194]. It 
has been suggested that this pair of domains might undergo a structural alteration 
upon binding, opening up to a more elongated conformation to accommodate a 
binding partner during the assembly of the MAC [194].  
 
STP predictions concur with the titration experiment. The side chains of all residues 
colored in orange, red, and magenta in the titration experiment (Figure  3-19) have 
been colored orange and red by STP. The results of the titration experiment show the 
importance of using STP scores in ranking docking orientations. With the help of 
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STP and Hex, we are now one step closer in understanding the complex nature of the 
MAC self-assembly process.  
 
 
Figure  3-19: The sites on C7-FIM likely to interface with C5-C345C. A, B, and C 
show the results of a titration experiment of C5-C345C into C7-FIM where the 
perturbation of the backbone amides upon binding to C5 was measured. Color 
spectrum is grey, white, yellow, orange, magenta, and red (in increasing order of 
perturbation). Residues affected most are expected to be either in the binding 
interface, or linked to other residues in the interface via secondary structure, or to 
have been displaced by interdomain rearrangement. The sites shown in B and C are 
opposite sides of an α-helix. The STP colored variants of B and C are shown in D 
and E respectively. STP successfully identifies the same sites as the NMR titration. 
 




3.4 Identifying Protein-Protein Binding sites in large multi-component 
complexes: the Cks1-Dependent recognition of p27 by the SCF-SKP2 
Ubiquitin Ligase 
Molecular functions are a result of interaction involving any number of proteins. 
Many assemblies include more than 2 subunits. Examples include the 
VHL/elonginC/elonginB complex (PDB 1vcb), where the tumor suppressor protein 
VHL inhibits the formation of the elonginA/elonginB/elonginC complex, a main 
reason behind the von Hippel–Lindau disease and the majority of kidney cancers 
[195]. Other large complexes are the 10-subunit RNA polymerase II elongation 
complex (PDB 1I6H) [196], the 7-subunit arp2/3 complex (PDB 1K8K) responsible 
for formation of Y-branch actin filaments and the motion in eukaryotic motile cells 
[197], and the 3-subunit MHC-II/TCR/SpeA complex [198] responsible for the 
activation of the immune system [81].  
 
The SCF-SKP2 Ubiquitin E3 Ligase comprises five subunits: Cul1 domains 1 and 2, 
SKP1, SKP2, and CKS1 (Figure  3-22). Successful Inhibition or regulation of such 
complexes depends on understanding the binding details of these complexes. Such 
details may include function, chronological order of binding, and strength of binding. 
We demonstrate the ability of STP to quickly highlight the binding strength between 





When the cell undergoes a transition from the G1 to the S phase, the commitment of 
the cell to the S phase is dependant on the activation of any the cyclin dependent 
kinases Cdk2/E or Cdk2/A [199]. Cdk2/E and Cdk2/A are responsible for down 
regulating p27 and that is a necessary step for the G1/S cell cycle transition [200]. 
Studies have shown that p27 becomes phosphorylated upon binding to Cdk2/E and 
that the down regulation of p27 takes place via the recognition of phosphorylated p27 
in the p27/Cdk2/E complex by the SCFSkp2/Cks1 E3 Ligase which would then lead to 
the ubiquitination and degradation of p27 at the G1/S transition [201, 202]. This 
interaction is of great importance, and that is due to the fact that p27 has been linked 
with several aspects of cancer. DNA replication and formation of tumors was 
prevented in certain cancer cells on nude mice by the over expression of p27 [203]. 
Moreover, p27 loss is associated in many human cancers like breast, prostate, colon, 
gastric, lung, and esophageal cancers [204]. Abnormal increase in the degradation of 
p27 could be the reason behind the loss of p27 in cancer cells [205]. Understanding 
more about the p27 regulation process is thus of vital therapeutic value.  
 
The interaction between SCFSkp2/Cks1 and p27 has been identified and the structure of 
the Cul1-Skp1-Skp2-Cks1-p27 complex has been solved [206, 207]. This complex 
has been reported to have an increased expression in cancer cells (which itself leads 
to low p27 levels) [208, 209]. The base SCF complex is formed by the binding of 
Skp1, Cul1, Rbx1, and the Fbox protein that binds to the substrate [210]. In this case, 





Figure  3-20: The structure of the SKP1 (BLUE) - SKP2 (magenta) - CUL1 (green) 
complex 
 
Figure  3-21: The coloring of Cul1 by STP and its respective binding partners. Skp1 
is shown in Yellow and the second domain of Cul1 in Magenta 
 
Figure  3-22: The SCF complex (PDB 2AST) chains colored by STP and the binding 
sites being marked. The coloring shows low binding affinity between SKP2 and 
CUL1, suggesting that SKP1 attaches the complex together, and that has been shown 
in the literature [207]
 
At first glance, Cul1 and Skp2 seem to be interacting. Upon 
those subunits by STP, Cul1 shows 2 distinct binding sites; the first binds to Skp1 
and the second binds the second subunit of Cul1 which in turn binds rbx1 (
 3-21). The surface of Cul1 that binds to Skp2 does not show a strong binding 
influence. In turn, the surface on Skp2 that binds to Cul1 is also of poor STP scoring. 
 







Skp1 and Skp2 both show strong binding surfaces that bind to each other. Those 
details are shown in Figure  3-22. This suggests that Cul1 and Skp2 have poor 
binding affinities towards each other, but are clipped together by Skp1. This STP 
prediction is correct since Cul1 is reported by [207] to be the rigid scaffold which 
binds Skp1, which in turn binds to Skp2. Had the structure of the SCF complex been 
hard to crystallize as a single unit, STP would have helped reach this conclusion just 
from examining the individual structures of Cul1, Skp1, and Skp2. 
 
STP has already been proven useful in locating binding sites. In this chapter, this 
functionality was taken one step further, with the location of several binding sites on 
each subunit of the SCF E3 Ligase and the comparison of the STP propensities of the 
triplets in these binding sites to reveal the strength of the binding at each interface. 
This shows that STP is useful not only in locating binding sites, but also in 
comparing them. For this reason, a special version of STP has been designed to color 
surfaces of several proteins on the same coloring scale (rather than each protein 
getting its own scale of 0-100). This facilitates the comparison of binding sites across 







3.5 Predicting Allosteric Binding Sites 
Allosteric binding sites form when a ligand binds to a protein, causing a structural 
change that leads to modified affinities at other (remote) ligand binding sites. 
Allosteric regulation controls many important cellular processes, including signal 
transduction, transcription, and metabolism [211]. Allosteric sites are difficult to 
locate both experimentally or computationally where molecular dynamics 
simulations need to be used. STP is helpful in this matter and can be used in two 
methods. First, the coloring of the protein surface often generates multiple highly 
scored patches. These patches can be investigated for being secondary or allosteric 
binding sites (Section  3.4). Alternatively, upon the existence of several 
conformational states identified through X-ray crystallography or dynamics, these 





Figure  3-23: The transition of Lm-PyK between the inactive T state and the active R 
state, with the help of the allosteric ligand F-2,6-BP to stabilize the structure in the 




We present an example, Pyruvate Kinase (PyK), an enzyme responsible for 
catalyzing the final reaction of glycolysis, where phosphoenolpyruvate (PEP) and 
ADP are converted into pyruvate and ATP, respectively [212]. PyK is a 
homotetramer, each monomer in the range of 50-60 kDa depending on species. The 
human embryonic and tumour (M2), erythrocyte (R), and liver (L) isoforms of PyK 
are allosterically activated by fructose 1,6-bisphosphate (F-1,6-BP) [86]. This 
enzyme for leishmania has been studied extensively and undergoes a transition 
between an inactive T-state and an active R-state (Figure  3-23), and the binding of 
fructose 2,6-bisphosphate (F-2,6-BP) in the effector sites of PyK leads to stabilizing 
the enzyme in the active R-state. PyK has been extensively studied and crystallized 
and studied in house by Hugh Morgan [86, 212, 213].  
 
The comparison between the STP colored versions of the R-State and the T-State of 
Lm-PyK is shown in (Figure  3-24). The increase in color intensity of the binding 
sites, as well as the formation of new red patches on the R-State concurs with the 
biological studies showing that the R-state is the active state of the enzyme. The 
colored surface of the R-state is also compared with the biological data gathered 
through crystal trials [86, 212, 213] about the location of the effector and active sites 
of the enzymes. This comparison also demonstrates STP’s success in picking out the 
allosteric sites of PyK (Figure  3-25). 
Figure  3-24: Comparison 
State of PyK. The increase in color intensity of the binding sites, as well as the 
formation of new red patches on the R
showing that the R-state is the active state of the
between the STP colored versions of the R
-State concurs with the biological studies 










Figure  3-25: The allosteric sites on Pyruvate Kinase (structure solved by Hugh 
Morgan in the Walkinshaw Group). Top Figure shows the allosteric sites highlighted 
in blue, yellow, and red. The bottom picture shows the STP-colored surface, where 





4 Spatial and Chemical Features of Protein Surfaces 
This chapter studies the spatial and chemical characteristics of protein surfaces from 
an STP perspective. Spatial features of protein surfaces in protein-ligand, protein-
protein, and protein-peptide interaction datasets are studied: the surface triplets are 
generated and certain geometrical characteristics are calculated. Inter-triangular 
distances (distances between the centroids of triangles) are calculated for whole 
protein surfaces and binding sites. The distributions of these distances are compared 
to study the compactness of protein surfaces in binding sites. The shape of the triplets 
is also studied, through the areas of the triplets, and the lengths of their edges. We 
use these characteristics to draw conclusions about the concavity of binding sites and 
to compare the binding sites of the three interaction datasets. 
 
The second part of this chapter studies the chemical features of triplets. Triplets are 
chemically classified based on their constituting atoms. The role of each chemical 
category of triplets in each of the interaction datasets in this work is studied and 
conclusions are drawn as to the importance of each of them in the three interaction 
types (protein-ligand, protein-protein, and protein peptide). The tendency of each of 
these chemical triplet categories to interact with ligand atom types is also studied and 
quantified (interaction preference values). These statistics are used to calculate a 
statistical free energy of interaction between triplets and ligand atoms. The 
interaction preference and statistical free energies give rise to interesting conclusions 
and provide quantitative proofs of many existing postulates of interaction (for eg, the 
preference of a hydrophobic atom to exist in a hydrophobic region). 
133 
 
4.1 Inter-triangular Distances 
4.1.1 Protein-Ligand Interaction Dataset 
This section details the studies aimed at assessing the distinct spatial characteristics 
that binding sites might possess compared with the protein surface as a whole. It is 
important to determine whether the binding sites display an atom compactness and 
configuration that is distinct from the entire surface distribution. The distribution of 
inter-triangular distances in binding sites was studied (Figure  4-2). The distances 
between every pair of triplets (all triangles in the binding site, not only the adjacent 
ones) in the binding site were calculated. The result was a normal distribution with 
an average of 10.6Å and a standard deviation of 5.36 Å. The positive skewness 
(0.96) is graphically demonstrated by the bell curve’s long right tail. Exceptionally 
large binding sites contribute to this skewness by introducing very large inter-
triangular distances to the distribution and consequently raising the average distance. 
This is clear in the right hand side slowly decaying tail of the bell shaped curve. It is 
impossible to find small counterparts for these high numbers (to restore the 
symmetry of the distribution) since that would mean having negative distances which 
is invalid. Nevertheless, the majority of inter-triangular distances in binding sites lie 
in the region of 2Å to 18Å. 
Figure  4-1: Distribution of the average inter
the protein-ligand interaction dataset.
 
Comparing the inter-triangular distances between binding sites and the entire protein 
surfaces faces the problem that protein surfaces are much larger than binding sites 
surfaces. This skews the protein surface distances towards a larger value (a histogram
of average inter-triplet distances on whole protein surfaces is shown in 
Therefore, while studying inter
maximum threshold (5Å) is used to remove this bias. 
between adjacent triangles was considered (instead of using the 5Å distance 
threshold). However, the distances between adjacent triangles will not provide a clear 
measure of the compactness of a binding site as the variations will be minimal. Using 
a maximum length of 5Å allows for greater variations in the distances to be recorded. 
Distances between the centroids of any 2 surface triplets (under 5Å) were used to 
contribute towards the entire protein surface inter
-triplet distances on protein surfaces in 
 
-triangular distances on the pro
Studying 





Figure  4-1). 
tein surfaces, a 
 the distances 
Similarly, distances between the centroids of any 2 binding site triplets (under 5Å) 
were used to contribute towards the entire binding site inter
average. The distributions of these 2 values were then compared. 
 
Figure  4-2: The Distribution of Inter
Sites shows a normal distribution with mean 10.61 










 deviation 5.36 Å. 
 
Figure  4-3: The average inter
triangle centroids) measured for all surface triplets (in blue) and all binding site 
triplets (pink) in the Protein
than 5Å were used for the calculation of the averages.
sites exhibit a smaller average distance in most cases, indicating that binding sites are 
more compact. This could be a result of the concavity of the surface in ligand 
binding sites. 
 
The average inter-triangular distance in binding sites is lower than that of the entire 
surface in the majority of the cases (
90.3% of the protein structures in the dataset, showing that binding sites are 
generally more compact (by 0.9 Å on average) than the rest of the protein surface. 
This observation is justified by the topology of binding sites since they 
larger number of clefts than the rest of the surface, and this concavity decreases the 
inter-triangular distances by increasing the number of atoms and triplets within a 
certain distance around a center atom.
-triangular distances (distance calculated between 
-Ligand Interaction Dataset. Only distances less or equal 
 This graph shows that binding 








4.1.2 Protein - Protein Interaction Dataset 
The distribution of surface and binding site inter-triangular distances in the protein-
protein dataset is studied. Inter-triangular distances under 5Å are used to contribute 
to the average inter-triangular distances in binding site and entire surface 
distributions (similarly to Section  4.1.1). These distributions are then compared 
(Figure  4-4), showing that binding sites generally have a lower inter-triangular 
distance than entire surfaces (in 89% of the cases). However, the difference between 
these 2 attributes is small (less than 0.1Å) and this is expected since protein-protein 
interfaces include large patches of the protein surface (unlike protein-ligand and 
protein-peptide interaction sites which are generally small) and thus are expected to 
be very similar to the entire protein surface. 
 
Figure  4-4: The average inter-triangular distances (distance calculated between 
triangle centroids) measured for all surface triangles (in blue) and all binding site 
triangles (pink) in the protein-protein Interaction Dataset. Only distances less or 
equal than 5Å were pooled for the calculation of the averages. Since protein-protein 
interaction sites are large surfaces and make up a large portion of the entire protein 


























4.1.3 Protein-Peptide Interaction Dataset 
 
Figure  4-5: The average inter-triangular distances (distance calculated between 
triangle centroids) measured for all surface triangles (in blue) and all binding site 
triangles (pink) in the Protein-Peptide Interaction Dataset. Only distances less or 
equal than 5Å were pooled for the calculation of the averages.  
 
The average inter-triangular distance in binding sites is lower than that of the entire 
surface in the majority of the cases (Figure  4-5). This property is valid through 
97.5% of the protein structures in the dataset, showing that binding sites are 
generally more compact than the rest of the protein surface. This observation is 
justified by the nature of protein-peptide interaction. In many cases, this interaction 
is a result of a peptide sitting in a small pocket or curling around the surface of a 
certain protein. This ends up in long but thin “rectangular” binding sites which 

























4.2 Triangle Areas and Edge Lengths 
4.2.1 Protein-Ligand Interaction Dataset 
The changes in triplet (triangle) dimensions between binding sites and the entire 
surface are studied. Figure  4-6 and Figure  4-7 show the distributions of triangle areas 
and triangle edge lengths in both binding sites and entire surface distributions. Both 
features are very similar (in terms of average and standard deviation), and that is due 
to the nature of the triangles being triplets of atoms that come in contact with a water 
molecule probe simultaneously. This leaves little margin for variability when it 
comes to the triangle dimensions. In fact, 2 carbon atoms in the same triplet will be 
furthest apart if the probe falls in between them (having 3 collinear atoms: carbon, 
probe, carbon; in that order). With a maximum radius of 1.88 Å for a carbon atom 
(atomic groups C4H1, C4H2, and C4H3), the maximum edge length of a triangle 
will be 6.56 Å. The minimum edge length will be that of a covalently bonded atoms, 
and the minimum distance observed in our datasets is 1.14 Å and occurs for atoms 
Cβ and Oγ of Ser 60 in structure 1BXO. 
 
Although the distributions seem to be similar in general, a few differences exist. The 
triangle area distributions (Figure  4-6) display a difference in kurtosis. Both curves 
show negative kurtosis, suggesting that the bell shaped curve is flatter than a 
standard normal distribution. However, the distribution of binding site triangle areas 
exhibits a more negative kurtosis, meaning a slightly wider bell-shaped curve. 
 
Figure  4-6: Comparison of the distributions of areas of surface and binding sites 
triangles in the Protein
slight difference of the mean of triangle areas is due to the
site surface giving rise to triplets with excentric shapes.
 
-Ligand interaction dataset shows no distinct differences.






Figure  4-7: Comparison of the distributions of edge lengths of surface and binding 











The edge length distribution (Figure  4-7) shows more interesting differences. The 
Entire surface distribution has virtually zero skewness, but the binding sites 
distribution exhibits a slightly negative skewness. This is due to the distances 
between 1Å and 1.75Å contributing more to the binding sites distribution than to the 
entire surface. This atom compactness in binding sites has already been shown in 
Section  4.1, and can also be justified by the amino acid side chains pointing outwards 
in binding sites since they generally play an important role in binding. The exposure 
of these side chains to the water surface leads to an increased number of these small 
distances. The triangle edge lengths in binding sites show a significant increase in the 
regions of 1Å to 1.75Å and 3.75Å to 5Å when compared to the entire surface 
distribution. This observation, put together with the fact that the average triangle 
areas does not change brings forward a conclusion that in binding sites, triangles 
with shorter and longer sides occur more frequently. This could be a sign of 
increased concavity, giving rise to triangles with acute shapes. A second high peak 
appears at [2.25Å -2.5Å]. Such distances are recorded for acidic or aromatic systems 
like OE1 and NE2 of Gln, NH1 and NH2 of Arg, and CE2 and CE3 of Trp. 
4.2.2 Protein-Protein Interaction Dataset 
The areas and edge lengths of surface and binding site triangles in the protein-protein 
dataset is studied (similar to Section  4.2.1). Although the distributions of triangle 
areas in binding sites and protein surfaces are similar (Figure  4-8), binding site 
triangles exhibit a smaller area (depicted by the mean area for binding site triangles 
being smaller than the mean area of surface triangles and also by the shifting of the 
distribution histogram to the left). This is also reflected in the distributions of triangle 
edge lengths in binding sites and protein surfaces (Figure  4-9). A slight increase in 
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triangle edges between 1.25Å and 1.5Å is noted. This could be a result of the 
induced fit both proteins undergo when they bind to each other at large patches of the 
surface, increasing the compactness of some parts of the binding surface. This does 
not result in a major change in the inter-triangular distances (Figure  4-4) as a result 
of the large number of triangles in protein-protein interfaces, which renders the 
impact of a change in the geometry of some interface triangle less influential on the 




Figure  4-8: Comparison of the distributions of areas of surface and binding sites 
triangles in the Protein-Protein interaction dataset shows no distinct differences. 
 
Distribution of Binding Sites Triangle Areas












































Distribution of Surface Triangle Areas 






























Mean 3.73 Å2 
Stdev 2.50 Å2 
Skew 0.89 
Kurtosis 0.29 
Mean  4.34 Å2 
Stdev  2.68 Å2 
Skew  0.66 
Kurtosis -0.18 
Triangle Area (Å2) 




Figure  4-9: Comparison of the distributions of edge lengths of surface and binding 
sites triangles in the Protein-Protein interaction dataset shows no distinct differences. 
Distribution of Surface Triangle Edge Lengths





















































Distribution of Binding Site Triangle Edge Lengths









































Mean  3.25 Å 
Stdev  1.36 Å 
Skew  0.17 
Kurtosis -1.06 
Mean  3.49 Å 





4.2.3 Protein-Peptide Interaction Dataset 
 
Figure  4-10: Comparison of the distributions of areas of surface and binding sites 
triangles in the Protein-Peptide interaction dataset shows no distinct differences. 
 
Distribution of Binding SiteTriangle Areas











































Distribution of Surface Triangle Areas












































Mean  4.04 Å2 
Stdev  2.54 Å2 
Skew  0.70 
Kurtosis -0.15 
Mean  4.21 Å2 
Stdev  2.65 Å2 
Skew  0.72 
Kurtosis -0.17 
Triangle Area (Å2) 




Figure  4-11: Comparison of the distributions of edge lengths of surface and binding 
sites triangles in the Protein-Peptide interaction dataset shows no distinct differences. 
 
 
Distribution of Binding SiteTriangle Edge Lengths


















































Distribution of Surface Triangle Edge Lengths



































Mean  3.37 Å 
Stdev  1.34 Å 
Skew  0.06 
Kurtosis -1.01 
Mean  3.42 Å 





The areas and edge lengths of surface and binding site triangles in the protein-peptide 
dataset is studied (similar to Section  4.2.1). The distributions of triangle areas in 
binding sites and protein surfaces (Figure  4-10) are similar in all aspects (average, 
standard deviation, skewness, and kurtosis). This is also reflected in the distributions 
of triangle edge lengths in binding sites and protein surfaces (Figure  4-11). A slight 
increase in triangle edges between 1.25Å and 1.5Å and also between 4Å and 4.75Å 
is noted (contributed by acute triangle shapes that exist in cavities). These differences 
are not large enough to induce a large change in the distribution of triangle areas and 
edge lengths distributions. 
4.3 Spatial Differences between Binding Sites of the Ligand, Peptide, and the 
Protein Interaction Datasets 
Comparing the binding sites of the three interaction types may provide insight into 
the general topology of each type of interaction. Ligands generally bind in deep 
semispherical pockets, peptides bind on the surface in long thin strips, and proteins 
bind each other at large surface patches. This may have implications on the inter-
triangular distances, triangle areas, and edge lengths. However, differences in the 
inter-triangular distances are more pronounced than triangle areas and edge lengths 
for the different binding site topologies. Due to the nature of the triangles being 
triplets of surface atoms that are touched by a probe sphere at the same time, the 
variation in the shape of the triangles is very limited; the space in which those three 
atoms can exist whilst still being in contact with the probe sphere and without any 
steric clash with each other and with other protein atoms is small.  
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Inter-triangular distances show distinct properties across the binding sites of the three 
interaction classes. Protein-Protein binding sites have an average inter-triangular 
distance that is very close (but still less) to that of the entire surface. This similarity is 
due to the large binding sites in which protein-protein interaction takes place. These 
binding sites include cavities of different sizes in addition to some flat surfaces as 
well (just like a normal protein surface). Protein-Ligand and Protein-Peptide binding 
sites have smaller inter-triangular distances (3.25Å and 3.33Å respectively compared 
to 3.43Å for protein-protein interactions). This difference is significant as this value 
is an average of all distances under 5Å. This is a direct result of the binding taking 
place in deep pockets where the surface is concave, including more triangles within 
the same distance of a certain central triangle. The deep pockets are sometimes very 
deep and cross from one side of the protein to the other, resulting in cases with 
average inter-triangular distances higher than that of the entire surface. In contrast, 
Protein-Peptide binding sites have the least percentage of cases with inter-triangular 
distances higher than that of the entire surface. This is due to the rectangular shape of 
peptide binding sites as this decreases the number of inter-triangular distances above 
a certain limit, leading to the decrease of the average inter-triangular distance. 
4.4 Chemical Composition of Triplets 
The Protein-Ligand dataset (made up of 309 structures) generated 1.223 million 
surface triplets out of which 34,228 were binding site triplets. The Protein-Peptide 
dataset (made up of 475 structures) generated 1.416 million surface triplets out of 
which 59,145 were binding site triplets. The Protein-Protein dataset (made up of 210 
structures) generated 1.708 million surface triplets out of which 93,054 were binding 
site triplets. The large increase in the number of triplets (relative to the number of 
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structures) for the Protein-Protein dataset is due to the interaction occurring between 
two large globular domain which increases the number of both surface and interface 
triplets. This section studies the chemical composition of the binding sites and 
protein surfaces in each of these datasets. 
 
The triplets are sub classified into four categories (Table 2): There are a total of 35 
types of ‘hydrophobic triplets’ containing three hydrophobic (carbon) atoms. The 
120 types of ‘polar triplets’ consist of permutations of three polar (N,O,S) atoms. 
The 120 types of ‘mostly hydrophobic triplets’ contain two hydrophobic atoms and 
the 180 types of ‘mostly polar triplets’ contain two polar atoms (Table  4-1).  






Ratio of all Triplets 
Hydrophobic 3 Carbon Atoms 35 0.08 
Mostly 
Hydrophobic 
2 Carbon Atoms 120 0.26 
Mostly Polar 1 Carbon Atom 180 0.40 
Polar Zero Carbon Atoms 120 0.26 
 
STP is created with three versions that study Protein-Ligand (Section  2.3.1), Protein-
Peptide (Section  2.3.2), and Protein-Protein (Section  2.3.3) interactions. The triplets 
in each of these datasets were studied based on the chemical classification described 
above (Table  4-1). Several attributes were analyzed including the range, average, and 
standard deviation of the propensity scores of the triplets that make up these sub-
categories (Table  4-2). The Protein-Peptide and Protein-Protein datasets show similar 
results. The interaction between protein domains is in fact between the peptide 
stretches that form their binding interfaces, and the similarity of propensity scores in 
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both profiles concurs with this fact. ‘Polar triplets’ have the highest average 
propensity score in the Protein-Ligand dataset while ‘hydrophobic triplets’ have the 
highest average propensity score in the Protein-Peptide and Protein-Protein datasets 
(Table  4-2). This is due to the ligands in the Protein-Ligand dataset being much 
smaller than the peptides or proteins in the other two datasets, suggesting a more 
important role for polar interactions in contrast to the dominance of hydrophobic 
interactions when it comes to the interaction between large domains. This is also 
evident in ‘mostly polar triplets’ having a higher average propensity than ‘mostly 
hydrophobic triplets’ in the Protein-Ligand dataset while the latter have higher 
average propensities in the Protein-Peptide and Protein-Protein Datasets. All triplet 
sub-categories in all datasets exhibit similar standard deviation of the propensity 
scores. 
Table  4-2: The distribution of propensities for different triplet types (Table  4-1) in 












Hydrophobic -1.3, 2.7 0.7, 1.1 
Mostly 
Hydrophobic 
-2.2, 3.5 0.4, 1.2 
Mostly Polar -3.5, 5.2 0.7, 1.3 
Polar -0.4, 4.2 1.4, 1.2 
Protein -
Peptide 
Hydrophobic -1.1, 2.2 0.8, 0.9 
Mostly 
Hydrophobic 
-1.8, 2.9 0.4, 1.0 
Mostly Polar -2.7, 3.0 0.2, 1.0 
Polar -1.7, 4.6 0.4, 1.3 
Protein -
Protein 
Hydrophobic -0.8, 2.1 0.7, 0.7 
Mostly 
Hydrophobic 
-2.7, 4.1 0.2, 1.1 
Mostly Polar -4.4, 4.1 -0.1, 1.4 




We next study the occurrence of these triplet sub-categories. Hydrophobic atoms 
constitute 61% of the surface in each of the 3 interaction datasets, and Polar atoms 
constitute 39%. Therefore, a ‘Hydrophobic triplets’ has an expected occurrence rate 
of 0.613, and a ‘polar triplet’ has an expected occurrence rate of 0.393. ‘Mostly 
hydrophobic and mostly polar triplets’ have expected occurrence rates of (0.612 × 
0.39 × 3) and (0.392 × 0.61 × 3) respectively. This ratio is calculated for all triplet 
subcategories (Table  4-1) and an expected occurrence per dataset is calculated as the 
expected occurrence rate of a triplet category multiplied by the total number of 
triplets in a dataset. This expected occurrence is compared with the actual occurrence 
in binding sites and entire surfaces for the three interaction datasets (Table  4-3 and 
Table  4-4). 
Table  4-3: The occurrence of different triplet subcategories on the protein surface of 
the structures in the protein-ligand, protein-peptide, and protein-protein dataset. The 
expected occurrence is calculated as the fraction of a specific type of triplet to all 
triplet types multiplied by the total number of triplets in the dataset. The occurrence 












(A ÷ B) 
Protein - 
Ligand 
Hydrophobic 204,987 277,600 0.74 
Mostly 
Hydrophobic 
608,379 532,445 1.14 
Mostly Polar 360,230 340,416 1.06 
Polar 49,412 72,548 0.68 
Protein- 
Peptide 
Hydrophobic 250,873 321,510 0.78 
Mostly 
Hydrophobic 
707,095 616,666 1.15 
Mostly Polar 406,941 394,262 1.03 
Polar 51,551 84,023 0.61 
Protein - 
Protein 
Hydrophobic 309,548 387,870 0.8 
Mostly 
Hydrophobic 
846,557 743,948 1.14 
Mostly Polar 486,885 475,639 1.02 




Table  4-4: The occurrence of different triplet subcategories in the binding sites of the 
structures in the protein-ligand, protein-peptide, and protein-protein dataset. The 
expected occurrence is calculated as the fraction of a specific type of triplet to all 
triplet types multiplied by the total number of triplets in the dataset. The occurrence 












(A ÷ B) 
Protein - 
Ligand 
Hydrophobic 8,883 7,783 1.14 
Mostly 
Hydrophobic 
14,218 14,928 0.95 
Mostly Polar 9,306 9,544 0.98 
Polar 1,881 2,034 0.92 
Protein- 
Peptide 
Hydrophobic 17,486 13,425 1.3 
Mostly 
Hydrophobic 
26,918 25,749 1.05 
Mostly Polar 13,082 16,463 0.79 
Polar 1,659 3,508 0.47 
Protein - 
Protein 
Hydrophobic 25,507 21,121 1.21 
Mostly 
Hydrophobic 
45,182 40,512 1.12 
Mostly Polar 20,362 25,902 0.79 
Polar 2,003 5,520 0.36 
 
The expected occurrence and the actual occurrence of the triplet sub-categories were 
compared by dividing the actual occurrence by the expected occurrence. We call this 
attribute the “Occurrence Factor”. An Occurrence Factor greater than 1 would 
indicate and over expressed sub-category while an Occurrence Factor less then 1 
would indicate and under expressed sub-category. The three interaction datasets 
exhibit similar occurrence factors for the triplet sub-categories all over the surface 
(Table  4-3). ‘Mostly hydrophobic and mostly polar triplets’ are overexpressed while 
‘hydrophobic and polar’ triplets are under expressed. However, a different result is 
observed when the occurrence factors are calculated for binding site triplets (Table 
 4-4). Comparing the results in Table  4-3 and Table  4-4 shows that the Occurrence 
Factors for ‘hydrophobic triplets’ is higher in binding sites than it is on the entire 
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protein surface. This is expected since hydrophobic interactions play important roles 
in protein function. Interestingly, the occurrence factor of ‘polar triplets’ in binding 
sites is larger than all over the surface in the sole case of Protein-Ligand interaction, 







α =  
Equation  4-1: Calculation of the Triplet Class Propensity for the different triplet 
subcategories. InterRatio(α) corresponds to the occurrence factor of triplet type α in 
the interface (Table  4-4). SurfaceRatio(α) corresponds to the occurrence factor of 
triplet type α on protein surfaces (Table  4-3). 
 
Table  4-5: The actual occurrence ratios and triplet class propensity for the triplet sub-
categories. The actual occurrence ratios are the result of a division of the number of 
occurrences of a certain triplet by the total number of triplets. The Triplet Class 
Propensity is a result of dividing the Binding Site Actual Occurrence Ratio by the 














(A ÷ B) 
Protein - 
Ligand 
Hydrophobic 1.14 0.74 1.54 
Mostly 
Hydrophobic 
0.95 1.14 0.83 
Mostly Polar 0.98 1.06 0.92 
Polar 0.92 0.68 1.35 
Protein- 
Peptide 
Hydrophobic 1.3 0.78 1.67 
Mostly 
Hydrophobic 
1.05 1.15 0.91 
Mostly Polar 0.79 1.03 0.77 
Polar 0.47 0.61 0.77 
Protein - 
Protein 
Hydrophobic 1.21 0.8 1.51 
Mostly 
Hydrophobic 
1.12 1.14 0.98 
Mostly Polar 0.79 1.02 0.77 
Polar 0.36 0.65 0.55 
 
Figure  4-12: The Triplet Class Propensity for the triplet subcategories in the three 
interaction datasets. This propensity is calculated as ratio binding site triplets that are 
of a certain category divided by the ratio of all surface 
category (Equation  4-
 
Comparing the occurrence of the subcategories between binding sites and entire 
protein surfaces can be better conveyed using the Triplet Class Propensity (TCP) 
scores (Equation  4-1). The Triplet Class Propensity compares the occurrence factor
of a certain sub-category of triplets in the binding site (
occurrence ratio of that category all over the surface (
Propensity is reported in 
important role in the interaction between proteins and their protein, ligand, o
binding partners. ‘Polar triplets’ however play an important role in the interaction of 
Protein-Ligand complexes only. This study shows that the role of “Polar” atoms 
increases in Protein-Ligand interactions, signaled by the increase in the Tripl
triplets that are of that same 
1). 
Table 
Table  4-3). This Triplet Class 










Propensity of ‘polar and mostly polar triplets’ and the decrease of the Triplet Class 
Propensity of ‘mostly hydrophobic triplets’ (Figure  4-12). 
4.5 Recognition of certain atoms by specific Triplets 
















































The triangular types proved useful in predicting the location of binding sites, 
classifying enzyme types, and ranking docking orientations. We now study the 
interaction between the surface triplets and ligand atoms, and search for preferences 
that some triplets might have for different ligand atom types. Ligand atoms in the 
dataset are classified as per the Tripos [214] forcefield definitions. The protein-
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ligand dataset contained 21 ligand atom types (Table  4-6). To simplify the problem 
of studying what triplets interact with what atoms, ligand atoms were classified into 
the 4 classes: Halogens, Hydrophobic, Polar, and Water.  
Table  4-7: The recognition of various ligand atom classes by the triplet classes in the 
protein – ligand interaction dataset shows a strong affinity between ‘hydrophobic 
triplets’ and Hydrophobic atoms, ‘polar triplets’ and Polar atoms, and ‘hydrophobic 
triplets’ and Halogens. OF/EF values can be transformed into statistical free energy 
by the formula ∆Gstat = -RT × ln(OF/EF) / 1000 to give a value in kcal/mol. 
Frequency 









Empty 58696 148453 75323 8430 290902 
Halogen 93 73 32 8 206 
Hydrophobic 5545 6023 2577 362 14507 
Polar 1810 4101 3406 734 10051 
Water 138843 449729 278892 39878 907342 




Empty 48758 144708 85684 11753 290902 
Halogen 35 102 6 8 206 
Hydrophobic 2432 7216 4273 586 14507 
Polar 1685 5000 2960 406 10051 




Empty 1.20 1.03 0.88 0.72 N/A 
Halogen 2.69 0.71 0.53 0.96 N/A 
Hydrophobic 2.28 0.83 0.60 0.62 N/A 
Polar 1.07 0.82 1.15 1.81 N/A 






Empty -0.108 -0.018 0.076 0.195 N/A 
Halogen -0.586 0.203 0.376 0.024 N/A 
Hydrophobic -0.488 0.110 0.303 0.283 N/A 
Polar -0.040 0.118 -0.083 -0.352 N/A 
Water 0.056 0.000 -0.023 -0.051 N/A 
 
The interaction between triplets and ligand atoms is then quantified as follows: for 
each surface triplet, the closest (distance between atom center and triplet centroids) 
ligand atom or water molecule is recorded as an interaction partner. If there are no 
atoms within a distance of 4Å, the closest atom type is recorded as “Empty”. The 
interaction between each triplet Class (Hydrophobic, Mostly Hydrophobic, Mostly 
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Polar, and Polar) and each atom class (Halogen, Hydrophobic, Polar, and Water, 
Empty) is studied. The observed frequencies of each interaction are recorded and 
compared with the expected frequency. The expected frequency of a certain 
interaction depends on the availability of a certain triplet class and a certain atom 
class in the dataset. For example, if we have 206 halogen atoms in the database, and 
240,987 hydrophobic triplets, and a total number of interactions of 1,223,008, the 
expected frequency of Hydrophobic/Halogen interactions is 206 × 240,987 ÷ 
1,223,008. After the expected frequencies are calculated, a final attribute is 
calculated by dividing the Observed Frequency by the Expected Frequency of a 
certain interaction. A result greater than 1 indicates the favouring of a certain 
interaction while a result less than 1 indicates a certain interaction being disfavoured 
(Table  4-7). 
 
The triplet:ligand atom interaction data indicated a higher tendency for ‘hydrophobic 
and mostly hydrophobic triplets’ to have no binding partners. These triplets are 
abundant all over the surface (Table  4-3) and have a lower propensity of interaction 
to water (as they are hydrophobic) and thus are rendered with no binding partners in 
the crystal structures. In contrast, ‘mostly polar and polar triplets’ attract more water 
molecules than ‘hydrophobic and mostly hydrophobic triplets’ and have less affinity 
to be without a binding partner in the crystal structure (as a water molecule is 
attracted to them). Hydrophobic ligand atoms are attracted to ‘hydrophobic triplets’, 
but not to “mostly hydrophobic triplets’, as they are possibly repelled by the polar 
atom in these triplets. However, the tendency of a hydrophobic atom to interact 
closely with ‘mostly hydrophobic triplets’ is higher than its tendency to interact with 
159 
 
a ‘mostly polar or polar triplets’ (Table  4-7). Halogens show a distinct affinity 
towards ‘Hydrophobic triplets’ compared with everything else. However, the 
Halogen atom : ‘polar triplet’ interaction is preferred over the Halogen atom / Mostly 
Hydrophobic interaction This is a key indicator in the organohalogens’ dual nature as 
hydrogen bond acceptors that fit comfortably in hydrophobic environments [215]. 
According to the Boltzmann and Gibbs classification of free energy [216, 217], a 
reaction of type A + B  C would have a statistical free energy according to the 
following equation: 
  	




where P(A), P(B), and P(C) are the probabilities of finding these substances in 
solution, i.e. the concentration of these substances. 
Equation  4-2: The free energy of a chemical interaction 
 
If we consider that a Triplet T reacts with a ligand atom A to produce and interacting 
complex C, the reaction would be of the form T + A  C. The value of the 
expression P(C) / [ P(T) x P(A) ] as given by the Gibbs free energy formula has 
already been computed as the interaction preference in Table  4-7. Hence, the 
interaction preference of the different triplets with particular atom types can be used 
to give a measure of statistcal ∆G values (Equation  4-2) according to the formula ∆Gstat 




For example, a non-bonded interaction between a Halogen-class atom and a 
‘hydrophobic triplet’ has an interaction preference of 2.7, where the interaction 
preference is calculated as the Observed Frequency (OF) / Expected Frequency (EF) 
(Table  4-7). This is equivalent to saying that the frequency of interaction of a halogen 
atom with a ‘hydrophobic triplet’ is about three times the expected value. The 
statistical free energy difference that accounts for this distribution can be calculated 
from: ∆Gstat = -RT ln (OF / EF), where R is the gas constant = 1.9872 cal deg
-1 mol-1. 
This gives a ∆Gstat = -0.59 kcal/mol at 298K for the interaction of Halogen atoms 
with ‘hydrophobic triplets’. The other clear preference for atom environment 
(Supplementary Table 6) is the interaction between Hydrophobic atoms and 
‘hydrophobic triplets’ (interaction preference 2.28) which gives a ∆Gstat of -0.49 
kcal/mol. The preference of Polar atoms interacting with ‘polar triplets’ is less 
marked with a ∆Gstat of -0.35 kcal/mol. 
4.6 STP Propensities and Statistical Free Energy Values 
The propensities of the 455 triplet types (defined in Chatper  1, Equation  2-1) range 
between -3.54 and 5.16. Similarly to section  4.5, these propensity values can also be 
related to statistical free energy values. Since the propensity is the log2(Interface 
Probability / Surface Probability), getting the probabilities back is generated be 
retrieved as (propensity)×ln(2). Thus, the statistical free energy calculations for the 
occurrence of a triplet type in binding sites can be calculated as: 
∆Gstat = - R × T × ln(2)×propensity 




For the protein-ligand interaction score table, the energy values range between -1.45 
kcal/mol and 2.12 kcal/mol (Table  9-4). These values correspond with the average 
interaction energy of a ligand (averaged over all ligand atoms and all atom types) 
with a particular class of atom triplet. Interestingly, the strongest interaction energy 
of -1.45 kcal/mol is very close to the maximum affinity value of -1.50 kcal/mol per 
ligand atom which was estimated from an analysis of experimental binding data 
[218]. Similarly, these energy values ranged between -2.22 kcal/mol and 1.80 
kcal/mol for the protein – protein interaction dataset (Table  9-2); and -1.88 kcal/mol 





5 Applying Computational Methods to Blys/BAFF 
interaction 
5.1 Introduction 
5.1.1 The TNF superfamily 
The superfamily of tumor necrosis factor cytokines (TNF) and their corresponding 
receptors (TNFR) constitutes a class of cell-signaling molecules which regulate 
essential biological functions such as cell proliferation, survival, differentiation, 
tissue homeostasis and apoptosis. The majority of these TNFs are predominantly 
expressed by immune cells. The TNF/TNFR superfamily (Figure  5-1) constitutes 19 
cytokines and 29 receptors [219]. Many of the TNF cytokines exert their functions 
either as type II transmembrane proteins and/or in soluble form by binding to one or 
more of the TNF receptors. The TNFRs are type I transmembrane proteins which 
often also exist as soluble proteins [220]. 
 
Figure  5-1: The TNF/TNFR superfamily (blue: TNFs, grey: TNFRs with the  




5.1.2 Structural and functional characteristics 
The active form of TNF-superfamily cytokines is as self-associating trimers. They 
share a relatively low primary sequence identity (20% to 30%) leading to diverse 
ligand/receptor interfaces. These diverse interfaces are responsible for the observed 
receptor/ligand specificities [221-223]. Avariety of TNF-family orthologues for 
BAFF, April, Tweak (Figure  5-1) etc. in zebra fish and other teleosts have been 
discovered through phylogenetic analyses [224].  
 
The TNF receptors are characterized by the presence of one or more extracellular 
Cys-rich domains (CRDs). The presence of the multiple disulfide bridges in the 
extracellular parts of the TNF receptors leads to the formation of relatively rigid, 
highly constrained loops, responsible for the interaction with the TNF-superfamily 
cytokines. TNFRs (Figure  5-1) are classified into three different classes, according to 
the presence of either an intracellular death domain (Fasr, Trail-R1 ...)  ]225[ , or TNF 
Receptor Associated Factor (TRAF) interacting motifs, TIMs (BaffR, Rank...) [226] 
or no functional intracellular signaling domain at all (OPG, DcR1) [227]. 
5.1.3 TNF cytokines and disease 
A few members of the TNF superfamily have been implicated in the development 
and progression of multiple diseases in the fields of autoimmunity, 
neurodegenerative diseases, bone destruction, liver diseases, and cancer [228]. The B 
lymphocyte stimulator (Blys) is a key survival factor for B lymphocytes [229]. Mice 
having their Blys knocked out lack mature B cells in peripheral lymphoid tissues 
[230], overexpression of Blys in transgenic mice produces key-symptoms of 
164 
 
autoimmune diseases and Blys plasma levels in patients with several autoimmune 
diseases [231] have been reported to correlate with disease burden [232].  
 
A proliferation inducing ligand (April) shares approximately 30% sequence identity 
to Blys in the TNF domain and is closely related to Blys; it recognizes two of the 
three reported Blys binding TNF receptors, Taci and Bcma. Blys (Figure  5-1) and has 
been implicated in autoimmune diseases such as Multiple Sclerosis, Systemic Lupus 
Erythematosus, Sjogren's Syndrome and Rheumatoid Arthritis [233, 234]. 
Furthermore, April was found to promote tumor cell survival in vitro and in tumor 
transplant in-vivo models. Both Blys and April have been found to play crucial roles 
in hematological malignancies [235]. Other TNFRs and their associated diseases 
include: Tweak (chronic immune diseases, arterioscleroses, and cancer), Rank (bone 
metastases and multiple myeloma) and LIGHT (intestinal inflammation and arthritis) 
[220, 236, 237]. 
 
In addition to their clear correlation with disease, TNF superfamily members are 
promising drug targets. Several TNF-receptors (Taci, Bcma, and BaffR) consist of 
only one or a partial Cys-rich domain. The extracellular parts of these receptors 
consist of highly constrained, short peptide stretches. Therefore, these receptors 
represent ideal examples of rigid natural ligands for docking and virtual screening 
experiments. Furthermore, the protein/protein interaction surface of TNF-receptors 
with their TNF-cytokines members (Blys, April and Tweak) is exceptionally small 
but of high affinity (low nanomolar to sub-nanomolar). The best studied example is 
Blys/BaffR, where a highly constrained 26 aminoacids core region of the receptor has 
been shown to be sufficient for high affinity (Kd 70 nM) binding 
recognition motif comprises a 6
characteristic loop motif of the interaction hot
April and Tweak (Figure 
5.1.4 Target validation
Figure  5-2: Binding modes of 
(pdb: 1OQD) shows the b
shows the binding of 
structure of BaffR. D) 
homology model for Fn14 
[238]
-residue hot-spot structured as a β
-spot is presumably shared at least by 
 5-2). 
 / medical need 
Bcma; Taci and FN14 to Blys, April
inding of Bcma (sticks) to Blys (surface).
Taci (sticks) to April (surface). C) (pdb: 1
(pdb: 1XU1) shows the structure of Taci. Finally, 
and while binding to Tweak [239]. 
165 
 
. The essential 
-hairpin loop. This 
 
 and Tweak. A) 
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Current strategies for targeting TNF-superfamily members focus on the development 
of biologics i.e. neutralizing or agonistic antibodies. Several TNF-targeting products 
have already been marketed: Remicade®, Enbrel®, and Humira®. Several biologics 
for targeting Blys and/or April are currently in development: Belimumab (a Human 
anti-Blys monoclonal antibody, GlaxoSmithKline, Human Genome Sciences, Phase 
III), Taci-Immunoglobin (Taci-Ig) (soluble Taci-Ig, ZymoGenetics/Serono, Phase II), 
AMG623 (Amgen, Blys targeting peptide-fusion protein, Phase I), BR3-Fc 
(Genentech, Soluble BAFF-R-Immunoglobin, Phase I). However, small-molecule 
ligands/peptides would provide a significant economic, scale, and bioavailability 
advantage over antibodies and whole-protein treatment. High affinity peptides (larger 
than 12-mers), derived from phage display studies have been described for Blys 
[240]. Furthermore, moderate affinity TNF-α trimerization inhibitors and inhibitors 
[241] of the TNF-α intracellular signaling cascade have also been described [242]. 
5.1.5 The Integrated Chemical Biophysics (ICB) Process 
Current experience in the protein-protein interactions field has shown that high 
throughput screening (HTS) does not routinely identify compounds that disrupt 
protein interactions [243]. However several starting points were identified from HTS 
with large compound collections (>250 000) to identify moderate hits (Ki in the mid 
micromolar range). Reasons for the limited success rate of routine HTS are: 
a) The large interaction surfaces 1,500-3,000 Å2 (compared with those of 
small molecule-protein interactions of 300-1000 Å2 )  
b) limited structural starting points (protein-protein interactions have proven 
to be highly adaptive and hence the best binding sites and modes can not 
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be often observed from static structures of either free protein target or 
protein-protein complexes)  
c) Current compound collections are extensively biased towards ATP 
mimics and GPCR binders [244-248]. Recent experience suggests that 
compound collections with higher molecular mass and significantly 
different design are required for tackling protein-protein interactions [243, 
249]. 
As protein-protein interactions are highly diverse, with only the most related proteins 
sharing common features, it has been proposed that target biased libraries will be 
needed for each interaction in order to derive optimized inhibitors. 
 
 
Figure  5-3: The ICB-process 
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The ICB-process (on-bead library synthesis, on-bead screening, solution 
conformation, and cellular validation (Figure  5-3) ) as developed by Auer et al. will 
provide an ideal technology starting point for targeting protein-protein interactions 
such as TNF-superfamily members due to: 
1. The possibility to generate project tailored libraries by on-bead synthesis of 
peptides, cyclic peptides and peptidomimetics with non-natural side chains 
and building blocks 
2. The ability to obtain ligand series with proven Kd’s and initial Structure – 
Activity Relationship (SAR) experiments from each primary screening round 
with minimal (ca. 50 picomols) substance without extensive re-synthesis. 
3. The ability to generate fluorescently labeled binders in combination with 
high-resolution imaging and micro-spectroscopy for resolving details of the 
signaling mechanisms and specificities of the TNF/TNFR superfamily.  
 
Previous experiments using Blys as a target have yielded mid-micromolar affinity 
(Kd) compounds based on a β-peptides with β-turn foldamers. These compounds are 
the first low molecular weight ligand binding inhibitors for one of the TNF-
superfamily members (a minimal binding motif for Blys has previously been reported 
to contain 12 amino acids, however its high-affinity binding was not reproduced in 
our hands). 
5.2 Strategy 
This work focuses on the computational methods focused at designing inhibitors for 
the Blys:BaffR interaction. The project outline, the role of computational biology, the 
specifics of the Blys:BaffR
designing inhibitors are discussed below.
5.2.1 General Project Flow
The proposed project flow consists of three main project tracks:
1. Design of new on
hypothesis testing by docking 
designs, synthesis and on
2. Virtual screening of existing virtual compound libraries, synthesis of 
compound collection around best hits on
3. Partnering with industry for competition screening of existing compound 
archives to obtain low
optimization by bead based synthesis and screening cycles.




-bead turn-mimicking peptidomimetic libraries, virtual 
experiments, prioritization of proposed library 
-bead screening of selected libraries.
-bead for experimental tes
-to-medium affinity starting points for further 










Following this plan, this project is expected to produce novel TNF/TNF-ligand 
crystal structures and provide valuable insight into targeting of other TNF family 
members. 
5.2.2 The Role of Computational Biology 
This work deals with the computational biology aspect of this project. The target will 
be the generation of several compound libraries starting from different starting 
models. The proposed methodology to reach this goal is: 
1. Search for possible inhibitor compounds using the program LIDAEUS [69] 
2. Search for possible inhibitor compounds using the programs UFSRAT 
(Steven R. Shave) and Autodock [71]. 
3. Design Peptides to inhibit the interaction 
a. Model choice/optimization 
b. Mutagenesis of side chains of the binding face to test Model viability 
c. Energy Minimization 
d. Scoring Fits and models and Deciding on the best Models to be used 
e. Creating the library 
5.2.3 Study of the Blys Binding Site 
The original binding site is located in PDB structure 1OSG, with chains 'D' and 'E' on 
the protein side of the molecule while chain J resembles the original peptide that 
docks in the groove (Figure  5-5). The peptide in chain J is immobilized on the cell 




Figure  5-5: The Binding Site of the protein 1OSG. Figure shows Chains D and E 
(Green and Blue) with the peptide (chain J, here in sticks) bound to the binding 
pocket. 
 
Study of the interaction between the protein and the peptide shows that the most 
important peptide residues in this interaction are the DLLVR (residues 26 – 30), with 
the L-27 not playing an equally important role in the interaction. These interactions 
are summarized in Table  5-1. 




Asp 26 Arg 265 of Chain D 
Leu 28 Met 208 and Gly 209 of Chain D 
Val 29 
Asn 242 (<4 Å) of Chain E 
Ala 207 (4.53 Å) of Chain D ( to be optimized) 




In order to mimic and eventually inhibit this interaction, a search for possible 
inhibitors was conducted. As a general guideline, it is important for any 
designed/discovered candidate inhibitor to mimic the interactions discussed above. 
Moreover, the Leu residue is inside a cleft on the protein surface, and a possible 
enhancement to this interaction is to have this residue going deeper into the groove 
(Figure  5-6). Those guidelines were used to filter out the virtually designed ligands 
and find out the best sequences and structures. This is discussed in Section  5.4. 
 
Figure  5-6: Important interactions in the Blys/BaffR complex. Mimicking these 
interactions is important for inhibiting the function of the complex. Left image shows 
the cartoon representation of Blys and the sticks representation of BaffR. Distances 
between Blys atoms and BaffR atoms within 4Å are labeled in yellow and the 
residues on the Blys side are marked (D-ASP 275 is ASP 275 of chain D). The figure 
on the right shows the surface of Blys and how the BaffR reaches deep within the 
pocket on the surface.  
 
5.2.4 Starting Models for Peptide Design 
Several starting models have been considered to use as scaffolds where different side 
chains could be installed. The designed peptides should exhibit a β-turn, mimicking 
the original ligand. On this assumption, a ligand library was constructed based on a 




Due to the cyclic nature of those peptides, they should exhibit a similar turn to 
that of the β peptides. The only difference will be that the turn comprises 8 
members rather than 10. However; cyclic α peptides are still good candidates for 
mimicking the Blys-BAFF interaction. 
 
 
Figure  5-7: Backbone alignment of a cyclic α peptide (yellow) with the original 
ligand (green) shows that the β-turn can be mimicked with a cyclic hexapeptides. 
 
α peptides have the advantage of being well researched, and therefore the side 
chain torsion angles can be more accurately predicted by the algorithms used. 
However, α peptides pose the challenge of finding a stable sequence that is not 
hydrolyzed quickly by the body. This is vital if any of the designed ligands are to 
be used as a drug. The use of irregular side chains might make it harder for the 




5.3 Searching for possible inhibitor compounds using the program LIDAEUS 
One strategy to tackle inhibiting the Blys/BaffR interaction is to check for chemical 
compounds that are likely to bind to the binding site in Blys. LIDAEUS is the best 
tool to conduct virtual screening experiments of this kind. In coordination with 
EDULISS, LIDAEUS has access to around 4 million compounds that are available in 
several supplier catalogues. A set of site points was generated based on the original 
ligand interaction with Blys, and is shown in Figure  5-8. Then LIDAEUS was run on 
the Bluegene supercomputer at Edinburgh University and set to return the best 1000 
hits. 
 
Figure  5-8: The site points generated by LIDAEUS for the Blys/BaffR complex. 
These Site Points indicate the most favorable type of atoms to be positioned at a 
certain location. Green indicates hydrophobic, Blue indicates Hydrogen Bond 
Donors, and Red indicates Hydrogen Bond Acceptors. The binding site of protein 





The top 200 hits were analyzed in an attempt to select good drug candidates that 
would inhibit the Blys/BaffR interaction. Lideaus appends a rough estimate of the 
binding enthalpy to each selected compound (∆H). The top 200 hits had a ∆H in the 
range of [-43.155 kcal/mol, -37.097 kcal/mol]. Values of -20 and below are usually 
considered good and worth checking. A few steps were taken to filter out molecules 
that are not likely to be good drug candidates. Sugars and large molecules were thus 
discarded. The remaining compounds were examined to decide whether they are 
worth buying or not. Three molecules were selected; they are referred to by their 
EDULISS IDs: 25SPH1-104-152, 42SPH1-002-100, and 28SPH1-443-207 (Figure 
 5-9). As denoted in Figure  5-9, those compounds will be referred to as compounds A, 
B, and C. 
 






Figure  5-10: The similarity between Estriol (Figure A) and Compound A (Figure B). 
Estriol is one of the three main estrogens produced by the human body 
 
 
Figure  5-11: The predicted binding between Compound A (Gitoxigenin) and Blys 
(notice the geometrical compatibility). The figure on the right shows a possible 
hydrogen bond deep inside the binding pocket. 
 
Compound A (named in the Sigma-Aldrich database as Gitoxigenin) is a steroid. Its 
strong resemblance to Estrogen (Figure  5-10) poses a lot of question marks about 
how useful it will be as a drug candidate. However, and as shown in Figure  5-11, this 
compound fits into the binding site of Blys in a geometrically perfect way. Its 
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calculated ∆H is -40.891 kcal/mol and can be cheaply acquired from Sigma-Aldrich 
(15.9 GBP for 10 mg). It has therefore been chosen for wet lab verification. 
Compound C (Figure  5-12) also shows a good and deep binding into the Blys pocket. 
It is found on Ambinter's website under the id of 6329476. 
 
Figure  5-12: The predicted binding between Compound C and Blys. The figure on 





Figure  5-13: The predicted binding between Compound B and Blys. The figure on 
the right shows the possible hydrogen bonds between the protein and the ligand. 
 
Compound B (named MEGxp on the Analyticon database) fits deeply into the pocket 
of Blys and has appeared 3 times in the top 205 compounds, each time being in a 
different orientation (Figure  5-13). These three orientations were scored at ∆H values 
of -38.51 kcal/mol, -37.136  kcal/mol, and -37.300 kcal/mol. This compound also has 
a unique attribute: the presence of 4 benzene rings attached to each other in a 
rhombus pattern. This attribute renders the compound to be easily distinguishable on 
the binding assay used (fluorescence anisotropy assay / polarization assay). 
Unfortunately, the supplier firm (Analyticon) has a 500 EUR minimum invoicing 
price, which will render this molecule too expensive although its real price is 31 
EUR per 1 mg. Four benzene rings were then searched for in the EDULISS database 
using the program UFSRAT. When given the entire compound, UFSRAT did not 
find a suitable similarity with any of the compounds. The 4 benzene rings where then 
searched on their own, and UFSRAT found an exact match (EDULISS ID 25SPH1-
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179-824), called Ellagic Acid in Sigma. Ellagic Acid was docked with LIDAEUS 
and gave an acceptable ∆H of -22.566 kcal/mol; presenting a good workaround for 
compound B. Compound B was also sent to Novartis to be checked against their 
private database. 
 
Moreover, the LIDAEUS search showed that a singly or doubly OH substituted 
benzene ring is a good binding motif for the Blys pocket. This motif could be a good 
basis for designing side chains for the peptide library (favoring a Tyr residue and its 
non-natural side chain analogues as possible mutations for Leu 28). 
5.4 Designing inhibitor Peptides 
5.4.1 Mutation Program 
The Mutation program is a vital component for creating the virtual database. It takes 
in a polypeptide in PDB format, and a text file that instructs it about which residues 
to mutate, the chi angles to use for the side chains, and the choice of substitute side 
chains to be used per location. The program will then fix the required side chains in 
the desired locations and output the resulting structures in Sybyl Mol2 format. The 
program will output 1 structure for each permutation. That means if we have n 
residues positions to be mutated, each with m different side chains in mind, with a 
specification of using r Chi-Angle rotamers for the Chi-1 angle (the dihedral angle 






The Program is of a recursive nature. Recursion was a necessary choice to be able to 
cope with a variable number of positions to be mutated. The Pseudocode of the 
algorithm used to generate the molecules is given below. 
Algorithm  5-1: The Mutation Program that constructs different molecules based 
around a specific cyclic hexapeptide backbone with a list of side chain choices at 
each residue position. 
Mutate(p, n) 
 IF (p > n) 
  Return 
 FOR each substitute side chain choice s: 
  Fix s in the position of p, overlapping N, C_α, and C_β atoms. 
  Get the rotamers from the database 
  FOR each rotamer choice r: 
   Adjust side chain atoms according to r 
   IF p is the position to be mutated 
    Print Molecule 
   ELSE 
    Mutate (p+1, n) 
   END_IF 




5.4.1.2 Geometrical Operations in the Mutation Program 
The operation of substituting the side chains at a certain position with other suitable 
ones in order to mutate the residue is done in the following way: 
1. Read in a template molecule with the desired side chain 
2. Delete the side chain atoms of the residue to be mutated, except the β-carbon 
3. Generate a transformation matrix that would transform the atoms N, Cα, and 




4. Apply the transformation for each side chain atom in the substitute amino 
acid to get the final coordinates 
The geometric operations needed to find the transformation matrix that would 
transform the atoms N, Cα, and Cβ of the substitute aminoacid onto those of the target 
aminoacid are: 
1. Let M1 be the transformation matrix that puts N, Cα, and Cβ of the target 
aminoacid residue in the XZ plane with Cα on the origin and Cβ on the Z-axis 
2. Let M2 be the transformation matrix that puts N, Cα, and Cβ of the substitute 
aminoacid residue in the XZ plane with Cα on the origin and Cβ on the Z-axis 
3. To transform the atoms of the substitute residue onto that of the target 
residue, apply transformation matrix M = inverse(M1) × M2. 
The geometric operations needed to find the transformation matrix that puts N, Cα, 
and Cβ of an aminoacid residue in the XZ plane with Cα on the origin and Cβ on the 
Z-axis are: 
1. Let M1 be the translation matrix that puts the α-carbon at the origin. 
a. Also let  
i. Cαx be the x coordinate of Cα 
ii. Cαy be the y coordinate of Cα 
































b. Apply M1 to N, Cα, and Cβ 
c. Normalize vector (CαCβ) 
 
2. Let M2 be the transformation matrix that puts the β-carbon on the Z-axis 
a. Also let 
i. Cβx be the x coordinate of Cβ 
ii. Cβy be the y coordinate of Cβ 
iii. Cβz be the z coordinate of Cβ 
iv. ) +=
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The matrix on the right rotates Cβ around the Z-axis, putting it in the XZ 
plane (setting y=0). The matrix on the left rotates Cβ around the Y axis, 
putting it in the YZ plane (setting x=0). The combination of those 2 matrices 
will put Cβ on the (XZ ∩ YZ) plane (which is the Z-axis). 
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b. Apply M2 to N, Cα, and Cβ 
c. Normalize vector (CαN) 
 
3. Let M3 be the transformation matrix that puts N in the XZ plane 
a. Also let  
i. Nx be the x coordinate of N 



























4. The resulting matrix would be: M = M3 × M2 × M1 
5.4.2 Energy Minimization 
After the generation of the various permutations and conformations of the molecule, 
a fast energy minimization procedure is necessary to make sure the final models are 
reasonable and depict the reality in a correct and accurate manner. The Minimax 
program (part of the witnotp suite [250]) was used to perform this task. Minimax 
utilizes the Broyden-Fletcher-Goldfarb-Shanno (VA13A, Harwell) algorithm to 
perform molecular mechanics simulations, making the designed molecules more 




5.4.3 Scoring Fits and Models 
The best way to assess the quality of the starting model is by scoring how well those 
models resemble the original ligand. After each starting model has been permutated 
with a few side chains and minimized, the backbone of each permutation was taken 
in addition to the β-carbons, and a best fit was calculated. This best fit then reports a 
root mean square deviation (rmsd) value that signals how close this backbone is to 
the original ligand. Details of how the permutations where created for each starting 
model are found in later sections.  
 
Figure  5-14: The basic structure of a cyclic hexapeptide. The dotted lines represent 
the backbone hydrogen bonds stabilizing the structure. The bead is to be connected at 





5.4.4 Cyclic Alpha Peptides 
Cyclic hexapeptides are good candidates for mimicking the β-turn motif of the BaffR. 
They are easier to synthesize and have a longer duration of activity compared to 
linear peptides [251]. Such structures exhibit 2 β-turn motifs and are stabilized by a 
pair of hydrogen bonds (Figure  5-14). One of those β-turn motifs will mimic the 
binding face of the BaffR (4 residues from the hexapeptide). A fifth residue will be 
fixed as an Ala in order to connect it to the bead. The sixth residue will be free and is 
dependent on the backbone from which the virtual library will be constructed. 
 
The residues of any cyclic hexapeptides will be referenced as per Figure  5-16. R3, 
R4, R5, and R6 of the hexapeptide will constitute the binding face that will mimic 
Residues 26, 28, 29, and 30 of BaffR. Whilst those residues are to be mutated and the 
entire structure minimized to check if we have a good fit with BaffR, it is essential 
that residues 3 to 6 are not originally Gly or Pro. Gly exhibits backbone flexibility 
due to the absence of a side chain, making the original model too flexible to use for 
modeling (especially in the binding face residues). Having Pro in the binding face of 
a hexapeptide model is also unfavorable as Pros exhibit backbone rigidity due to the 
side chain coupling with the nitrogen atom. This rigidity will not be mimicked by the 
other aminoacids. With one of the remaining two positions (R1 and R2) restricted to 
Ala (for bead connection), that leaves only one free residue that could virtually be 
any aminoacid. That means that while searching for hexapeptide models, only one 
Pro or Gly residue should be present in the original sequence of the model. 
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Table  5-2: Cyclic hexapeptides in the Cambridge Crystallographic Database, their 
sequences and number of Pro/Gly residues. 
















































































Two searches were conducted to find the proper hexapeptide models. The first was in 
the protein data bank, and returned zero hits. There were 4 cyclic hexapeptide 
structures in the PDB (1SKI, 1SKL, 1SKK, 1QVK), but they were NMR models 
rather than X-ray structures and were neglected. The second search was conducted in 
the Chemical Database Service (CDS, part of the Cambridge crystallographic 
database) and returned 26 X-ray structures (Table  5-2). Those structures were filtered 
by the number of Pro or Gly residues they have and limited to those with only one 
(based on the discussion above). This gave two structures to check as possible 
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templates for the peptide design experiment to construct the virtual library: GAJFAY 
and ZUKRAY. Figure  5-15 shows those 2 structures superposed over the original 
ligand. 
 
Figure  5-15: The superposition of the backbones of GAJFAY (A) and ZUKRAY (B) 
on the BaffR backbone. The rmsd values shown correspond to the superposition by 
Cα and Cβ atoms of R3, R4, and R5 and Cα atom of R6. In the case of R6, the β-
carbon was neglected because of the difference in orientations between the models 
and the original ligand, which will be discussed in Figure  5-16. 
 
Figure  5-16: The difference in s
changing the conformation of R6 into a D
Figure B (representing both ZUKRAY and GAJFAY) will be more capable of 
mimicking that of Blys
their corresponding positions on the cyclic hexapeptides. 
 
All starting models were stripped 
positions 3, 4, 5, and 6. The 
into an Ala where the bead is to be connected. Similarly, 
was kept as is and R1 changed into an Ala where the bead is to be attached. As 
denoted in Figure  5-16
aminoacids. In the case of R5 which is supposed to mimic 
ligand, the positioning of C
GAJFAY and ZUKRAY while it is pointing upwards in the original ligand. 
change of stereochemistry is 
and ZUKRAYD6 are the homologues of GAJFAY and ZUKRAY
ide chain orientation in Arg 30 of A and R6 of B. By 
-amino acid conformation, the backbone in 
 (Figure A). The arrows connect the BaffR amino acids and 
 
of their side chains except the 
Pro at R1 in GAJFAY was kept as is and R2 changed 
the Gly 
, the binding face of the peptides is formed of 4 consecutive 
Arg
αCβ is not optimal as it's pointing sideways in both 





at R2 in ZUKRAY 
 30 of the original 
A 
. GAJFAYD6 
, having a D-amino 
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acid at R6. Table  5-3 gives the original residue numbers in these structures referred 
to by R1 through R6. 
 
Table  5-3: Distinct starting Models for Cyclic hexapeptides. The second column 
denotes the original residue numbers in the structures to position as R1, R2, R3, and 
R4. 
Model R1, R2, R3, R4 
GAJFAY 
ZUKRAY 
3, 4, 5, 6 
2, 3, 4, 5 
 
To check which of these starting models is capable of mimicking the conformation of 
the original ligand, the binding face residues of these ligands were mutated to all 
aminoacids {Arg, Asp, Glu, Leu, Lys, and Val}. The remaining 2 residues were 
fixed as discussed above. Based on this permutation, each starting model will 
generate 64 = 1296 possible structures. Those structures were then minimized by 
Minimax to ensure they are in the most favorable energy conformations. A study on 
the strength of the backbone was conducted by calculating the rmsd between the 
minimized structures with their unminimized analogues. The rmsd was calculated as 
the mean rmsd of all the backbone atoms of the binding face residues in addition to 




Figure  5-17: Each model produced 1296 different analogues, each having a unique 
sequence at the binding face of the molecule. Each of these analogues was 
minimized and the rmsd between the minimized and unminimized structures 
recorded. The values shown here correspond to the mean and standard deviation of 
the rmsd values recorded, per Backbone. GAJFAYD6 is GAJFAY with R6 in D-
amino acid conformation. 
 
The choice of the most suitable starting models was based on which model has a 
binding face with a backbone fairly close to the original ligand after being minimized 
and mutated with different side chains. For each of the 1296 permutations, an rmsd 
was calculated between the permutation and the original ligand. The rmsd values 
were generated based on the α and β-carbon atoms of the binding face residues (R3, 
R4, R5, and R6). Results are shown in the Figure  5-18. 
 




















Figure  5-18: Each of the 1296 structures produced per model was superposed onto 
the BaffR using the α and β-carbons of R3, R4, R5, and R6. This figure shows the 
mean and standard deviations for the 1296 rmsd values recorded per model. 
 
The studies done on the starting models showed that indeed, residues R6 should be in 
a D conformation. This is shown by both templates getting better positioning when in 
a D6 conformation. Although ZUKRAY initially had a lower rmsd than GAJFAY, 
the study showed that GAJFAY has a more stable backbone (Figure  5-17 shows that 
the rmsd between the minimized and unminimized analogues is lower in the cases of 
GAJFAY and GAJFAYD6 compared to ZUKRAY and ZUKRAYD6). This is 
probably due to GAJFAY having a Pro residues while ZUKRAY having a Gly 
residue in their sequences, the first giving the backbone more rigidity while the 
second making it more flexible. Even more, Figure  5-18 clearly shows that after 
studying the structures' behavior under several sequences (1296 to be exact), the 
minimized structures of both GAJFAY and GAJFAYD6 had lower rmsd values than 





















RMS of uniminimized permutations RMS of minimized permutations
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ZUKRAY and ZUKRAYD6.Consequently, all results point towards GAJFAYD6 as 
the optimal model to be chosen for building the cyclic hexapeptide library. 
5.4.5 Building the library 
Now that the model hexapeptide backbone has been chosen, the next step would be 
to optimize the side chain choices on this hexapeptide. To recap, the side chains at 
R1 and R2 are kept unaltered (as per GAJFAY). R3, R4, and R5 are used to mimic 
the original interactions contributed by Asp 26, Leu 27, and Leu 28 of the original 
ligand respectively. Two choices would then exist for R6: 1) as a D-Amino acid to 
mimic Arg 30 of the original ligand, and 2) as an L-aminoacid to mimic Val 29 of 
the original ligand. It was decided to focus on the D-amino acid choice as a start and 
then to explore the L-side chain choices later. 
 
The choice of side chains was not restricted to the 20 natural aminoacids, but 
extended to several non-natural side chains. Other than increase the space of 
combinations we can produce, this also helps in further optimization of the 
interaction. For example, although the binding of Leu 28 in the hydrophobic deep 
pocket of Blys would lead us to search for hydrophobic side chains at position R5, 
that pocket (Figure  5-6 and Figure  5-8) has a strong hydrogen bond acceptor (the 
main chain oxygen of Cys 232). The LIDAEUS experiments have shown that that 
this oxygen can be exploited to strengthen the interaction of Blys with a bound 
ligand in that pocket. Compared to the size of the pocket, Leu is relatively small and 
we would like to test larger hydrophobic side chains in that pocket as well (and 
possibly with variations that would include a hydrogen bond donor). R4 was to be 
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given similar hydrophobic choices, while R3 and R6 would be given polar choices, 
mimicking the Asp and Arg interactions with Blys (Figure  5-16). 
Table  5-4: Side chain Choices for residues R3, R4, R5, and R6 in the first docking 
experiment (see Figure  5-19 and Figure  5-20). 






























The choices of the first experiment are given in Table  5-4, and a 2 dimensional 
description of the non-natural side chains is found in Figure  5-19 and Figure  5-20. 
With R3 given 7 choices, R4 and R5 each given 9 choices, and R6 given 3 choices, 
that sums up to a total of 7 × 9 × 9 × 3 = 1701 molecules. These molecules were 
docked with Autodock using standard parameters (except for the GA_RUN being set 
to 3). GA_RUN sets the number of starting points for the Monte-Carlo genetic 
algorithm. The more starting points you have, the higher the probability to find the 
global minimum in your energy minimization attempts; the corollary to this is the 
longer your experiments will take. As this docking run is large (1701 peptide 
molecules with a large number of rotatable bonds), the GA_RUN was fixed to 3 
instead of 10. 
 


















Figure  5-21: The distribution of the side chain choices in the correct docking poses 
from the first docking experiment. 
 
Out of the 1701 molecules tested, 307 (18%) exhibited the correct docking pose 
(where the backbone of the docked hexapeptide is mimicking the position of the 
backbone of the original BaffR ligand. Autodock generated energy scores for these 
1701 poses where in the range of [-8.79, -2.12] kcal/mol. The best poses were 
studied to evaluate the side chain compositons at R3-R6, and the results are shown in 
Figure  5-21. R3 showed a strong preference for Asp. R4 showed less preference for 
Dmb, Leu, Tbu, Gln, and Htr (when compared to the other choices). In R5, Phe was 
the only side chain to be considered as disfavored by the docking algorithm. No 
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preference was shown in R6, but Lys was excluded as since it did not contribute 
much to the interaction energy of the poses. 
 
Table  5-5: Side chain Choices for residues R4, R5, and R6 in the second experiment. 
































Consequently, a second docking run was designed (this time with GA_RUN set to 
10). R3 was fixed to Asp. R6 was fixed to Arg and Hrg. R4 and R5 were given 9 and 
17 choices respectively (the original choices without the disfavored side chains, and 
a few extra choices that include Fluorine atoms in the side chains (Table  5-5). A total 
of 1 × 9 × 17 × 2 = 306 molecules were tested. 217 (71%) of them were docked in 
the correct pose. the Autodock energy scores were in the range of [-8.07, -3.03] 
kcal/mol. This indicates an increase in the quality of the choices as a larger 
percentage is being docked in the correct pose, and the high end of the energy score 
interval has become more negative. Although the low end of the energy scores has 
shifted a bit to the right (which is not optimal), it is still considered as a good result 
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as this range represents a majority of correct poses (unlike the first experiment where 
the majority of the poses were not mimicking the original conformation). Figure  5-22 
shows the distribution of the top 102 of the correct poses. The library being tested is 
made up of permutations of side chains on R3-R6. With 71% of the docked 
molecules were in a correct pose, searching for the favored side chain choices at R3-
R6 among these poses will not generate a strong signal, and the choices will tend to 
be equally distributed. Therefore the top third of the docking results were chosen 
(102 structures) to give a better signal of favored side chains. Based on these results, 
Leu, Arg, and Lys were removed as possibilities for R4 while Leu, Pza, Hfl, Tbu, 
Val, Tza, Tfl, His, and Trp were removed as possibilities for R5. Although Hrg was 
not as favorable as Arg in R6, the next experiment was to increase choices in R6 and 





Figure  5-22: The distribution of the side chain choices in the top 102 correct docking 
poses from the second docking experiment. 
 
Table  5-6: Side chain Choices for residues R4, R5, and R6 in the third experiment. 

































The third docking run was designed to test for further possibilities on R6 and 
included introducing L-Aminoacids to R6. As per Table  5-6, a total of 1 × 6 × 8 × 13 
= 624 molecules were designed and tested. 534 (85.6%) of these molecules were in 
the correct pose. the Autodock energy scores were in the range of [-8.54, -4.53] 
kcal/mol. With the percentage of docked molecules exhibiting the same pose as the 
original ligand and the range of the energy scores shifting to the left on both of its 
extremities, the docking run was considered successful. Figure  5-23 shows the 
distribution of the side chain choices in the top 208 of the correct poses (again, 
taking 33%). As a result, Tfa and His were discarded from R4 and Fg4 was discarded 




Figure  5-23: The distribution of the side chain choices in the top 208 correct docking 
poses from the third docking experiment. 
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Table  5-7: Side chain Choices for residues R3, R4, R5, and R6 in the fourth 
experiment. 






















A final docking run to check for further optimization of R3 was designed. Glu and 
Hgu were taken (based on the results of the first docking experiment) and tested 
again at the fine resolution of GA_RUN = 10. It was already clear that Asp was the 
best choice for R3, but we wanted to investigate whether Glu and Hgu (which would 
actually produce the same interactions like Asp) would also improve the docking 
energies. As per Table  5-7, a total of 3 × 4 × 7 × 6 = 504 molecules were designed 
and tested. 460 (91%) of them were docked in the correct pose, and the Autodock 
energy scores were in the range of [-8.90, -4.64] kcal/mol; showing further 
improvement on the side chain choices. Figure  5-24 shows the distribution of the top 
168 of the correct poses (33% of the 504 choices). Although Glu and Hgu are not as 
favorable as Asp, they did enhance the Autodock energy scores and are worth trying 
in vitro. R4 and R5 show no favoring at all between the choices, asserting that no 
further improvements could be made with the current choices. Same observation 
goes for R6, except for D-Leu being less favored than everything else. The details of 
the entire set of docked molecules from the fourth docking experiment are found in 





Figure  5-24: The distribution of the side chain choices in the top 168 correct docking 
poses from the fourth docking experiment. 
 
With those four Autodock experiments, we were capable of converging to the best 
possible choices of aminoacids that could be used to synthesize molecules that would 
inhibit the Blys/BaffR complex. At every step, we discarded the unfavorable choices 
and tried to formulate educated guesses at what new side chains would help the 





Table  5-8: The cyclic hexapeptide virtual screening library. The number of clusters 
denotes the number of clusters in which the 10 docking experiments per molecule 
can be classified (the less the clusters, the better the confidence). Drg, Dhr, and Dlu 
refer to D-Arg, D-Hrg, and D-Leu respectively. 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5.4.6 Benchmarking against related structures 
The library was built and optimized for the best interaction mimicking the Blys/BaffR 
complex (as given in PDB structure 1OSG). Several related structures exist in the 
PDB: Blys/Bcma complex (PDB 1OQD), another crystal structure for Blys/BaffR 
complex with minor structural changes in Blys (PDB 1OQE), April/Bcma complex 
(PDB 1XU2), April/Taci complex (PDB 1XU1), and the apo structure of Blys (PDB 
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1KXG). We now test the performance of the top 100 compounds from the ligand 
library against each of these structures. 
 
The top 100 ligands from the library were docked with Autodock [71]. We then 
assess the performance of these ligands using several criteria including: 
1. the minimum, maximum, average, and standard deviation of the predicted 
energies of interaction 
2. the number of clusters per docking generated 
3. the percentage of the compounds mimicking the original pose of the ligand in 
each structure 
Table  5-9: The docking of the top 100 ligands from cyclic hexapeptide library (Table 
 5-8) onto 6 structures. Blys/Bcma complex (PDB 1OQD), Blys/BaffR complex (PDB 
1OQE), April/Bcma complex (PDB 1XU2), April/Taci complex (PDB 1XU1), the 
apo structure of Blys (PDB 1KXG), and the Blys/BaffR complex used in this chapter 
(PDB 1OSG). The correct pose is defined as any pose mimicking the original ligand 
binding mode. The “average clusters per compound” denotes average of the number 
of clusters in which the 10 docking experiments per molecule can be grouped (the 




































































The docking of the top 100 ligands was assessed based on the attributes discussed in 
Table  5-9. Some compounds showed a higher affinity towards the related structures 
tested (shown with the minimum energy in some of these experiments being more 
negative than the minimum energy in the Blys/BaffR complex). However, the overall 
performance of these ligands was best with the original Blys/BaffR complex (PDB 
1OSG). When docked to 1OSG, the ligands exhibited the lowest average energy, the 
smallest standard deviation, the lowest maximum energy, and the highest percentage 
of ligand orientations mimicking the original BaffR binding mode. We also studied 
the average number of clusters per docked ligand for each structure. Autodock 
generates the best 10 poses per ligand and ranks them based on binding energy. 
These poses are then clustered based on rmsd. In theory, if all the top 10 poses 
belong to the same cluster, then we have a higher confidence that the virtual docking 
screen is accurate and will mimic the reality. The more clusters we have, the less our 
confidence in the docking result. The ligands showed the lowest average clusters per 
docking in case of 1OSG, indicating a more reliable prediction of the correct docking 
position.  
 
The related structures included 3 Blys structures (1OQD, 1OQE, and 1KXG) and 2 
April structures (1XU1 and 1XU2). The ligands showed a more negative average 
energy with the Blys structures when compared with April. With the exception of 
1KXG which is the Blys Apo structure, the ligands had a high percentage of correct 
poses (poses that mimic the original ligand binding mode) when docked on these 
Blys structures (66% and 83%). The percentage of correct poses with the April 
structures is low (22% and 31%). The low percentage of correct pose on the Blys apo 
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structure (34%) is expected as the pocket undergoes structural changes upon binding. 
This makes it hard to mimic the BaffR binding pose with the Apo structure. 
 
We conclude that the created ligand library has a better binding affinity to Blys 
structures and very successful at mimicking the Blys/BaffR interaction. Some of these 
ligands do bind tightly to April, and this is not surprising as April and Blys bind 
common ligands. However the ligands in the created library show a preference to 
bind to 1OSG and analyses of the docking experiments show a high confidence in 
the docking results with 1OSG. Synthesis of the molecules has been designed by 





6 Screening for Inhibitors of Protein - Peptide 
Interaction 
6.1 Introduction 
Protein-protein interactions are important targets for the development of therapeutics 
[252-257]. Often, protein-protein interaction is determined by a short contiguous 
stretch of aminoacids that acts as the recognition and binding signal. For example, 
MDM2/p53 [258, 259], PCNA/p21 [260-262] and eIF-4E/eIF-BP1 [263] form such 
complexes. There is a growing interest in such linear peptide motifs [264], as 
highlighted by resources like the Eukaryotik Linear Motif Server (ELM) [265]. 
Small-molecule inhibitors [252, 253, 255, 256, 266-268] targeted at protein-protein 
interactions have been described [258, 269-278]. These include nutlin (inhibits 
MDM2 and p53 interaction [258, 259]), compounds which inhibit members of the 
apoptosis regulating Bcl-2 family of proteins [270, 274, 275, 277], and mimics 
blocking the interaction of Smac (second mitochondria-derived activator of caspases) 
and X chromosome-encoded inhibitor-of-apoptosis protein (XIAP) [269].  
 
The growing awareness of the biological and medical importance of protein-peptide 
interactions as around 40% of signal transduction events are dependent on such 
interactions [264, 279]. This has led to research and analysis of peptide structural 
motifs [280] and the development of searchable databases like PepX [99]. ProPep 
[103] is an inhouse repository for X-ray structural data, used to study trends, motifs, 
residue pairing frequencies, and amino acid enrichment propensities in protein-
peptide interaction. This chapter discusses updating and automating the ProPep 
database to the November 2008 version of the PDB. As an example of how the 
database can be used, a study of the interactions made by the LxxL 
motif is presented. The incorporation of virtual screening 
[98] and AutoDock 
possible peptidomimetic small molecules for a subclass of this LxxL 
6.2 The ProPep Database
Figure  6-1: The ProPep dataset consists of 12 tables. PDB holds all information 
about the PDB structures in the database and what chains of these structures are used 
for the protein and peptide sides of the interface. ProResidue and PepResidue hold 
information about the residues of the protein and peptide chains. ProAtom, PepAtom, 
and HOHAtom hold information about the atoms of the protein and peptide chains 
and the water molecules in the dataset as well. PepProVDW and PepProHB hold 
information about the VDW and hydrog
in the interface. PepHOHVDW and PepHOHHB hold information about the VDW 
and hydrogen bonds between the peptide atoms and water molecules. Finally, 
ProHOHVDW and ProHOHHB hold information about the VDW and hydrogen
bonds between the protein atoms and water molecules. 
programs like UFSRAT 
[71] into this process leads to the development of a list of 
 




α helical binding 





The ProPep database [103] is designed to study the binding of short contiguous 
peptides to proteins (Figure  6-1). This type of binding is a good target for inhibiting 
protein-protein interaction. This repository conatins a representative dataset of all 
protein-peptide interactions in the PDB [17]. The February 2007 version of the PDB 
is represented by a dataset of 274 Protein-peptide complexes. This dataset represents 
all 3.0 Å resolution (or better) X-ray structures of complexes made up of 2 to 6 
chains (excluding nucleic acid chains), of which one is between 3 and 50 residues in 
length (the peptide) and one between 50 and 600 residues (the protein). All the 
structures in the dataset share less than 90% sequence identity between each other. 
Measures are taken to ensure the protein and the peptide are interacting and that 
membrane proteins are excluded [103]. This database lists and studies all VDW and 
hydrogen bond interactions between the protein and the peptide, the protein and 
water molecules, and the peptide and water molecules. 
 
6.3 Updating the ProPep database 
A newer version of the ProPep database has been created to represent all the 
structures existent in the PDB as of November 2008 (54077 PDB structures). The 
new database, ProPep08, comprised 481 protein-peptide interaction complexes. This 
database is stored on ‘ocycfs’ and can be accessed via: 
mysql -h ocycfs -u <username> -p<password> ProPep08 
 
Compiling the ProPep database is divided into 2 stages. First, all structures are 
checked for eligibility and sequence identity to create the smallest possible 
representative dataset of all protein-peptide interactions in the PDB. Then, these 
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chosen structures are processed and analyzed and the data is all recorded in the 
ProPep database. This is a very lengthy process and is performed by a group of 
scripts that have been designed specifically for this purpose [103]. These scripts are 
located on the scibs file system in the directory:  
‘/usr/people/wissam/Simon/perlScripts/wissam’. 
An automation script (Appendix Programming Code  12-1) is created (scripts.c). This 
script facilitates the creation of the entire dataset without human intervention. A 
readme file is present in this directory, indicating how to compile hbplus [281], 
naccess [282], and torsion [283]. A programming bug in newrestoatom.pl was found 
and fixed. The program is now capable of dealing with with protein atoms numbered 
"0000". Moreover, a similar script (additionalUpdates.c) is created to update the 
VDW, Node, HB, Prob (problems), and Contact columns in the database (Appendix 
Programming Code  12-2). The calculation of the data needed to produce the analysis 
graphs introduced by [103] is also automated (Appendix Programming Code  12-3). 
6.4 Changes to the database upon the update 
6.4.1 Database Size 
The number of complexes constituting the database increased from 274 to 481 (76% 
increase). This resulted in a similar increase in the size of the 12 tables constituting 
the database (Table  6-1). All tables increased consistently (around 72% increase), 
except for ProHOHHB and PepHOHHB which record the hydrogen bond interaction 
between protein atoms and water, and peptide atoms and water respectively. 
ProHOHHB and PepHOHHB are small tables (Table  6-1) which may account for the 
inconsistent change in their sizes. 
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Table  6-1: The ProPep database tables and their functions. 
Table Name Data Summary Number of entries 
PDB Complexes constituting the database 481 
ProResidue All protein residues in the database 12225 
ProAtom All protein atoms in the database 102334 
PepResidue All peptide residues in the database 6015 
PepAtom All peptide atoms in the database 48232 
HOHAtom All water molecules in the database 7340 
PepProVDW Protein-peptide VDW interactions 323838 
PepProHB Protein – Peptide hydrogen bond interactions 4000 
ProHOHVDW Protein – Water VDW interactions 11164 
ProHOHHB Protein – Water HB interactions 1770 
PepHOHVDW Peptide – Water VDW interactions 18050 
PepHOHHB Peptide – Water HB interactions 4616 
 
 
Figure  6-2: The increase in size of the database tables upon updating the ProPep 
database to the November 2008 version of the PDB. 
 
 
The increase in size of the Propep database tables after being updated
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6.4.2 Relative Abundance of Amino acids and Residue Pairing Preference 
ℎ = % !"!#!  !" − % !"!#!  $%##! 
Equation  6-1: Calculation of the enrichment of amino acid composition in protein – 
peptide interaction sites. Three enrichment values are calculated for each of the 20 
amino acid types: the first for enrichment on the peptide side of the interface, the 
second for enrichment on the protein side of the interface, and the third for the entire 
protein – peptide interface. 
 
The ProPep database allows the study of the relative abundance of amino acids at the 
protein-peptide interface. Each amino acid has an expected frequency of occurrence 
according to the Swissprot database. The observed frequency of occurrence for each 
amino acid on the peptide and protein side of the interface is compared with its 
expected frequency, yielding an enrichment value (Equation  6-1). A positive 
enrichment value indicates an increased expression of a certain amino acid. The 
relative abundance frequencies for the 20 amino acids in the earlier and updated 
version of ProPep are shown (Figure  6-3). Pro and Leu occur more frequently on the 
peptide side of the interface and less frequently on the protein side while the 
aromatic residues His, Phe, Trp, and Tyr occur more frequently in ProPep than in 
Swissprot [103]. Only subtle differences exist between the enrichment values of 
amino acids in the February 2007 and the November 2008 versions of ProPep. The 
absolute value of the change of enrichment per aminoacid on the peptide side of the 
interface (between the 2007 and 2008 versions of ProPep) has an average of 0.41% 
and a standard deviation of 0.20% with a maximum change observed for Asn at 
0.76%. As for the protein side of the interface, the change in enrichment has an 
average of 0.23% and a standard deviation of 0.16%, with a maximum change 
observed for Leu at 0.71%. For the interface as a whole, the change in enrichment 
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has an average of 0.22% with a standard deviation of 0.11%, and a maximum value 
observed for Gly at 0.37% (). The absence of major differences between the two 
versions of ProPep (Table  6-2) validates the conclusions drawn from the relative 
abundance of amino acids. 
Table  6-2: The change of amino acid enrichment between the Nov 2008 and Feb 
2007 versions of ProPep. A positive value shows an increase in 2008. Enrichments 
are calculated as percentage differences between the composition of protein-peptide 









































































































Figure  6-3: Calculation of the enrichment of the occurrence of Amino Acids 
(Equation  6-1) at different sides of the protein peptide interface according to the 
February 2007 (A) and November 2008 
Preference for Leu and Pro to overexpress on the peptide side of the interface as well 
as a general over-occurrence of the aromatic residues 
 
 
(B) versions of ProPep. Results show a 





Figure  6-4: Residue Pairing Preference Diagrams in the February 2007 (A) and the 
November 2008 (B) versions of ProPep. Both graphs show high pairing preference 
between Trp and His, Glu and Arg, Pro and Tyr, Pro and Trp, and Cys and Cys 
residues. 
 
(, ') =  
!()(*

Equation  6-2: The calculation of the residue pairing frequencies of 2 amino acids i 
and j, where NumPairs (i, j) is the number of observed pairs (i,
NumAA(i) is the number of occurrences of amino acid i in the dataset. A pair is 
defined as 2 aminoacids on opposite sides of the protein
contact with each other.
 
The ProPep database defines the Residue
a normalized probability score of a particular pair of residues interacting across
protein-peptide interface 
RPP values for salt b
!()(* ! + ") (, '
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 j) in the dataset, and 
-peptide interface that are in 
 
 Pairing Preference (RPP, 
[103]. The study of residue pairing in Pro
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Equation  6-2) as 
 the 
-Pep showed high 
 (3.95, 4.02, 4.56 
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and 5.31 respectively). These interactions have been documented in the literature 
[284-286]. Pro pairs frequently with Tyr (4.28) and Trp (5.51), possibly due to Pro’s 
tendency to interact with aromatic residues in many different modes [282, 286]. 
Updating the ProPep database produced no significant changes in the RPP of the 20 
amino acids (Figure  6-4). 
6.4.3 The participation of protein atoms in protein – peptide interaction 
The ProPep database defines every protein atom as a Node, based on the position it 
occupies, and not the atom type (Figure  6-5). The main chain nitrogen, carbonyl, and 
oxygen atoms occupy positions M2, M1, and M3 respectively, while the side chain 
atom positions are named according to their PDB atom order (α, β, gamma, delta, 
epsilon, zeta, and eta). The reduction of accessible surface area (RASA, Equation 
 6-3) of an atom is defined as the difference between the accessible surface area of a 
certain atom before and after binding of the protein to the peptide [103]. The 
pictogram (Figure  6-5 and Figure  6-6) illustrates the RASA of every possible protein 
node on a green to red scale. A higher RASA value indicates a more involved role in 
interaction. It is therefore not surprising that the further the atom is from the 
mainchain, the more involved it is in protein peptide interaction, with the exception 
of the main chain oxygen atom which plays an important role in hydrogen bond 
interactions across the protein-peptide interface [103]. Updating the ProPep database 
did not change the output of this pictogram significantly (Figure  6-5 and Figure  6-6). 
$() = $ () (! (+ − $ () ) (+ 
 
where ASA (i) is the accessible surface area of a amino acid i 
and RASA (i) is the reduction in accessible surface area of amino acid i 
Equation  6-3: Calculation of the reduction in accessible surface area of amino acids 
 
Figure  6-5: The Amino acid Pictogram is used to show the Reduction of Accessible 
Surface Area (RASA) on 
of the interface in the entries of the February 2007 version of the ProPep. In general, 
the RASA increases the further the atom is from the mainchain. The main chain 
oxygen displays a high RASA bec
across the protein – peptide interface.
 
Figure  6-6: The Amino acid Pictogram is used to show the Reduction of Accessible 
Surface Area (RASA) on different ami
of the interface in the entries of the November 2008 version of the ProPep. In 
general, the RASA increases the further the atom is from the mainchain. The main 
chain oxygen displays a high RASA because of its r
across the protein – peptide interface.
different amino acid nodes on the Protein and Peptide side 
ause of its role in hydrogen bond interactions 
 
no acid nodes on the Protein and Peptide side 






6.5  The LxxL Interaction Motif
Molecular function relies
sequence and/or structural elements that are vital to the fold and functi
[287-289]. The importance of these short segments is evident in the fact that 
homologous proteins and proteins with similar folds can perform distinct 
biochemical functions 
function with the same set of residues and a similar mechanism 
segments, or motifs, are widely used as markers for protein function and are 
targets for inhibiting a certain class of molecular interaction. 
 
Figure  6-7: Motifs in protein interaction: (A) shows a model of the Ribbon
Helix dimer interacting with a DNA molecule, Figure taken from Schreiter et al, 
(2007) [292]. (B) shows the structures of the 
oxidases [W/Y]xxYPPL, Figure taken from Marsico et al, (2010) 
 
 
Many motif mining programs are currently available like Rasmot
MultiBind [295], MegaMotifBase 
SPASM server [298]
 
 on the interaction between short segments of conserved 
[290] while proteins with different folds can perform the same 
 
heme-binding loop in heme
[293]
[289], PAR-3D [296], Superimpose 
. Many examples of motifs are discussed in the literature, like 
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[297], and the 
the ribbon-helix-helix (RHH) mot
to bind to DNA [292]
binding loop in heme
of molecular oxygen to water, a reaction used to produce chemic
transfer protons across the cell membrane and generate an electro chemical proton 
gradient [293] (Figure 
Figure  6-8: The interaction of the LxxL 
dataset. (A) shows a viral protein, paramyxoviral polymerase (pdb 1T6O). (B) shows 
a transferase, Mineralocorticoid Receptor (pdb 2A3I). (C) shows a signalling protein, 
chemotaxis protein cheY (pdb 2FMK). (D) s
farnesoid X receptor (pdb 3BEJ).
 
The LxxL α-helical is another motif and has many documented roles in various 
biological pathways (
include a steroid-binding role in the large
binding related proteins 
if that is a conserved three dimensional motif used 
 (Figure  6-7 A). Another example is the [W/Y]xxYPPL heme
-copper oxidases responsible for the catalysis of the reduction 
al energy needed to 
 6-7 B).  
α helical motif with various structures in the 
hows a transcription protein, the 
 
Figure  6-8). The biological functions played by this motif 
 family of human and yeast oxysterol 





l and growth 
230 
 
arrest activities of the CCAAT/enhancer-binding protein α [300], a coactivator role 
of the androgen receptor [301], and Alix-mediated budding of HIV [302, 303]. 
 
 Being an α-helical motif, the structure of the main chain of this motif is conserved, 
with the only alterations happening at the side chains of the XX amino acids in the 
motif. The role of the XX amino acids in ProPep is discussed later in this chapter 
(Table  6-3 and Table  6-4). This motif is a strong candidate for drug discovery, due to 
its numerous applications and conserved structural attributes. We use the ProPep 
database to search for the occurrence of this motif, its roles, variations, and pave the 
way towards ligand based virtual screening in a search for LxxL-mimic compounds. 
 
The ProPep database is designed to enable fast motif searches. Searching for the 
LxxL α helix motif yielded 42 protein-peptide interfaces (8.7%), distributed on 18 
protein classes (Table  6-3). Four of these classes stand out for binding an LxxL motif 
frequently in ProPep (Figure  6-9). Of these 4 classes, “transcription proteins” is the 
largest, with 17 structures (16 nuclear receptors and 1 nuclear coactivator, 1OJ5) 







Table  6-3: The occurrence of the LxxLx α helical motif in the ProPep dataset. The 
dominance of Leu in the last residue (number 5) is obvious at 60%. 














































COMPLEX (ONCOGENE ProTEIN/PEPTIDE) 






















































































Table  6-4: The occurrence of the LxxLx α helical motif in the ProPep database. The 
sequences are aligned to show the LxxL motif highlighted in Yellow. The LxxLL 
motifs (25 out of 42 structures) are further highlighted with green. Ten nuclear 
receptor structures discussed later in this chapter are highlighted in bold font. Their 
extended motif shared by these receptors (HKILHRLLQ) is highlighted further in 
grey. 























































































Figure  6-9: The distribution of the LxxL 
according to protein classification.
 
Figure  6-10: The distribution of amino acids at the second, third, and fifth positions 
of the LxxLx motif shows a high preference for His at position 2, Arg at positio
and Leu at position 5.
 
 










We study the distribution of amino acids in positions 2, 3 (the XX between the two 
Leus), and 5 (the amino acid after the second Leu) of all the 42 structures in ProPep 
(Table  6-4). Position 2 is occupied mostly by the polar amino acids Asp, Glu, His, 
Lys, Met, Gln, Arg, Ser, Thr, Trp, and Tyr. Only seven structures (17%) included 
one of the hydrophobic amino acids Ala, Leu, and Val at position 2. A similar 
distribution of amino acids is found at position 3 with only six structures (14%) 
exhibiting a hydrophobic amino acid. Position 5 exhibits a different distribution, with 
Leu being a dominant occupier of the fifth slot in 25 structures (60%). Two 
structures exhibit an Ala residue in the fifth position while the remaining 15 
structures include a polar amino acid side chain. Looking closely at positions 2 and 3 
(Figure  6-10), the preferred amino acids are His and Arg (26% and 33% 
respectively). Consequently, the highest occurring LxxL fragment is LHRL (10 
occurrences). 
6.6 Screening for LHRLL mimics with UFSRAT and Autodock 
The LxxLL motif occupies 60% (25/42) of the LxxLx occurrences in ProPep. This 
motif plays a role as an activator of nuclear receptor functions. It binds and activates 
the Hepatocyte nuclear factor 4 which regulates the development and physiology of 
vital organs like the liver, pancreas, and kidney [304]. Mediatory-1 LxxLL motifs 
play important roles in Estrogen Receptor α-mediated functions in early mammary 
gland development [305, 306] and the inhibition of this interaction perturbs the 
localization of the Estrogen Receptor α. Involved in PPARγ and vitamin D receptor 
interaction [307-310] and mimetics of the LxxLL motif inhibit the interaction of 
vitamin D receptor with coactivators [311]. As shown in Table  6-4, 10 out of the 25 
LxxLL motifs in ProPep are LHRLL (24% of the LxxL motif structures and 2% of 
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the ProPep database). This section studies these occurrences and documents the 
virtual screening approach used to find mimetics of the LHRLL motifs. 
 
Table  6-5: The entries in Propep which contain the extended HKILHRLLQ α helical 
peptide motif. All ten entries are crystal structures of nuclear receptors. The extended 
motif is marked in green, and the LHRLL motif is marked in yellow.  
PDB 
ID 
Function Peptide Sequence 
1NQ7 





Pregnane X Receptor (PXR): 
detection of foreign compounds and 
regulation of the expression of genes 





Gene regulation of nutrient transport 
and metabolism functions 
CPSSHSSLTERHKILHRLLQEGSPS 
1UHL 
Liver X Receptor: regulation of 
















Peroxisome proliferator activated 
receptor α: lipid homeostasis 
---------ARHKILHRLLQE---- 
2QZO 




Farnesoid X Receptor: regulation of 
bile acid and cholesterol homeostasis 
CPSSHSSLTERHKILHRLLQEGSPS 
 
The LHRLL motif occurs ten times in the ProPep database. Seven out of these ten 
occurrences are classified as Transcription proteins. All ten structures are nuclear 
receptors (Table  6-5). A closer look at those 10 structures reveals that they all 
include the 9-amino acid motif HKILHRLLQ (Table  6-4 and Table  6-5), 
significantly larger than the LHRLL motif. This motif was extracted from all ten 
structures and superposed, giving a maximum 
 6-11). It is hence a structurally conserved motif that binds to nuclear receptors. 
Figure  6-11: The superposition of the 
receptors in ProPep (
full motif in sticks, (B) and (C) show the full motif in 
in sticks, and D shows the superposition of the LHRLL segments of this motif. First 
analysis shows that the 
the Arg and the His side chain
 
We conduct a virtual screening experiment to 
database that would structurally mimic the behavior of the LHRLL motif. The 
LHRLL fragment of the PDB structure 1NQ7 is used as a template. The 
of the His and Arg amino acids are stripped away since they are the least structurally 
consistent among the superposed 10 nuclear receptor ligands. We use UFSRAT 
to perform a ligand-
backbone RMSD of 0.3 Å (
HKILHRLLQ motif across 
Table  6-5) shows a maximum RMSD of 0.3 Å. (A) shows the 
cartoons and the LHRLL parts 
Leus in the LHRLL segment are structurally conserved while 
s undergo slight conformational changes.
search for molecules in the 













ligands that would best mimic the structure of the LHRLL motif. The MISCC 
(Maybridge, InterBioScreen, Specs, Chemdiv, and Chembridge) multiconformer 
subset of EDULISS is used as a compound repository. This set of oprea filtered [92] 
compounds contains 3,803,396 multi conformer compounds (conformers generated 
based on flexibility and number of rotatable bonds in a compound, on average, 4 
structures per compound). The top 50 UFSRAT hits are then docked into the pockets 
of the 10 nuclear receptor structures and the results are analyzed. 
Table  6-6: The top 50 generated compounds by UFSRAT as mimetics to the LHRLL 
















































































































The top 50 UFSRAT hits were docked into the LHRLL binding domains of the ten 
nuclear receptor structures in the ProPep database using an adapted version of the 
docking program AutoDock [71]. This version has been adapted to handle high-
throughput virtual screening experiments, by docking a group of molecules to the 
same receptor using parallel computing (adaptation done by Dr Douglas Houston). 
This version of AutoDock then analyzes the docking results for all the screened 
compounds and ranks these candidates by the predicted binding energy to the target. 
The performance of these compounds against the ten nuclear receptors was analyzed 
(Table  6-7 and Table  6-8). The best results were observed with the structures 1NRL 
(Pregnane X Receptor), 2HC4 (Vitamin D Receptor), 3BEJ (Farnesoid X Receptor), 
2P54 (Peroxisome Receptor α), and 1UHL (Liver X Receptor). That being said, the 
performance of these 50 compounds against the other nuclear receptors is also good; 
producing estimated affinities in the low micromolar region (Table  6-7 and Table 
 6-8). 
Table  6-7: The estimated binding affinity (by AutoDock) of the top 50 LHRLL 
peptidomimetic compounds (generated by UFSRAT) against the ten LHRLL binding 
nuclear receptors in ProPep. All sub-µM affinities are marked in bold font (Part 1/2). 






































































































































































































































































































































Table  6-8: The estimated binding affinity (by AutoDock) of the top 50 LHRLL 
peptidomimetic compounds (generated by UFSRAT) against the ten LHRLL binding 
nuclear receptors in ProPep. All sub-µM affinities are marked in bold font (Part 2/2). 



























































































































































































































































































Figure  6-12: The five top scoring compounds mimicking the interaction between the 
LHRLL α helical motif and the ten nuclear receptor structures in the ProPep 
database. Compounds are scored based on the average affinity of interaction with the 
ten nuclear receptors.
 
Table  6-9: The binding energie













































s of the best 5 LHRLL peptidomimetic compounds 
 
 1NRL 1PZL 1UHL
µM 1.22 µM 8.70 µM 2.89 µM
µM 772.69 pM 1.65 mM 74.17 nM
µM 950.51 pM 415.60 µM 124.88 nM
µM 24.27 µM 32.44 µM 23.77 µM






















 1.85 µM 
 62.99 µM 
 45.68 µM 
 13.87 µM 
 6.19 µM 
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Table  6-10: The binding energies of the best 5 LHRLL peptidomimetic compounds 
(Figure  6-12) against the ten nuclear receptors (Part 2/2). 
Compound 2HC4 2P1T 2P54 2QZO 3BEJ 
A 987.94 nM 1.14 µM 1.51 µM 1.60 µM 1.14 µM 
B 15.24 nM 61.07 µM 37.40 µM 3.74 µM 8.48 µM 
C 19.18 nM 112.16 µM 50.05 µM 8.03 µM 8.27 µM 
D 2.06 µM 7.91 µM 1.07 µM 7.58 µM 3.23 µM 
E 13.41 µM 9.6 µM 4.1 µM 17.72 µM 5.61 µM 
  
Out of the 50 generated compounds, 5 stand out, having the highest average binding 
affinity to the LHRLL binding sites of the ten nuclear receptors in the ProPep 
database (Figure  6-12, Table  6-9, and Table  6-10). These compounds are referred to 
as compounds A through E, as per Figure  6-12. The predicted binding affinities of 
these compounds towards each of the nuclear receptors ranged between 773 
picoMolar and 416 microMolar. However, most of the predicted affinities lie in the 
high nanoMolar to low microMolar region. The binding of compound B to the 
Pregnane X Receptor (1NRL) at a predicted affinity of 773 pM is solidified by a 
network of 4 hydrogen bonds in addition to the hydrophobic stacking between the 
molecule and the protein (Figure  6-13). Similar interaction profiles are noticed for 
the other UFSRAT hits as well (Figure  6-14). 
 
Figure  6-13: The binding of compound B (cyan) to the 
at a predicted affinity of 772.69 pM. The LHRLL motif is shown in yellow, making 
2 hydrogen bonds (yellow) with 1NRL. The benzene rings of compou
area occupied by the 
interaction is solidified by 4 hydrogen bonds (in cyan).
Figure  6-14: The interaction with top scoring UFSRAT hits (cyan sticks) with 
nuclear receptors (cartoons). The original LHRLL motifs are shown for comparison 
(yellow sticks). (A) shows the binding of compound C to the 
(pdb 1NRL) at a predicted aff
to the vitamin D receptor (pdb 2HC4) at a predicted affinity of 15 nM, and (C) shows 
the binding of compound C to the vitamin D receptor (pdb 2HC4) at a predicted 
affinity of 19 nM. The benzene rings of 
by the Leu side chain
solidified with hydrogen bonds.
Pregnane X Receptor (1NRL) 
Leu side chains of the LHRLL motif (red circles) and its 
 
pregnane X receptor 
inity of 950 pM, (B) shows the binding of compound B 
the UFSRAT hits fill in the areas occupied 





nd B fill in the 
 
Figure  6-15: The binding sites of the 
1NRL is shown) are mainly hydrophobic pockets. This justifies the favouring of 
benzene rings and their halogenated and methylated derivatives (A). The existence of 
a few polar atoms resulted in the substituti
oxygens to facilitate hydrogen bonding (B).
 
Figure  6-16: The AutoDock simulations showed that benzene rings are good 
substitutions for the hydrophobic 
overlap of the docked compounds B and C (
Structures shown are docked to the Pre
 
The ligand binding sites of the nuclear receptors are mainly hydrophobic pockets. A 
few polar atoms exist but that is not enough to change the hydrophobicity of the 
binding sites (Figure 
Leu side chains in the pockets. Indeed, the UFSRAT/AutoDock screening for 
nuclear receptors (the pregnane X receptor, pdb 
on of some ring carbons with nitrogens or 
 
Leu side chains. Figures (A) and (B) show the 
Figure  6-12) with the LHRLL motif. 
gnane X Receptor, pdb 1NRL.








LHRLL mimetics generated compounds with mainly hydrophobic substructures. The 
hydrophobic Leu side chains are often substituted with ring substructures: 44 out of 
the 50 docked molecules to 1NRL resulted in a benzene ring or one of its derivatives 
(eg naphthyl) occupying the place of the Leu side chain (Figure  6-16). Benzene rings 
and their derivatives have been selected as good mimetics for the Leu side chains via 
the UFSRAT shape and atom type matching algorithm. AutoDock simulations 
backed up this selection by revealing strong interactions between these ring 
substructures and the proteins. In some cases, the carbons on these ring substructures 
are substituted by nitrogens, oxygens, carbonyl, or halogenated carbons. These 
substitutions allowed for the creation of hydrogen bonds between the compounds and 
the protein, enhancing the binding energy.  
 
Although the predictions produced in this chapter are virtual results and have to be 
validated with wet-lab experiments, the results of this experiment are still important. 
UFSRAT [98] and Autodock [71] are well established programs known for their 
success in virtual screening. Careful examination of the results showed that the 
interaction between the generated hits and the nuclear receptors is solid (Figure 
 6-13). The selected hits react similarly with the nuclear receptors and this is assuring 
as all ten structures bind the same LHRLL motif. The actual binding affinities will 
not be as high as predicted by the virtual programs (AutoDock predicted picoMolar 
affinity for the interaction between compound B the Pregnane X Receptor), but we 
are still confident of a strong binding between the two molecules. By using all these 
carefully crafted programs and combining them in a synergetic and self validating 
method, we have managed to reduce a space of testable compounds from millions to 
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tens, or even hundreds. With the parallelization of most of our systems, the time 
spent on running the virtual screening experiments is less than two weeks. In just that 
time, computational drug discovery is capable of providing insights on inhibiting the 






This work contributes to protein based, ligand based, and database based drug 
discovery. The STP method (Chapter  2) plays an important role in detecting protein 
binding sites. This functionality serves an important role in minimizing the search 
space for docking algorithms by creating pseudo ligands used as markers for the 
locations of binding sites. Chapter  3 demonstrates the power of this method in 
predicting allosteric binding sites, enzyme commission classes, and ranking docking 
orientations. Chapter  4 discusses the chemical and topological characteristics of 
binding sites and compares the binding sites that bind ligands, peptides, and protein 
domains. This study shows the importance of polar interactions in protein-ligand 
binding only while hydrophobic interactions play important roles in all types of 
interaction. The statistical binding preference between STP triplets and ligand atom 
types has also been studied, quantified, and converted to statistical free energy of 
binding between ligand atoms and surface triplets. 
 
Chapter  5 discusses a different aspect of computational drug discovery, and focuses 
on ligand-based drug discovery. It outlines the use of a ligand (Baff-R) with 
computational algorithms to design a virtual library of molecules that are likely to 
mimic the interactions of this Baff-R ligand. It also outlines the use of docking and 
structural similarity algorithms (Autodock and UFSRAT) to study protein interaction 
and hence refine the molecules included in the virtual library. Finally, Chapter  6 
discusses the use of interaction databases to detect interaction motifs and then the 
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virtual screening for molecules that are likely to mimic the interactions performed by 
this motif. Consequently the ProPep database has been used to identify the LHRLL 
alpha helical motif that binds to nuclear receptors. Docking and structural similarity 
methods (Autodock and UFSRAT) are then used to create a virtual library of 
possible inhibitors for the interaction of the LHRLL motif with nuclear receptors. 
Virtual experiments show that the molecules bind consistently to all the ten 
receptors. 
7.2 Future Work 
The results and methods introduced in this work pave the way towards further 
advancements including: 
• Creating an STP profile for allosteric binding sites 
• Creating an STP profile for metal binding sites 
• Using the STP coloring routine on snapshots of molecular dynamics 
simulations to show the formation and concealing of binding hotspots 
• Creating STP profiles with varied probe molecule size (this work used 1.4 Å). 
This should allow for assessment of the protein surface at different 
resolutions. Using smaller probes would account for atoms located at the 
bottom of pockets (such atoms are likely to be missed by larger probes). 
Using larger probes would define the protein surface from the point of view 
of non water molecules (e.g. carbon). 
• Using the statistical free energy of interaction between ligand atoms and 
surface triplets to score and rank small molecule docking results  
• Using the statistical free energy of interaction between ligand atoms and 
surface triplets to create maps showing the best choices of atom types at 
certain locations around the protein. These maps can then be used manually 




• Using the triplet composition of a binding site to identify its function 
(expansion on the EC number prediction to cover a wide range of functions) 
• In-vitro testing and optimization of the high scoring compounds genertated 
by the virtual screening simulations for CRK3 (Chapter  3) 
• In-vitro testing and optimization of the high scoring cyclic peptides 
genertated by the virtual screening simulations for BLYS (Chapter 5) 
• In-vitro testing and optimization of the high scoring compounds genertated 
by the virtual screening simulations for the Nuclear receptors (Chapter  6). 
7.3 The Age of Multiplicity 
Despite the current advances, our understanding of molecular interaction is still 
limited. Different models try to simulate real interactions in various methods and 
sometimes reach contradicting results. The increasing power of computing is still 
insufficient to perform detailed calculations quickly (molecular dynamics 
simulations require days and sometimes weeks to finish the simulation). As a result, 
all computer simulations are mere approximations of reality and rely on heuristics 
extensively to perform their predictions. Nevertheless, the input provided by these 
simulations is very influential. Using the results of many simulations by multiple 
programs and trying to reach a consensus is currently the best approach to generate 
reliable results. Rentzsch and Orengo (2009) [53] define this as the age of 
multiplicity, where the use of multiple tools and multiple starting points to study a 
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9 Appendix A: Interface propensity scores for triplets 
and atomic groups based on the different Score 
Tables 
This appendix presents the calculation results for the different atomic and triangular 
groups based on each of the Protein-Protein (Table  9-2 and Table  9-5), Protein-
Peptide (Table  9-3 and Table  9-6), and Protein-Ligand (Table  9-4 and Table  9-7) 
score tables. 





























Table  9-2: The propensities and statistics for different atomic triplets in Protein-
Protein Binding Sites. ZERO indicates and division by zero result which is not 
calculatable. In such a case, the triplet is given a score of 0. This work is part of my 
Masters Degree research. We also present the free energy calculations from these 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table  9-3: The propensities and statistics for different atomic triplets in Protein-
Peptide Binding Sites. ZERO indicates and division by zero result which is not 
calculatable. In such a case, the triplet is given a score of 0. We also present the free 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table  9-4: The propensities and statistics for different atomic triplets in Protein-
Ligand Binding Sites. ZERO indicates and division by zero result. In such a case, the 
triplet is given a score of 0. We also present the free energy calculations from these 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table  9-5: The propensities and statistics for different atomic groups in Protein-
Protein Binding Sites. ZERO indicates and division by zero. In such a case, the 















































































































Table  9-6: The propensities and statistics for different atomic groups in Protein-
Peptide Binding Sites. ZERO indicates and division by zero. In such a case, the 










































































































Table  9-7: The propensities and statistics for different atomic groups in Protein-
Ligand Binding Sites. ZERO indicates and division by zero result which is not 












































































































10 Appendix B: The C5/C7 complex docking with Hex 
and STP 
Table  10-1: Docking Experiment 1/3: Hex docking orientations and STP Scores - 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table  10-2: Docking Experiment 2/3: Hex docking orientations and STP Scores - 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table  10-3: Docking Experiment 3/3: Hex docking orientations and STP Scores - 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































11 Appendix C: HyHEL-10 Fab-Lysozyme docking 
with Hex and STP 
 
This appendix presents the results of ranking Hex docking orientations for the 
structure 3HFM. Table  11-1 shows the hex dockings sorted by STP scores. 200 Hex 
solutions are named from dock0001 to dock0200 (0001 being the one most preferred 
by Hex. 
Table  11-1: Hex docking orientations and STP scores - HyHEL-10 Fab-Lysozyme 









































































































































































































































































































































































































































































































































































































































12 Appendix D: Programming Code of all the scripts 
Used in Chapter  6 
 
Programming Code  12-1: The script that automates the creation of the ProPep 




int main(int argc, char **argv) 
{ 
 system("./PDBextract_v3.pl"); 
 system("./which_chains_scibs.pl PDBextract_v3_chlist.log"); 
 system("wget ftp://ftp.wwpdb.org/pub/pdb/derived_data/NR/clusters90.txt"); 
 system("./clusterv2.pl clusters90.txt complex_nice3.log"); 
 system("./bestres.pl clusters90_outBIG.log"); 
 system("./interaction_extract.pl clusters90_outBIG_BEST.log"); 
 system("rm *.pdb *.hb2"); 
 system("./perl2sqlSDH.pl updatedList.log"); 
 system("cp *.log logs/"); 
 system("cp *.txt logs/"); 
 system("./torsion_out22.pl updatedList.log"); 
 system("./pdb_edit.pl updatedList.log"); 
 system("mv *.asa InteractionOutput/"); 
 system("mv *.rsa InteractionOutput/"); 
 system("cp logs/updatedList.log ."); 
 system("./runasa.pl updatedList.log"); 
 system("./runasa_atom.pl updatedList.log"); 
 system("./sql_update_amino acids.pl"); 
 system("wget ftp://ftp.wwpdb.org/pub/pdb/derived_data/NR/clusters50.txt"); 
 system("wget ftp://ftp.wwpdb.org/pub/pdb/derived_data/NR/clusters70.txt"); 
 system("./family_update.pl clusters50.txt Fam50"); 
 system("./family_update.pl clusters70.txt Fam70"); 
 system("./family_update.pl clusters90.txt Fam90"); 
 system("./update_BSA.pl");  
} 
 











 system("echo \"UPdaTE PDB set Prob = 'OK' where Prob IS NULL\" | mysql -h  




 system("echo \"Create temporary table TEMP select PDBID, PepAtom,   
  count(PDBID) as No from PepProVDW where Distance <3.8 Group By  
  PDBID, PepAtom; Update PepAtom as P, TEMP set P.VDW_CN =  
  TEMP.No where P.PDBID = TEMP.PDBID and P.AtomNo =   
  TEMP.PepAtom\" | mysql -h cycfs -u wissam -p<password> ProPep08"); 
 system("echo \"UPdaTE PepAtom set VDW_CN = 0 where VDW_CN is NULL\" | 




 system("echo \"Create temporary table TEMP select PDBID, PepAtom,   
  count(PDBID) as No from PepProHB where Distance <3.8 Group By  
  PDBID, PepAtom; Update PepAtom as P, TEMP set P.HB_CN = TEMP.No 
  where P.PDBID = TEMP.PDBID and P.AtomNo = TEMP.PepAtom\" |  
  mysql -h cycfs -u wissam -p<password> ProPep08");  
 system("echo \"UPdaTE PepAtom set HB_CN = 0 where HB_CN is NULL\" | mysql 




 system("echo \"Create temporary table TEMP select PDBID, ProAtom,   
  count(PDBID) as No from PepProVDW where Distance <3.8 Group By  
  PDBID, ProAtom; Update ProAtom as P, TEMP set P.VDW_CN =  
  TEMP.No where P.PDBID = TEMP.PDBID and P.AtomNo =   
  TEMP.ProAtom\" | mysql -h cycfs -u wissam -p<password> ProPep08");  
 system("echo \"UPdaTE ProAtom set VDW_CN = 0 where VDW_CN is NULL\" | 




 system("echo \"Create temporary table TEMP select PDBID, ProAtom,   
  count(PDBID) as No from PepProHB where Distance <3.8 Group By  
  PDBID, ProAtom; Update ProAtom as P, TEMP set P.HB_CN = TEMP.No 
  where P.PDBID = TEMP.PDBID and P.AtomNo = TEMP.ProAtom\" |  
  mysql -h cycfs -u wissam -p<password> ProPep08"); 
 system("echo \"UPdaTE ProAtom set HB_CN = 0 where HB_CN is NULL\" | mysql 
  -h cycfs -u wissam -p<password> ProPep08"); 
   
 printf("6/8\n"); 
 fflush(NULL); 
 system("./Update_nodes.pl");  





 system("echo \"UPdaTE ProResidue, ProAtom Set ProResidue.Contact ='Y' where  
  ProResidue.PDBID = ProAtom.PDBID AND ProResidue.ResidueNo =  
  ProAtom.ResidueNo AND ProAtom.VDW_CN>0\" | mysql -h cycfs -u  
  wissam -p<password> ProPep08"); 
 system("echo \"UPdaTE ProResidue Set Contact ='N' where Contact IS NULL\" | 
  mysql -h cycfs -u wissam -p<password> ProPep08"); 
   
 printf("8/8\n"); 
 fflush(NULL); 
 system("echo \"UPdaTE PepResidue, PepAtom Set PepResidue.Contact ='Y' where  
  PepResidue.PDBID = PepAtom.PDBID AND PepResidue.ResidueNo =  
  PepAtom.ResidueNo AND PepAtom.VDW_CN>0\" | mysql -h cycfs -u  
  wissam -p<password> ProPep08"); 
 system("echo \"UPdaTE PepResidue Set Contact ='N' where Contact IS NULL\" | 
  mysql -h cycfs -u wissam -p<password> ProPep08"); 
} 
 
Programming Code  12-3: Automation of the creation of the Amino acid Pictogram. 









 system("echo \"SELECT A.Node, count(*) AS Int_Nodes, SUM(A.VDW_CN) AS  
  Total_VDW, AVG(A.VDW_CN) AS Avg_VdW, STD(A.VDW_CN) AS  
  SD_VdW, SUM(A.HB_CN) AS Total_HB, AVG(A.HB_CN) AS Avg_HB,  
  STD(A.HB_CN) AS SD_HB, SUM(A.ASA_Solo-A.ASA_Comp) AS  
  Total_RSA, AVG(A.ASA_Solo-A.ASA_Comp) AS Avg_RSA,   
  STD(A.ASA_Solo-A.ASA_Comp) AS SD_RSA FROM PepAtom A, PDB P 
  WHERE A.VDW_CN > 0 AND A.PDBID = P.PDBID AND P.Prob = 'OK' 
  GROUP BY A.Node\" | mysql -h cycfs -u wissam -p<password> ProPep08 




 system("echo \"SELECT A.Node, count(*) AS Int_Nodes, SUM(A.VDW_CN) AS  
  Total_VDW, AVG(A.VDW_CN) AS Avg_VdW, STD(A.VDW_CN) AS  
  SD_VdW, SUM(A.HB_CN) AS Total_HB, AVG(A.HB_CN) AS Avg_HB,  
  STD(A.HB_CN) AS SD_HB, SUM(A.ASA_Solo-A.ASA_Comp) AS  
  Total_RSA, AVG(A.ASA_Solo-A.ASA_Comp) AS Avg_RSA,   
  STD(A.ASA_Solo-A.ASA_Comp) AS SD_RSA FROM ProAtom A, PDB P 
  WHERE A.VDW_CN > 0 AND A.PDBID = P.PDBID AND P.Prob =  
  'OK' GROUP BY A.Node\" | mysql -h cycfs -u wissam -p<password>  






 system("echo \"SELECT A.Node,count(*) AS Int_Nodes, SUM(A.VDW_CN) AS  
  Total_VDW, AVG(A.VDW_CN) AS Avg_VdW, STD(A.VDW_CN) AS  
  SD_VdW, SUM(A.HB_CN) AS Total_HB, AVG(A.HB_CN) AS Avg_HB,  
  STD(A.HB_CN) AS SD_HB, SUM(A.ASA_Solo-A.ASA_Comp) AS  
  Total_RSA, AVG(A.ASA_Solo-A.ASA_Comp) AS Avg_RSA,   
  STD(A.ASA_Solo-A.ASA_Comp) AS SD_RSA FROM PepAtom A, PDB  
  P, PepResidue R WHERE A.VDW_CN > 0 AND A.PDBID = P.PDBID  
  AND A.ResidueNo = R.ResidueNo AND A.PDBID = R.PDBID AND  
  R.SStruc = '1' AND P.Prob = 'OK' GROUP BY A.Node;\"|mysql -h cycfs -u 




 system("echo \"SELECT A.Node,count(*) AS Int_Nodes, SUM(A.VDW_CN) AS  
  Total_VDW, AVG(A.VDW_CN) AS Avg_VdW, STD(A.VDW_CN) AS  
  SD_VdW, SUM(A.HB_CN) AS Total_HB, AVG(A.HB_CN) AS Avg_HB,  
  STD(A.HB_CN) AS SD_HB, SUM(A.ASA_Solo-A.ASA_Comp) AS  
   Total_RSA, AVG(A.ASA_Solo-A.ASA_Comp) AS Avg_RSA,   
  STD(A.ASA_Solo-A.ASA_Comp) AS SD_RSA FROM PepAtom A, PDB  
  P, PepResidue R WHERE A.VDW_CN > 0 AND A.PDBID = P.PDBID  
  AND A.ResidueNo = R.ResidueNo AND A.PDBID = R.PDBID AND  
  R.SStruc = '3' AND P.Prob = 'OK' GROUP BY A.Node;\"|mysql -h cycfs -u 
  wissam -p<password> ProPep08 > tables/NodeAnalysisβ.txt");    
    
 printf("5/6\n");  
 fflush(NULL); 
 system("echo \"SELECT A.Node,count(*) AS Int_Nodes, SUM(A.VDW_CN) AS  
  Total_VDW, AVG(A.VDW_CN) AS Avg_VdW, STD(A.VDW_CN) AS  
  SD_VdW, SUM(A.HB_CN) AS Total_HB, AVG(A.HB_CN) AS Avg_HB,  
  STD(A.HB_CN) AS SD_HB, SUM(A.ASA_Solo-A.ASA_Comp) AS  
  Total_RSA, AVG(A.ASA_Solo-A.ASA_Comp) AS Avg_RSA,   
  STD(A.ASA_Solo-A.ASA_Comp) AS SD_RSA FROM PepAtom A, PDB  
  P, PepResidue R WHERE A.VDW_CN > 0 AND A.PDBID = P.PDBID  
  AND A.ResidueNo = R.ResidueNo AND A.PDBID = R.PDBID AND  
  R.SStruc = '5' AND P.Prob = 'OK' GROUP BY A.Node;\"|mysql -h cycfs -u 
  wissam -p<password> ProPep08 > tables/NodeAnalysisOther.txt"); 
   
 printf("6/6\n");  
 fflush(NULL); 
 system("echo \"SELECT R.AminoAcid, count(*) FROM PepResidue R, PDB P  
  WHERE R.PDBID = P.PDBID AND P.Prob = 'OK' AND R.Contact = 'Y' 
  AND R.AAType = 'N' GROUP BY R.AminoAcid\"|mysql -h cycfs -u wissam -
  p<password> ProPep08 > tables/AminoAcidComposition.txt"); 
} 
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